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Abstract  
A published meta-analysis on breast cancer and vegetables and fruit consumption was described 
to present a methodology used on meta-analysis in Epidemiology. Meta-analysis confirmed the 
association between intake of vegetables (RR=0.74; 95%CI 0.65-0.84) and, to a lesser extent, 
fruit and breast cancer risk (RR=0.93; 95%CI 0.79-1.09). Using this methodology, present in a 
peer-reviewed journal, a systematic meta-analysis on melanoma was conducted extracting RRs 
from published studies. Fully adjusted estimates were obtained from those studies, when 
available; RRs adjusted for confounders not related to sun exposure, such as naevi, were 
considered for sun exposure and sunburns pooled estimates. Pooled estimates were obtained for 
all main risk factors for melanoma: sun exposure (total, intermittent and chronic), sunburns (in 
childhood and in adulthood), indicators of actinic damage, family history of melanoma and 
phenotype characteristics. Investigation of biases and inconsistencies among studies was one of 
the key phases of the meta-analysis to look for patterns among studies that might explain 
discrepant findings. The analyses on pigmented lesions and sun exposure showed that the choice 
of sources of cases and controls influenced significantly the estimate. An indication of a 
protective effect of chronic sun exposure came from studies that did not include subjects with 
dermatological problems (significantly different from the other studies: p=0.01). Publication year 
was an important factor for total sun exposure (p=0.005). Latitude of the study seemed to be an 
important factor for sunburns (p=0.002) and for high density of freckles (p=0.04). Estimates for 
hair colour and eye colour adjusted for phenotype and/or photo-type were significantly lower 
than unadjusted ones (p=0.06 and p=0.06, respectively). This study highlighted how several 
features of study design, type of analysis, categorization of exposures, study location and 
populations significantly explained between-study heterogeneity. 
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CHAPTER 1. META-ANALYSIS IN EPIDEMIOLOGY 
 
1.1 Introduction 
The New York Times, 7 January 1994, stated "A meta-analysis aims at gleaning more 
information from existing data by pooling the results of smaller studies and applying one or 
more statistical techniques. The benefits or hazards that may not be detected in small studies 
can be found in meta-analysis that uses data from thousands of subjects." Eysenck,1 on the 
contrary, described meta-analysis as an exercise in "mega-silliness" and Feinsten defined 
meta-analysis of non-randomised observational studies “as the attempt of a quadriplegic 
person to climb Mount Everest unaided”.2 
The term “meta-analysis” was formulated for the first time by Glass in 1976 and its 
meaning is related to an analysis of several other analyses with a process that includes a 
search of the results of independent studies as well as a quantifiable combination of effect 
sizes.3 It provides a systematic approach to selecting and integrating findings across studies 
and to control for chance and potential bias. It is a methodology used for contrasting and 
combining results of different studies, where the individual unit of the statistical analysis is 
the study result. Study characteristics are first carefully coded, then mean effect sizes are 
examined according to different study characteristics, in order to look for patterns among 
studies that might explain discrepant findings. This approach allows hypothesis testing 
regarding sources of heterogeneity and quantification of biases. Meta-analysis can also help to 
identify gaps in knowledge found in the published literature and thus can help provide 
guidance for future research.  
Meta-analysis differs from qualitative or narrative review because conclusions from 
publications are not only discussed qualitatively but also involves a quantitative manipulation 
of the available information. Narrative reviews may present several problems because they are 
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influenced by several biases and do not have tools to analyse them. They may be simple 
catalogues, without integration, affected by publication bias; or they may be based upon a 
subset of possible studies, which may lead to reviewer bias in selecting studies to be 
included.4 Without the obligation to clearly state inclusion criteria, it is likely that researchers 
include studies that support their own opinion and ignore those that do not. Cooper and 
Rosenthal5 showed that even with only seven studies, narrative and quantitative reviews led to 
different results. However in a research area with only two or three similar studies, there is no 
need to integrate the data. In these situations, a narrative review of the studies is perhaps the 
more suitable approach.  
A number of definitions and synonyms of meta-analysis exists: quantitative review, 
combined analysis, pooled analysis, literature synthesis and quantitative synthesis. Some of 
them define substantially different methods and the main differences are to be found among 
the meta-analysis of literature (quantitative synthesis of published data), the re-analysis of 
individual primary data (pooled analysis) and finally the prospectively planed pooled analysis, 
where pooling is already part of the protocol and which offers the highest degree of 
comparability between studies. 
Pooled meta-analysis considers primary data obtained from authors of the papers and 
it is characterized by numerous advantages. It allows analyses among exposures and 
confounders, not investigated in the original studies, and it permits variables to be recoded 
across studies to make them more compatible and to make adjustments to deal more 
extensively with heterogeneity. A major impediment to this kind of meta-analysis is the fact 
that it is very time–consuming because it requires several years just to obtain the data and 
demands close cooperation between the authors of the studies.6 Therefore meta-analysis of 
published studies can be considered a sound approach when resources and time are limited 
and when original study data are not available. In public health epidemiology, data from 
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original studies are often accessible only to limited numbers of research groups and few 
opportunities for pooled analysis exist.7;8  
Prospective meta-analyses, in which studies are designed jointly so they may be 
combined later via meta-analysis, are becoming an interesting area of research. However in 
contrast to multicenter clinical trials, more heterogeneity in the individual study centres will 
still exist, arising from differences among populations or study designs. Furthermore the costs 
for this meta-analysis are very high and the planning, which is substantial, may be not easy.9 
The use of meta-analysis for published observational studies is less accepted than in 
the area of clinical trials for their intrinsic biases and differences in study designs. However in 
many situations randomised controlled designs are not feasible, and only data from 
observational studies are available. 
In this Chapter, I introduce the purposes and features of meta-analysis of published 
observational studies and I present the aims of the meta-analyses of epidemiological studies 
on breast cancer and melanoma that I carried out: This will be described in detail in Chapters 
3, 4 and 5.  
 
1.2 Meta-analysis of observational studies 
Although significant progress was made in the systematic approach to clinical studies with 
meta-analytic procedures being widely employed since the early 1970s, the inherent 
challenges of published observational studies have meant that only recently these methods 
have become more and more important in epidemiology. However a continuous increase in 
the number of published meta-analyses, concerning observational studies, was observed 
during the past four decades.10 The need to assess risks that are small, but that may have large 
public interest or have important implications for public health, has amplified their use in 
summarizing the evidence. Because of pressure for appropriate informed decisions in public 
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health and the explosion of information in the scientific literature, research results must be 
synthesized to face urgent problems. Thus, in order to be able to cope with the current 
information explosion, meta-analysis has now become essential. 
Epidemiological studies are traditionally classified as either observational or 
experimental. In practice, primarily the ethical problems in human experimentation usually 
preclude extensive use of the experimental design. Most studies, therefore, are observational 
and the investigator measures association between changes in outcomes of interest. Two 
aspects characterize an observational study: the aim is to study relationships among certain 
elements and controlled experimentation cannot be employed. Since a meta-analysis appears 
to embrace both of these features, it may not be illogical to also think of a meta-analysis as an 
observational study. One of the main problems with meta-analysis, working at the individual 
study level, is that it has limited control over the availability of studies and the information 
collected and reported in the individual studies. Thus researchers are dealing with associations 
rather than causation and should be aware that the hazards in meta-analysis on observational 
studies are much more numerous than in meta-analysis of randomised clinical trials, because 
of their intrinsic biases and differences in study designs.11;12 
Conflicting results among studies may arise when sample sizes of individual studies 
are too small to find stable results. Actually most epidemiological studies are too small to 
detect anything but a comparatively large Relative Risk (RR) associated with a fairly common 
exposure. Thus meta-analyses may become a useful tool to evaluate weak risk factors that 
have large public health impact. An increase of risk of only 20% of certain cancers, for 
example, may involve millions of people and to detect such small increases in risk, huge 
studies are necessary.13 If, however, many studies produce modest relative risks, those 
estimates may well be due to same biases in all the studies. If the same systematic biases are 
present across a range of studies, the only effect of meta-analysis is to reinforce them, to 
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produce spurious statistical stability. Thus meta-analysis can lead to insights when study 
design, exposure assessment or exposure levels, study populations, etc., are found to relate to 
study outcome. An important function of meta-analysis is the investigation of between-study 
heterogeneity which is an opportunity to understand study variation. Investigation of 
heterogeneity can provide interesting hypotheses for future analyses and should be viewed as 
strength of meta-analysis, not a barrier to its use. Actually if all of the studies show same 
results, meta-analysis would not be very useful because it would not provide much more 
information than the original studies.  
Longnecker14 in a meta-analysis assessing the association between alcohol 
consumption and risk of breast cancer noted that the strength of the relation varied by study 
design. The association was stronger in prospective follow-up studies compared to case-
control studies. Accumulating evidence suggested that retrospective assessment of diet and 
alcohol of case-control studies may be biased by differential recall among those who have 
been diagnosed and treated for cancer. 
Discrepancies in study design were found in several meta-analysis on diet and breast 
cancer. Several meta-analyses15-17 showed a considerable association with saturated fat intake 
in case-control studies but much lower in cohort studies The most likely explanation for this 
finding is that biases in the recall of dietary items and in the selection of study participants 
have created a spurious association in the case-control comparisons.  
The importance of the methods used for assessing exposure is illustrated by a meta-
analysis18 of cross-sectional data of dietary calcium intake and blood pressure from 23 
different studies. It was found that the approach used for assessing the amount of calcium 
consumed strongly modified the change in systolic blood pressure per 100 mg of calcium 
intake. The association was small and only slightly significant when diet histories were used 
but large and highly significant when food frequency questionnaires were used. In fact, diet 
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histories and food frequency questionnaires are very different methods to assess food 
consumption. Diet histories are conducted with a nutritionist and determine patterns of usual 
intake over long periods of time, whereas food frequency questionnaires are simpler methods 
that reflect current food consumption. It is likely that differing precision in the evaluation of 
current calcium intake may explain discrepancies in the strength of the associations found. 
 
1.3 Main aims of the thesis 
This work discusses some typical issues, involved with meta-analysis of published data in 
cancer epidemiology, describing two studies on breast cancer and melanoma. Statistical 
methods, useful to calculate summary estimates and to investigate between-study 
heterogeneity and potential sources of bias, are presented in Chapter 2.  
There are several indications that a diet rich in green vegetables and/or fresh fruit can 
provide some protection against a number of cancers. Several studies have also suggested a 
relationship linking vegetable and fruit consumption to hormone related cancers. A meta-
analysis was carried out to investigate results from published epidemiological studies on 
breast cancer and fruit and vegetable consumption.  
Breast cancer was chosen because it is a major public health problem in 
industrialized countries. However in cancer studies incidence and mortality are relatively rare 
and meta-analysis effectively provides a gain in statistical power for average estimates. Meta-
analysis may offer an opportunity to observe more events of interest in the groups followed. 
Thus, when incidence or mortality is rare, combined estimates are likely to be more precise. 
Published data on vegetables, fruit and some micronutrients, were evaluated to 
estimate their potential protective effect on breast cancer. Variation in study results was 
addressed, adopting some inclusion criteria and investigating the potential sources of 
heterogeneity. Results from this work are published in the European Journal of Cancer with 
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the title “Meta-analysis of studies on breast cancer risk and diet: the role of fruit and 
vegetables consumption and the intake of associated micronutrients”.19 Thus, Chapter 3 is 
extracted from this paper, which I completed in 1999. This section was included in the thesis 
to present an approved methodology in meta-analysis of epidemiological published studies, 
which was later applied to meta-analyses on melanoma, described in Chapter 4 and Chapter 5. 
Melanoma presents an increase in the incidence rate that in men has exceeded that 
for any cancer. Several publications have investigated risk factors for melanoma, producing 
results that appeared conflicting. In point of fact they used different methods of information 
ascertainment and statistical analyses, and considered completely different populations. Thus 
a systematic revision of all literature for a comprehensive meta-analysis of all main risk 
factors on melanoma allowed a deep exploration of associations and interactions among risk 
factors and provided some clues in epidemiology of melanoma looking extensively at 
inconsistencies and variability in the estimates. Meta-analysis permitted questions to be 
debated on whether the association of melanoma with some risk factors may depend on the 
composition of the population under study, the level of exposure in the study population, the 
definition of disease employed in the studies, or methodological quality of the studies. 
Therefore prior to embarking on any research study, a meta-analysis should be attempted in 
order to establish reliably of what is already known.  
Pooled estimates, which summarize results of all the literature, became essential to 
quantify the risk associated to all risk factors and thus identify subsets of the population at 
high risk of its development. It is hoped in the future to evaluate the possibility to combine the 
summary relative risk estimates of all main risk factors, calculated with meta-analytic 
techniques, to build an individual probability score. A combination of the estimates, obtained 
for all risk factors, could be useful for discriminating high-risk subjects who can be targeted 
for prevention. A case-control study is carried out by IDI (Istituto Dermopatico 
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dell'Immacolata, IRCCS), in Rome, to validate a possible score based on them. (Personal 
Communication)  
Meta-analysis on melanoma and pigmented lesions is presented in Chapter 4. The 
procedure adopted for this analysis, extensively described in this Chapter, was used for 
investigation of the other risk factors, presented in Chapter 5. Heterogeneity and potential 
sources of bias were widely explored in these two chapters, because a considerable number of 
studies was available. The possibility of exploring all the literature on all main risk factors 
together allowed investigation of methodological correspondences and symmetries among 
types of studies and among risk factors, providing interesting considerations on study 
variability.  
Conclusions and suggestions for future works are illustrated in Chapter 6. 
 
1.4 Previous meta-analyses on breast cancer and melanoma 
No meta-analysis looking at the association between breast cancer and vegetable and fruit 
consumption had been published at the time of the meta-analysis presented in Chapter 3 and 
published in 2000.19 One of the reasons may be related to the fact that it is not easy to deal 
with heterogeneity of coding, categorizations, definitions and quantification of portions of 
foods.  
An individual data meta-analysis,16 which included twelve case-control studies 
completed by 1986, published pooled estimates on the relationship between vitamin C and 
beta-carotene intake and breast cancer. Heterogeneity was significant for some dietary factors 
and the authors used an approach, which they called conservative, that restricts the analysis to 
the studies showing lack of heterogeneity. Thus sources of inconsistencies were not subject to 
much investigation and some interesting information on between-study differences was 
probably lost. Their results support the hypothesis that increased consumption of fruit and 
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vegetables and a consequent higher intake of vitamin C and beta-carotene may reduce breast 
cancer, as I have found in my study. 
Very good reviews were published20-23 on melanoma but mostly had a narrative 
style. There are few studies24-28 that tried to assess and quantify information from independent 
studies in a more systematic way employing meta-analytic techniques but they looked only at 
some risk factors and used different approaches to deal with heterogeneity. 
Whiteman24 calculated pooled estimates on sunburns on four studies that fulfilled 
some strict inclusion criteria. At the beginning all studies published between 1975 and 1993 
were considered. However several papers at the end were excluded. First, all publications that 
did not present raw data on sunburns were not included. Second, severe inclusion criteria, 
defined as essential, were applied to choose a core group of studies. Even though only a small 
subgroup of studies was considered, between-study heterogeneity was significant. Thus 
another study was excluded, to obtain a homogeneous group of papers Sources of 
heterogeneity were not investigated and interpretations on inconsistencies were not proposed. 
This, in my opinion, neglected one of the more interesting aspects of meta-analysis. 
Furthermore the pooled estimates are calculated using a scores system but this method is very 
controversial. As a matter of fact, as I will discuss in Chapter 2, the subjective reviewer’s 
point of view may heavily influence the results. 
Bliss25 conducted an individual data meta-analysis, on studies published before 1990, 
which look at pigmentation characteristics. The authors stated that they had included in the 
analysis melanoma case-control studies “which had included an independent physical 
examination of naevi by a trained individual, for which data collection was completed and 
where cases and controls were treated similarly”. Thus studies with only self-reported nevus 
counts were excluded. Even though the subset of studies considered for the analysis was not 
large, between-study heterogeneity was found to be significant for some factors and in this 
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case the pooled estimate was not considered. Again inconsistencies and differences in patterns 
of estimates were not much investigated. The same group of authors that conducted this meta-
analysis (International Melanoma Analysis Group, IMAGE) published a further meta-analysis 
on a subset of the studies included by Bliss25, looking at influence of family history of the 
disease.27 Similar methodology was used. 
Nelemas26, who looked at the influence of sunlight exposure to melanoma, in papers 
published before 1990, adopted an approach more similar to my own. The author started from 
the idea that non-experimental studies, such as case-control studies, do not allow for the 
assumption that the variation in study results is merely attributable to statistical sampling 
error. Thus he clearly showed that an important function of a meta-analysis is the exploration 
of sources of variation in study results. When studies with some degree of blinding were 
combined only a small and non-significant effect was evident. Conversely, in studies without 
blinding, the effect was considerably greater and significant because differential recall of past 
exposures may have introduced bias. Meta-regression, which could have been useful to 
investigate interaction between factors, was not applied because the authors considered the 
number of the studies available too low to produce reliable results. Only case-control studies 
published in English were included and this may have introduced a bias, as will be explained 
in Chapter 2. 
A very recent meta-analysis28 included case-control studies published in English 
between 1966 and 1999, which separately reported relative risks for melanoma associated 
with sun exposure during childhood and adulthood. Again heterogeneity was found 
significant for some subgroup of studies but was not deeply investigated.  
 
1.5 Conclusions 
 11
When the magnitude of the underlying risks is small or when the results from individual 
studies disagree, meta-analysis is an attractive tool. 
Occasionally, a meta-analyst has the opportunity to work with individual-level data. 
In most situations, relative to published data, individual-level data would provide great 
flexibility to address issues of control of confounding and exploration of effect modification 
or subgroup effects. More often, however, published reports of research are the only sources 
of data available.  
A meta-analysis19 that I carried out on published studies, looking at the association 
between vegetables and fruit consumption and breast cancer, is described in Chapter 3 to 
present an approved methodology for meta-analysis in epidemiology.  
A systematic meta-analysis that assessed all risk factors for melanoma is illustrated 
in Chapter 4 and 5. As we have seen in the previous paragraph, few meta-analyses24-28 were 
published on melanoma. Some of them used original individual records and this possibility 
enabled, for example, elimination of variations due to different coding and analytic 
procedures in the studies. However between-study heterogeneity was very often found 
significant, even when the authors considered subsets of studies identified with strict inclusion 
criteria. In fact many analysts identify heterogeneity and deal with it by excluding studies 
until a satisfactory degree of homogeneity is achieved. Authors sometimes exclude 25% of 
the data and still generalize to the total population. The problem is that they did not deeply 
investigate possible sources of variations and inconsistencies. Similarly, potential effect of 
publication bias was not explored in any meta-analysis.  
This work differs from the previous analyses, which try to quantify and summarize 
previous studies, first of all because a deep exploration of between-study heterogeneity and 
possible sources of biases was carried out and it provided some clues in epidemiology of 
melanoma, looking extensively at inconsistencies and variability in the estimates. Thus 
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investigation of variation in the estimates by differences in study features, definitions, 
characteristics of the populations and of the analyses, is shown to be essential because 
interesting interpretations arise from these issues. Instead of using strict inclusion criteria or 
quality scores, to deal with differences among the studies, sensitivity analysis and 
heterogentiy analysis were carried out to examinate associations among factors influencing 
the estimates for all risk factors, looking at similarities and asymmetries. Thus much more 
studies were considered in this meta-analysis, compared to the previous ones. In fact the most 
recent papers were included and wider inclusion criteria were used, so that, for example, 
cohort studies were incorporated.  
The best way to assess contrasts between risk factors is to concentrate on the studies 
that provide estimates of all measures of exposures together as this brings some consistency to 
the choice of measures used by the authors and the study methods. Thus comparisons, 
between risk factors and between different measures of exposures, are also carried out 
through a multivariate approach for multiple risk factors, published very recently29 and never 
before used in the previous meta-analyses.  
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CHAPTER 2. HETEROGENEITY AND BIAS:  
STATISTICAL METHODS 
 
2.1 Introduction 
A good meta-analysis should help to understand differences in results from the mass of papers 
from which they are derived. Four are the main steps to carry out a meta-analysis: identify all 
relevant studies; assess study characteristics; deal with between-study heterogeneity and 
possible bias; and summarize the results.  
The main goals of a meta-analysis in epidemiology are the estimation of an overall 
association and the identification of sources of bias and between-study heterogeneity. In 
particular investigation of biases and inconsistencies should become one of the key phase for 
a meta-analyst because it can lead to more insights than the mechanistic calculation of an 
overall measure of effect, which will be often be biased.  
Many potential sources of heterogeneity occur within epidemiological research when 
using case-control and cohort designs. Colditz30 in 1995 reviewed several meta-analyses in 
epidemiology and observed that the majority derived an overall quantitative estimates of the 
association between exposure and outcome but only a quarter of them tested for heterogeneity 
and even fewer explored for sources of variability. 
In this Chapter I present some methodologies useful to deal with these typical issues 
of meta-analysis of observational studies: heterogeneity and bias.  
Two main models to study variation in a meta-analysis are presented. One, the fixed 
effects model, considers the studies being analysed as universe of interest; the other, the 
random effects model, takes these studies as representing a sample from a larger population of 
possible studies.  
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Efficient methods that provide pooled trend estimates from dose-response data are 
illustrated. This technique takes into account the correlation among different exposures. 
Multivariate analysis of multiple outcomes is briefly described in this Chapter. 
General linear MIXED models are applied in the next Chapters to compare few outcomes 
summarized in a multi-dimensional approach.  
A brief description of the Bayesian method is introduced at the end of the Chapter. 
They were not applied to my data because Bayesian approaches are controversial: the 
definition of prior probability will often be based on subjective assessments and furthermore 
complex computational techniques are required for their application. 
 
2.2 Bias in meta-analysis 
One of the most crucial steps in a systematic meta-analysis is study identification. In order to 
control the biases the process of identifying and selecting studies is very important. Refined 
methods to search for studies are fundamental to include all potentially eligible studies. The 
effect on the estimates of the exclusion of each study not contributing to the analysis should 
be investigated. In fact, if the studies included are a biased sample of all the studies 
conducted, then the force of any possible inference is limited. 
Publication bias is the most mentioned bias in meta-analysis because when it is 
present the significance of results may influence whether a study is submitted, positively 
reviewed and eventually accepted for publication or not. Commonly meta-analysts refer to 
publication bias but this is only one of the possible biases, included in the term “dissemination 
bias”. In general when the analysis is influenced by the accessibility of research findings we 
should talk of dissemination bias. This depends not only on whether a study is published but 
also on when, where and in which format this occurs.31 For example, language bias is related 
to the fact that studies without significant results are preferably published in languages other 
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than English and this implies that it will be more difficult to find such ‘negative’ studies. 
Authors try more likely to publish positive findings in an international, English language 
journal, whereas negative findings end in local journals. Therefore bias could be introduced in 
meta-analyses based exclusively on studies published in English. 32;33;34 Moreover if most of 
the major west European journals, published in languages other than English, are indexed in 
Embase or Medline, this is not the case for journals published in less developed countries. 
Obviously it will be very difficult to find studies that are published in journals not indexed in 
one of the major databases.  
Searches in computerised databases are usually extended examining the reference 
lists of other studies and reviews. When reference lists are used, citation bias may have an 
important role. Citation bias leads to underreporting of ‘negative’ studies being referred to 
less often.35;36 On the other hand, significant results are sometimes published in more papers, 
increasing the probability for them to be discovered (multiple publication bias).37 Furthermore 
it is not always obvious that more publications come from a single study, and one dataset may 
thus be included in an analysis twice.38 
Another source of bias comes from differences in methodological quality of studies. 
Methodological accuracy of smaller studies is not at the same level of larger studies and 
papers of lower quality also tend to show larger effect estimates.39;40 In these cases there is 
often an interaction between sample size and statistical significance. To publish a non-
significant result sample sizes must be very large. This is reasonable because the statistical 
power to detect a significant difference is low when samples are small.41;42-44 The real 
problem arises when the true relationship is modest as in the majority of epidemiological 
analyses.45 Actually for studies with small samples, the only results published will tend to be 
those that are significant and this can lead to a systematic overestimation of the true effect 
size.  
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2.2.1 Funnel plots and graphical tests to detect bias 
In meta-analysis, funnel plot and related statistical analyses are the most commonly used 
methods for assessing the possible existence of publication bias. Funnel plots are simple 
scatter plots of the risk estimates, on the x axis, versus some measure of their precision, as 
standard error, variance, inverse of variance, sample size, on the y axis. The name ‘funnel 
plot’ arises from the fact that risk estimates from small studies will spread out more widely at 
the bottom of the graph, with the spread narrowing among larger studies that present more 
precise estimates. In the absence of bias the plot should look like a symmetrical inverted 
funnel. (See Figure 1.1) If there is a bias, because for example smaller studies without 
statistically significant effects remain unpublished, this will lead to an asymmetrical form of 
the funnel plot with a gap in a bottom corner of the graph. (See Figure 1.2) The more the 
asymmetry is pronounced, the more likely it is that the amount of bias will be substantial and 
the pooled effect calculated from meta-analysis will probably overestimate the true risk 
estimate.46  
In absence of bias the shape of the plot depends on the choice of the axes. Standard 
error was shown to be the best choice for the vertical axis because the expected shape in the 
absence of bias corresponds to a symmetrical funnel, straight lines to indicate 95% confidence 
intervals can be included and emphasis of the plot is on smaller studies where bias is more 
likely. The only disadvantage, compared to other choices for the vertical axis, is that that axis 
has to be inverted to place the largest studies at the top of the graph.47 
Visual evaluation of funnel plots may be subjective and more formal statistical 
methods, to examine associations between the study effects and size, were proposed.46;48 
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Figure 2.1. Asymmetrical funnel plot.  
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Figure 2.2. Symmetrical funnel plot. 
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Duval and Tweedie have proposed the so-called "Trim and fill" method. It is based 
on a rank data augmentation technique that adds studies to a funnel plot so that it becomes 
symmetrical.49 Smaller studies at the bottom are omitted until the funnel plot is symmetrical 
(trimming). The trimmed funnel plot is used to calculate a pooled estimate by standard meta-
analysis approach. The trimmed studies are then replaced and their missing counterparts 
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around the centre imputed or "filled". This provides an estimate of the number of missing 
studies and an adjusted pooled estimate that is obtained including the "filled" studies.  
Begg and Mazumdar proposed a rank correlation method that uses Kendall’s Tau to 
evaluate the association between the effect estimates and their variances.48  
Egger introduced a linear regression approach, which is equivalent to a weighted 
regression of the estimate on its standard error:  
loge(RR)/SE(loge(RR)=a+b * (SE(loge(RR))-1 
The intercept value (a) provides an estimate of asymmetry of funnel plot. Positive 
values of “a” indicate a trend towards higher levels of study estimate in publications with 
smaller samples sizes.46 
Egger’s method is more sensitive than Begg’s rank correlation approach, but the 
sensitivity of both methods is generally low in meta-analyses based on less than 20 studies.50 
Both Egger's regression method and the “Trim and fill” method may be related to a great 
false-positive rate in detecting significant asymmetry of funnel plots. Furthermore Egger’s 
method is known to be intrinsically biased.51 
Copas proposed a model in which the probability that a study is included in a meta-
analysis depends on its standard error. The model describes the process of study selection 
(publication bias) and evaluates the pooled RR for different parameter choices, which can be 
interpreted as the probabilities that a paper with a certain value of “standard error” is 
published (publication probability). For any given value of publication probability Copas and 
Shi proposed a method to estimate the number of studies that were undertaken but not 
published and the correspondent reduction in the estimated risk. As there are not enough data 
to choose a single "best" model, the authors proposed a sensitivity analyses in which the value 
of the estimated risk factor is computed under a range of assumptions on the severity of the 
selection bias.52 
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These statistical methods, which investigate the asymmetry of the funnel plot, try to 
estimate how big the impact of publication bias might be on the results. However none of 
them can be considered the ideal statistical method for assessing publication bias and any 
method should be considered indirect and exploratory. Modelling assumptions used may 
heavily influence the estimates adjusted for publication bias. Many factors may be involved in 
the publication process, and it is difficult, if not impossible, to adequately model them. These 
methods may detect "missing" studies even in the absence of bias, adding and adjusting for 
non-existent studies in response to funnel plot asymmetry arising from nothing more than 
random variation.53 As a matter of fact their sensitivity is generally low in meta-analyses 
based on less than 20 studies, as I said previously.50;51;54 
It was estimated that missing studies change the conclusions in less than 10% of 
meta-analyses, suggesting that publication bias, although widespread, may not be a major 
problem.55 It is therefore wise to restrict the use of statistical methods that model selection 
mechanisms to the identification of bias rather than correcting it.56;57  
 
2.3 Meta-analysis dilemma: heterogeneity 
There may be different kinds of heterogeneity: population heterogeneity and methodological 
heterogeneity. The term 'population heterogeneity' covers factors such as study location, age, 
sex, types of diseases. Methodological heterogeneity has to do with differences between study 
designs and analyses. 
When different studies give different results the aim of the meta-analysis should be 
to investigate the reasons why effects differ across studies, identifying methodological 
discrepancies among studies, assessing the possibility of confounding factors and evaluating 
differences among populations under study.30;58;59 
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As was seen in the previous Chapter, exploration of sources of heterogeneity can 
lead to insights over modification of apparent associations by various aspects of study design, 
exposure measure and population and may allow identification of features of study design that 
may have implications for future research.59 
Subgroup analyses and “meta-regression” are techniques useful to work out when 
particular characteristics of studies are related to the sizes of the estimates. Subgroup analyses 
are meta-analyses on subgroups of the studies that partition the observed effect size variability 
into two components: the portion attributable to subject-level sampling error and the portion 
attributable to other between-study differences. This is obtained dividing results into different 
types of subjects, outcomes or study characteristics, but it requires cautious interpretation. 
When several outcomes are measured, but only a selected subset of them are reported and 
discussed, it is possible to have misleading results. Furthermore the more subgroup analyses 
are performed, the more likely it is that a statistically significant result will be found due 
simply to chance. Any subgroup analysis should be best considered as generating hypotheses 
for testing in the future and should have a scientific rationale.60 
"Meta-regression" models represent a useful tool to investigate possible explanations 
for between-study heterogeneity because they allow also to test interactions between factors. 
The term meta-regression indicates the use of study-level covariates, as distinct from 
regression analyses that are possible when individual subjects data on outcomes and 
covariates are available. Subgroup analysis is equivalent to meta-regression with a categorical 
study-level covariate. Considering subgroup analysis formally as a meta-regression has 
advantages, since it properly focuses on the differences between subgroups, rather than the 
effects on each subgroup separately. Also random effects models allow for residual 
heterogeneity, not explained by sub-grouping.58;61-63 
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When there is a small number of studies and many differing characteristics, the risk 
of obtaining a spurious explanation from meta-regression is high. This is a particular problem 
in meta-analysis because there are many characteristics, which differ among the studies, and 
these can be highly correlated. Further summarizing of subject’s characteristics at study level 
implies the risk of completely failing to detect genuine relationships between these 
characteristics and the size of risk factors. Meta-analysis carried out on individual subjects 
data can alleviate some of these problems. In particular within-study and between-study 
relationships can be more clearly distinguished, and confounding by individual level 
covariates can be investigated. However, as we have seen earlier, this kind of meta-analysis is 
much more expensive and time–consuming and very often not feasible.61;62;64 
Since poor-quality studies sometimes produce systematically different results, a 
meta-analysis may yield misleading results if the quality of the studies is poor.39;40;65 In an 
attempt to cope with these problems and to control heterogeneity, many researchers restrict 
analysis considering some inclusion criteria. However an extensive investigation of the effect 
of inclusion criteria on results is recommended to avoid introduction of reviewer’s own bias. 
Use of quality scoring in meta-analysis is controversial because it is not clear its 
validity and may not be associated with quality. It is very difficult to score and measure 
quality that is best evaluated qualitatively.45;66 Greenland called quality scores “perhaps the 
most insidious form of subjectivity masquerading as objectivity” because they modify data 
information by using arbitrary judgments in their assignment.67  
Sensitivity analysis is recommended rather than quality scores because it helps to 
establish the influence of individual study results to the overall pooled estimate. The main role 
of a sensitivity analysis is to discuss robustness of results and determine whether the 
assumptions or decisions to either exclude or include studies have a major effect on the final 
estimates.68 
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After exploration of the contributions of all known or suspected factors that may 
have introduced variation in the estimates, heterogeneity remains very often unexplained and 
statistical models that can take into account this variation are essential.69  
 
2.3.1 Fixed effects models  
Fixed effects models are based on the mathematical assumption that a single common (or 
'fixed') effect underlies every study in the meta-analysis. In other words, if we were doing a 
meta-analysis of odds ratios, we would assume that every study is estimating the same odds 
ratio. Under this assumption, if all studies were infinitely large they would produce identical 
results. This means that between-study heterogeneity is not statistically significant. 
The fixed effects model is used to obtain a pooled estimate “b” of the effect 
estimates, that is:  
b=
w b
w
i
i
i
i
i
∑
∑
*
 
where bi are the study results (as the loge(RR) estimates) and wi are the weights of 
the studies. The study’s weights is obtained calculating the inverse of the variance of the 
effect estimate: wi=1/[SE(log(RRi))]2. 
In cancer studies the distinctions among the various measures of relative risk (e.g. 
odds ratios, rate ratios, and risk ratios) are ignored, because cancer is a rare disease in all 
populations under review. The relative risks and confidence intervals extracted from each 
study are converted to the natural log of the risk estimates and the associated variance.  
If confidence intervals or standard errors of the relative risks are not available, crude 
data are used in Woolf’s formula as follows: ( )[ ]se ORlog = 1 1 1 1/ / / /a b c d+ + + , where a, b c 
and d represent the values of Table 2.1.  
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Table 2.1. Table 2x2 with cases and controls by exposure categories. 
When the standard error of the odds ratio is found in the publication then the 
approximate estimate of the standard error (SE) of the logarithm of the OR is obtained from:  
SE(logOR)=SE(OR)/OR  
When between-study heterogeneity is investigated the fixed effect approach may be 
applied to meta-regression models where the expected value of a study estimate is modelled 
as a fixed function of measures of study characteristics. Again this meta-analytic approach is 
based on weighted regression, where the log of the odds ratio from each study is the variable 
response and the weights depend on the precision of the estimates, i.e. the standard errors of 
the log(RR).  
 
2.3.2 Random effects models  
Random effects models make the assumption that individual studies are estimating different 
underlying risks. The idea of a random effects meta-analysis is to learn about the distribution 
of risks across different studies.  
When large heterogeneity is found, diversities in the designs and analyses of the 
various studies should be taken into account in the final model and it can be assumed that the 
true effects estimated will vary among studies. There are two sources of variability that must 
be addressed, the usual sampling variation in the estimates and variation in the underlying 
parameter. To account for both sources of variation in the meta-analysis, the DerSimonian and 
Laird70 method was used. 
To evaluate between-study heterogeneity a sample test based on the statistic: 
Qw= w b bi i
i
w
( )∑ − 2  
 Cases Controls 
Exposed a b 
Not exposed  c d 
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is used, where bi is the ith effect estimate (loge(RR) estimates) and  
b w b w
w i i i
ii
= ∑∑ /   
is the weighted pooled estimator of effect estimate and wi is the inverse of the ith 
sampling variance. Under the null hypothesis of no effect of the factor considered, Q follows 
approximately a Chi-squared with k-1 degrees of freedom, where k is the number of studies 
considered in the analysis.  
The random effects model uses weighted least squares estimates of the effect 
estimates (as the logarithm of the RRs):  
b w b w
p i i i
ii
* * */= ∑∑  
where the weights are 
w w
i i w
* ( )= +− −1 2 1Δ   
and Δ
w
2  gives an estimate of the degree to which studies have different assessments 
of the relative riss. Thus the calculations to obtain Δ
w
2  are based on the Chi-squared.70 
Chi-squared test does not have a big power, therefore heterogeneity should not be 
considered statistically significant at the p-value=0.1 level of association.71 
The consequence of performing a random rather than a fixed effects model is that the 
confidence intervals for the pooled estimate are wider. A random effect analysis therefore 
suggests more uncertainty in estimating the underlying parameter than a fixed effects model 
does. Moreover estimates from random effects models tend to be more sensitive to 
publication bias than fixed effect estimates, because smaller studies have larger relative 
weights. It follows that random effects models will be more strongly biased than fixed effects 
models by any tendency not to publish small statistically non-significant studies.  
 
2.3.3 Dose response 
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An important criterion supporting causality of associations is a dose-response relation. In 
order to allow an estimation of the shape of a dose-response relation, fixed and random effects 
approaches for dose-response models may be used for summarising the results across the 
studies. An estimate of the change in the relative risk per unit of exposure within each study 
may be obtained, and they should be combined across studies.  
The individual log relative risks are modelled as a function of exposure level in the 
following way:  
E(bij)=log (RRij)=bxij 
where i=1,...,I is the index study, j=1,...,J-1 is the value of the exposure in the j-th 
non-reference exposure category within each study. 
The dose-response of the logarithm of the relative risks for separate exposure levels 
depends on the same reference (Unexposed) group; therefore the estimates cannot be 
independent. The method of pooling proposed by Greenland and Longnecker72 adjusts the 
estimates for within-study covariance and accounts for the correlation between estimates. This 
approach is based on constructing an approximate covariance estimate for the log odds ratios, 
from a fitted table that conforms to the log odds ratios. To fit the cell counts to the interior of 
the total data table an iterative algorithm, that is based on Newton Rapson method, is used and 
the asymptotic covariance is obtained. 
It is necessary to assign numeric values to the categories before estimating 
coefficients. As a frequency distribution for exposure is very often not available, the method 
used is to assign category midpoints to categories. To fit the cell counts to the interior of the 
total data table, in order to obtain the asymptotic covariance, the number of cases and the 
number of observations for each exposure level is needed. When this information is not 
available, it is not possible to use the method of pooling proposed by Greenland and 
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Longnecker72 to adjust the estimates for within-study covariance. In this case the inverse 
variance-weighted least squares estimate of the logarithm of the RR can be calculated from: 
b=
w x y
w x
j j j
j j
∑
∑ 2  
where wj=1/var(log(RR)), yj=log(RR) and xj is the value of the exposure. When the 
j-1 values are independent, the standard error of log(RR) is:  
SE(b)= ( )1 2 1 2w xj j∑ / . 
 
2.4 Multivariate analysis 
Multivariate analysis is potentially much more informative and more correct than univariate 
analysis to evaluate multiple risk factors together. First because it permits to compare 
estimates extracted from the studies that provide all measures of exposures together and this 
allows having data with some consistency in study methods and in the populations 
considered. Second because it can take into account the correlation between risk factors. 
Actually estimated effects obtained from the same samples are correlated and an estimate of 
this correlation is needed to perform the analysis. However very often in meta-analysis of 
observational studies, as in my work, estimates of covariance are not available and 
independence has to be assumed.  
Methods proposed in statistical literature are not easy to apply in practice, because 
self written programs have to be used. Arends showed that general linear MIXED model 
software is a very convenient framework for multivariate meta-analysis.73  
Models were fitted using SAS (Proc Mixed74) that is based on an approximate 
likelihood approach. This method does not assume a normal distribution for the underlying 
parameters, as the mixture model introduced by DerSimonian and Laird70 does, but the 
estimates are obtained with maximum likelihood algorithm.  
 27
Detailed description of statistical aspects of this approach can be found clearly 
described in the “Tutorial in Biostatistics” published in Statistics in medicine, where some 
SAS procedures, which I used for this work, are clearly described and interpreted.29  
 
2.5 Bayesian meta-analysis 
Bayesian approach to meta-analysis is based on the principle that each observation or set of 
observations should be viewed in conjunction with a prior probability describing existing 
knowledge about the phenomenon of interest. The new observation alters this probability to 
generate a posterior probability. In Bayesian terms, traditional statistical methods used in 
meta-analysis assume that the prior probability distribution is uniform, with all outcomes 
being equally probable. Bayesian method allows the incorporation of indirect evidence and 
opinions in the generation of the prior distributions.75-77 
Specific advantages conferred by the Bayesian approach include: full allowance for 
all parameter uncertainty in the model, the ability to include other pertinent information that 
would otherwise be excluded, and the ability to extend the models to accommodate more 
complex, but frequently occurring, scenarios. 
Bayesian models are available under both the fixed and random effect assumptions.78 
The confidence interval (or more correctly in Bayesian terminology, the 95% credible 
interval, which covers 95% of the posterior probability distribution) will often be wider than 
that derived from using the conventional models because another component of variability, 
the prior distribution, is introduced.  
This approach is controversial because it depends heavily on opinions, and these will 
often vary considerably. To implement reliable Bayesian analyses, additional development in 
drawing prior probability distributions and conducting robust analyses is needed. Furthermore 
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Bayesian inference in meta-analysis requires complex computational techniques to be 
routinely applied. 
 
2.6 Conclusions 
Between-study heterogeneity is very frequent in meta-analyses of epidemiological data59 and, 
if it is statistically significant, there are several choices open. One option is that of avoiding to 
calculate pooled estimates and to perform the meta-analysis. An unwise meta-analysis can 
lead to highly misleading conclusions. However a pooled risk estimate based on several small 
diverse populations and studies may provide a useful generalization of the results. 
Furthermore meta-analyses reporting effect estimates that may contain bias may provide 
relevant information, as long as potential underlying reasons for inconsistencies are 
addressed.  
Finding systematic variation in results and identifying factors that may account for 
such variation aid in the interpretation of existing data and the planning and execution of 
future works. Subgroup analysis and meta-regression are described in this Chapter as 
statistical techniques of exploratory data analysis and they are applied in both the meta-
analyses on breast cancer and melanoma. However for the systematic meta-analysis on 
melanoma there were more chances to explore deeply bias and heterogeneity. The reasons are 
more than one. First of all more studies were available. Secondly, the investigation of 
correspondences between all main risk factors allows more insights in epidemiology of 
melanoma. Thirdly, some analyses on different aspects of methodologies, as funnel plots, 
graphical tests and meta-regression, useful to detect significant variation in the estimates and 
bias are very recent.47;50-52;54;61 
The danger of the testing approach for funnel plot is the temptation to assume that, if 
the test is not significant, there is no problem and hence the possibility of publication bias can 
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be ignored. Copas and Shy argued that publication bias is endemic to all empirical research 
even if it is not evident from the funnel plot. Approaches, which try to estimate exactly how 
many studies are missing, are very hazardous, and graphical tests make assumptions that 
cannot be tested. The sensitivity analysis proposed by Copas and Shi monitor how sensitively 
the results depend on the assumptions using a model to describe the process of study 
selection, estimate the effect of interest for different parameter choices within this model, and 
then check the fit of each estimate with the evidence in the funnel plot. Thus Copas and Shi’s 
method was applied for all risk factors for melanoma. The application was quite 
straightforward because they published the S-plus routines, which were useful to carry out the 
calculations. 
Meta-analysis needs only partially statistical skills but the statistical part constitutes a 
large and important fraction of what a meta-analysis consists of. The common technique for 
combining results across studies is the weighted average of study specific results. The choice 
of weights to be assigned to the studies and ways to deal with among-study variability differ 
from method to method.  
A statistical issue is whether to incorporate between-study variation into the 
calculation of combined estimates. Thus fixed and random effects models are described. 
When existing studies are considered a random sample of a population of studies and 
heterogeneity is seen as an integral part of the data, then random effects model was used. 
Regression methods that take into account  the correlation between exposures were applied to 
obtain summary relative risk for dose-response relationships.  
Quality scores are adopted by some authors to deal with possible bias, imprecision 
and in general poor quality, which are generally more frequent in observational studies than in 
controlled trials. However in the absence of a rigorous and validated statistical method to 
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include quality assessment in the calculation of the summary estimates, weighting by quality 
is not considered in this meta-analysis. 
Multivariate approach is applied to meta-analysis on melanoma in Chapter 4 and 
Chapter 5 to evaluate contrasts among multiple risk factors and to make comparisons with the 
classical pooled estimates, which are calculated with a different methodology. It was not used 
in breast cancer meta-analysis because practical applications with general linear MIXED 
model software have been explained only in a recent publication73. An hypothesis of 
independence among risk factors was assumed, even if it is unrealistic, because no estimates 
of the correlations between risk factors were available. This model has been applied to make 
comparisons with the pooled estimates obtained with the other models. An estimate of 
covariance can be obtained from the application of the model. 
Bayesian approach is briefly presented but it is not applied in my meta-analyses 
because it leads to complicate calculations and so far only sophisticated software is available 
for this method. Moreover recent investigations demonstrated that, for practical purposes, the 
differences with the other methods are not substantial.9 
In cancer studies distinctions among the various measures of relative risk are ignored 
in all meta-analyses that I carried out, because cancer is a rare disease in all populations under 
review.  
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CHAPTER 3. BREAST CANCER AND  
FRUIT AND VEGETABLES CONSUMPTION 
 
3.1 Introduction 
 
Breast cancer is a major public health problem in industrialised countries. It is estimated that 
one in eight American women will develop breast cancer in her lifetime.79;80 The most 
convincing evidence that breast cancer is possibly preventable is that the rate of breast cancer 
increases after a woman migrates from a country with a low rate of cases to one with a higher 
rate. Dietary change was consistently suggested as a major contributor factor to this 
situation81 even if a change82;83 in health-care system, which may emphasize mammography 
and other methods of detecting breast cancer in its early stages, is also fundamental.  
When breast cancer risk was examined in relation to intake of vegetables, fruits or 
both as a food group the results provided some evidence of a protective effect.84 Fruits and 
vegetables are common sources of many candidate protective substances, including 
carotenoids, with and without vitamin A activity, and ascorbic acid. Carotenoids and Vitamin 
C may protect against breast cancer due to their role in antioxidant defence.  
Among epidemiological studies, there is a convincing pattern showing that women 
with diet  with high contents of vegetables and fruits, have a decreased risk of breast cancer. 
However, the results are not consistent. The aim of this work was to analyse published results 
that explore the relationship between breast cancer risk and the consumption of fruits and 
vegetables and two associated micronutrients (vitamin C and beta-carotene). A meta-analysis 
of all published studies from 1982 to 1997 was carried out starting from the published 
reviews16;85-87 on vegetable and fruit consumption and breast cancer risk.  
 
3.2 Materials and Methods 
3.2.1 Selection of studies 
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Two bibliographic databases were screened from January 1982 to April, 1997:  
• the online MEDLINE (National Library of Medicine, Bethesda, MD, USA 
(http://www.nlm.nih.gov/) using PUBMED (http://www.nlm.nih.gov/PubMed/) as 
system of querying from January 1966. 
• Elsevier Science online EMBASE (http://www.ovid.com/) from January 1988. 
No language restrictions were applied. The MEDLINE search was conducted using 
the following key-words: vegetable*, fruit*, Vitamin C, Betacarotene, Beta-carotene, 
Carotene in combination with breast, cancer*, tumour, tumor, neoplas*, malignan*, carcino*, 
metasta* and case control*, case-control*, cohort*, cross section*, cross-section*, follow up, 
follow-up, followup, prospective.  
A possible search strategy using PUBMED on Text Word could be: (breast*[Text 
Word]) AND (cancer*[Text Word] OR tumour*[Text Word] OR tumor*[Text Word] OR 
neoplas*[Text Word] OR malignan*[Text Word] OR carcino*[Text Word]) AND (case 
control*[Text Word] OR case-control*[Text Word] OR cohort*[Text Word] OR cross 
section*[Text Word] OR cross-section*[Text Word] OR follow up*[Text Word] OR follow-
up*[Text Word] OR followup*[Text Word] OR prospective[Text Word]) NOT 
(animal[Mesh]) AND ("1982"[PDat] : "1997"[PDat])  
Successively the following mesh terms were used: vegetable, fruit, Vitamin C, 
Betacarotene associated with breast cancer, breast neoplasms and case-control studies, cohort 
studies, prospective, follow-up and cross-sectional studies. The final search strategy was 
carried out combining the search strategy for “text word” and “mesh terms”. Similar strategies 
were used to search EMBASE. The search was limited to human studies only. 
The references of publications obtained from the MEDLINE search were also reviewed for 
relevant articles. A total of 45 articles88;89-123;124;125-132 were identified, presenting results from 
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case-control and cohort studies, 27 dealing with vegetables, 20 with fruits, 30 with beta-
carotene and 19 with vitamin C (Table 3.1). 
At the first stage of the analysis, some inclusion criteria were identified to obtain a 
group of studies, each with a least a minimal information. This group of studies is known as 
the main group and the bulk of the meta-analysis is based upon these studies. In the sensitivity 
analysis, a comprehensive meta-analysis was carried out including all possible studies found 
to assess any bias induced by this selection. 
The following inclusion criteria were used: 
• The studies had to provide sufficient information to estimate the relative risk and 95% 
confidence intervals (i.e. they had to publish the Odds Ratios (OR), Relative Risks 
(RR), Standardize Incidence Ratio (SIR) or crude data and standard errors, variance, 
confidence intervals or p-value of the significance of the estimates). An estimate and 
its variance were  required to calculate a weighted pooled-estimate of the RR. When 
the variances were not reported, they were calculated from the published confidence 
intervals, from the crude data or an estimate of them, or in an approximate way from 
the p-values.133 Published results from three studies only101;102;125 could not be 
included in the meta-analysis, because the authors did not present enough information 
to evaluate the variance.  
• The studies had to be independent in order to avoid giving double weight to some 
studies. If results for micronutrients and food groups were derived from one study, but 
were published separately, both articles were considered. Simard124 was not 
considered, because this study is based on a cohort which was also analysed in an 
article by Rohan122; the latter was chosen because the first presented only the 
percentages of people regularly eating fruit and vegetable. Cooper89 and Ambrosone88 
were not included because they were not wholly independent from other studies 
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found.94;123 They presented adjusted estimates that refer to very specific subgroups of 
the population. In Ambrosone’s paper88 the estimates are presented separately for 
women who had a family history of breast cancer. Cooper’s paper89 looked at 
oestrogen receptor status. The estimates for vegetable and fruit consumption from La 
Vecchia (1987)108 paper were excluded from the analysis because updated figures 
were published subsequently in 1991.113  
• As regards the consumption of food items and the intake of micronutrients the 
categories for which the results are reported had to be comparable. In the analysis of 
Vitamin C I calculated the relative risk of about “400 mg/day or more” compared to 
“70 mg/day or less”, while for Beta-carotene I used ”7000 μg/day or more” compared 
to ”1000 μg/day or less”. These categories are indicative and the rational for choosen 
them is explained in the following section. In five publications93;110;121;127;130;131 the 
cut-off points for the highest frequencies were close to the lowest categories of all the 
other studies. This meant that these studies could not be used to give a relative risk 
estimate of the comparisons above. For this reason they were excluded from the main 
analysis. Some publications90;100;101;105;112;117;119;127;128 at this stage were not 
considered, since it was not possible to assess comparability with the other studies 
because no value of the cut-off points was  shown. Ingram25 calculated RR estimates 
for quartiles and for median consumption, but without showing the values of the cutoff 
points. Only mean consumption was indicated and it appeared to be quite low. 
Consequently this study was excluded.  
• The questionnaires to assess diet had to be equivalent. The vast majority (all except 
one) of the papers found presented estimates obtained from food frequency 
questionnaires (FFQ) that are simple methods, completed in only one session, that 
usually assesse intake over long time periods. Diet histories and other methods like 
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24-hour recalls or 7-day diaries are much more precise because they are often 
conducted with a nutritionist and provide comparable estimates to more intensive 
methods like food records. For this analysis we required that dietary information 
should be based on a standadised method of assessment as, at least, a food frequency 
questionnaire. Zemla129 was not taken into account because it did not use a very 
simplified and not comparable questionnaire. 
• The populations studied should be homogeneous, at least for the main risk factors for 
breast cancer. Hislop97 was excluded in the first part of the analysis, because only 
women with benign breast diseases, having  an increased risk of breast cancer, were 
considered. Kato presented two estimates calculated including as controls patients 
with benign breast disease and without including them. The estimates coming from the 
last group was chosen, even if they were not adjusted. I also excluded studies that 
presented the risk estimates for pre-menopausal women only92;109, since a stronger 
influence of genetic predisposition for breast cancer at early ages is suggested.134;135 In 
one study96 risk estimates were given for pre- and post-menopausal women separately. 
Crude data (cases and controls for each categories) were also presented and pre and 
post-menopausal women were combined into one group in order to represent all 
women.  
 
Twenty-seven studies were identified as fulfilling the entry criteria and this main 
group of studies, 18 for vegetables, 13 for fruits, 11 for beta-carotene, and 9 for vitamin C are 
listed in Table 3.2. The effects of excluding some estimates are critically investigated in the 
sensitivity analysis. 
 
3.2.2 Extraction and unification of the data 
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A major concern in the discussion on the selection of controls for case-control studies has 
been the risk of introducing selection bias. Population controls, randomly sampled from the 
same population from which the cases originate, during a specified time interval in the same 
geographic area, are thought to be the best controls. The reason for this is that when cases and 
controls come from the same study base the risk for selection bias should be reduce. Patients, 
who were hospitalised even for other diseases, may be unrepresentative for the exposure 
distribution in the source population.136 However population-based estimates are reliable if 
there is a full coverage of cases occurring in the population being studied and this is not 
always assured. In developing countries, for example, full ascertainment of cases of a specific 
disease is difficult to obtain. This is not only due to limited access to health care and lack of 
knowledge of how to access health care facilities, but also to financial barriers to health care 
for certain segments of the population. Furtheremore sometimes in population-based studies 
there is low rate of response among controls. In such circumstances hospital-based case-
control estimates are the best choice.  
In this meta-analysis one study137 presented two different estimates, considering 
separately hospital and population controls. Results from population controls were chosen for 
the analysis but the choice it is not expected to influence the final pooled estimate because the 
two controls groups were consistent with each other, and in general their food consumption 
patterns resembled each other rather than the case pattern.   
Whenever possible, a risk estimate for an overall item (food group “vegetable” and 
food group “fruit”) was chosen. If such a risk estimate was not presented an indicator item 
(preferably a food item with a high density of the micronutrients of interest) was selected 
taking into account the availability of micronutrients as well. Between “cooked vegetables” 
and “raw vegetables” the cooked91 ones w ere chosen because bioavailability of carotenoids in 
raw green leafy vegetables is low compared to cooked vegetables concentration of 
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betacarotene.138 Thus, between “green vegetables” and “raw vegetables” the green ones were 
chosen96; between “yellow vegetables” and “other vegetables” the latter were chosen16; 
between “citrus fruits” and “fruits rich in beta-carotene” the latter were chosen121; between 
“citrus fruits” and “other fruits”91 the latter were chosen. Pawlega118 presented estimates only 
on boiled vegetables and these estimates were included.  
When comparing categories with different units (e.g. frequencies per day, week, 
month, year or grams per day, week, month, year), it was observed that the upper limit of the 
cut-off points, that is the highest category, corresponds more or less to “one portion (around 
250 g) per day or more”. The reference category (low consumption) refers to “3-4 portions 
per week or less”. These categories were chosen because they were the average of most 
common upper and lower limits of the cut-off points. This quantity is much lower than the 5-
in-a-day portions suggested by the National Cancer Insitute in USA139, but if I find a 
protective effect even with a lower consumption I have a stronger indication that high 
consumption of vegetables and fruits should be taken as an important suggestion even for 
hormone related cancers as breast cancer.           
The distributions of lower and upper limits of the cut-off points for micronutrients 
were analysed and an average of the most common limits were chosen, as for vegetables and 
fruit consumptions. The categories were about “400 milligrams per day or more” of vitamin C 
compared with “70 milligrams per day or less” and intake of “7000 micrograms per day or 
more” of carotene compared with “1000 micrograms per day or less”. Although this analysis 
is concerned with beta-carotene, Graham,94 Hunter99 and Kushi106 focused on carotene intake. 
This difference was expected to be of minor importance and these studies were used. When 
estimates of vitamin C or beta-carotene were presented separately for participants who took 
supplements, and people who did not take any supplements, the former were chosen. 
 38
The studies show a large heterogeneity regarding adjustments that were made for 
age, energy intake, alcohol intake, age at menarche, place of birth, Quetelet index, education, 
socio-economic status, parity, menopausal status and social status. If the risk of breast cancer 
associated with dietary intake was expressed in more than one way, the estimate extracted 
from the study was the one that reflected the greatest degree of controlling for confounders. 
Some of the estimates were obtained from crude data and hence they were not adjusted for 
confounders. 
Since a history of benign breast disease is a possible confounder, only risk estimates 
which were based on a comparison between controls without a history of benign breast 
disease and breast cancer cases were included in the meta-analysis, if both were presented.101 
 
3.2.3 Analysis 
Studies were classified as case-control or cohort and the meta-analysis was performed for 
each study design separately as well as for all studies combined. Analyses were also 
conducted on subgroups of studies based on other features (year of publication, geographical 
area, and characteristics in design). 
The distinctions among the various measures of relative risk (e.g. odds ratio, rate 
ratio, risk ratio) were ignored in the overall combined analysis, assuming that breast cancer is 
a rare disease.140 
Fixed and random effect dose-response models were used to estimate the dose-
response relation across the studies. Estimate of the change in the relative risk per unit of 
exposure within each study was obtained from the publication.  
A meta-analysis of epidemiological dose-response141 data was carried out.  
It was necessary to assign numeric values to the categories before estimating the 
coefficients and category midpoints were used here.133 For the open-ended categories a value 
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for the maximum and minimum intake for each nutrient had to be specified in order to  
calculate the numeric assignments to the categories. For fruit and vegetable consumption the 
values assigned to the categories went from 0 to 8 times per week (there was only one study 
on vegetables for which a greater upper limit of consumption was accredited: 12 times per 
week). For vitamin C intake the values went  from 20 mg to 480 mg per day, for beta-carotene 
from 1000 μg to 10000 μg per day. Estimates were obtained for different assumed values of 
the endpoints of the open-ended intervals, but no big changes were found between the 
estimates of the parameters of interest. 
The values of the exposure levels were calculated using the cut-off points presented 
in the articles. When there was only a broad indication of the categories as “High”, 
“Moderate” and “Low” an estimate of the values was taken from the average of the studies. 
For micronutrients the studies presented completely different distributions of intake. For this 
reason studies, which did not show the values of the cutoff points, were excluded from the 
analysis, as no commonality was present. Two studies, which were included in the analysis 
comparing “high” versus “low” consumption, were excluded from the dose-response analysis: 
Holmberg98 because estimates for all cutoff points were not presented and Iscovich101 because 
no information on variability (SE or p-value, or crude data) of the individual estimates was 
presented.  
Estimates of the change in the relative risk per unit of exposure within each study  
obtained with the method of pooling proposed by Greenland and Longnecker141 were 
combined across studies. Fixed effects model was used to pool the estimates of 11 studies on 
beta-carotene because no between-study heterogeneity was found. For vegetable and fruit 
consumption and vitamin C intake there was betweenstudy heterogeneity and so the random 
effects model was used to summarise 18, 13 and 9 studies, respectively. 
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3.2.3.1 Heterogeneity analysis 
Studies included in this analysis differed in a number of aspects of their design and execution. 
Possible sources of heterogeneity are: publication year, country of origin, type of controls, 
type of study design, adjustment factors for the estimates, confounding factors, validation of 
the dietary questionnaire, type of questionnaire (number of items and definition of food 
groups), geographical region (Mediterranean vs. non-Mediterranean area), presentation of 
data in the papers, cut-off points and levels for categorisation of consumption, number of 
items in the food frequency questionnaire. Analyses were carried out in order to investigate 
reasons for heterogeneity. These analyses focused on the association between vegetable intake 
and breast cancer risk, because the greater number of studies permitted investigation of 
further sub-groups. The main effects and interactions between the factors characterizing the 
studies were explored by analysis of a variance model. PROC GLM in SAS was used to fit 
the random effects models on the log(RR).74 The weight for each study was equal to the 
inverse of the sum of the within-study variance and the residual between-study variance, in 
order to correspond to a random effect analysis. 
 
3.2.3.2 Sensitivity Analysis  
Sensitivity analyses were carried out to evaluate if variations or violations of the inclusion 
criteria, or decisions about the category cutoff values influenced the results. In order to check 
if the exclusion criteria may have influenced the results, meta-analysis was carried out 
including all possible studies found. Four studies88;89;108;124 were not included because they 
were not independent. A further two studies102;125 were not considered because it was not 
possible to obtain any variability of the relative risk estimate. Finally a number of “distortion 
hypotheses”142 were also considered, to try to account for the effects of selection publication 
bias.  
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3.3 Results 
3.3.1 Characteristics of studies 
An overview of the 27 studies included in the first selected groups is given in Table 3.2. 
Fifteen studies were carried out in European countries, eight in North America, three in Asian 
countries and one in Australia. Five studies were cohort studies by design and 22 studies were 
case-control studies. Seven case-control studies used population controls. These 27 studies 
included a total of 23143 cases.  
Twenty-six studies used a food-frequency questionnaire to obtain information on 
diet; one used a diet history. Large differences within the studies were observed regarding the 
number of food items (8 to 236). In all studies the relationship between breast cancer and 
food/nutrient intake was based on partitioning the intake distribution into tertiles, quartiles or 
quintiles. 
 
3.3.2 Pooled relative risk estimates  
The extracted estimates and confidence intervals of the risk for breast cancer associated with 
the consumption of vegetable and fruit are presented in Figure 3.1 and 3.2, respectively, 
comparing highest versus lowest consumption. The relative risk for nutrient intakes and breast 
cancer risk, are presented in Figure 3.3 and 3.4.  
The fixed effects model is quite unrealistic insofar as it implies that only sampling 
error is associated with differences among estimates from studies with identical measured 
characteristics. Actually the Chi-squared estimates that measure the between-study 
heterogeneity in the analysis referring to vegetables (Chi-squared=42.4, with d.f.=17, 
p<0.001) and fruit consumption (Chi-squared=37.5, with d.f.=12, p<0.001) and vitamin C 
intake (Chi-squared=18.4, with d.f.=8, p<0.02), are all significant. This is an indication that 
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the homogeneity assumption at the base of the fixed effects model may be not correct. A 
random effects model was performed for vegetable, fruit and Vitamin C to take account  of 
the variation among studies in the model. Thus, it is not assumed that the studies represent the 
same effect. Rather, the effects estimated from the different studies come from some 
underlying distribution of effects. Since no heterogeneity problem was detected for 
publications on breast cancer risk and beta-carotene (Chi-squared=9.3, with d.f.=10, p=0.5) a 
fixed effects model was used.  
Relative Risk and Confidence Intervals for the food groups and micronutrients, 
comparing “High intake” versus “Low intake”, are presented in Table 3.3. These estimates 
suggest a significant protective effect for breast cancer due to higher vegetable consumption, 
high intake of Vitamin C and beta-carotene. The pooled estimate for fruit intake indicates that 
this food group may have a possible protective effect, but without statistical significance.  
As can be seen from Table 3.4 there are some indications that an increase in the 
consumption of vegetables and fruit is associated with an increase in the protective effect.  
 
3.3.3 Results from heterogeneity analysis 
Only one of the features considered seems to explain some of the between-study 
heterogeneity: validation of the questionnaire (Table 3.5). Use of validated questionnaire is 
associated with a weaker protective effect of vegetable consumption. We can also observe 
that the kind of controls used, in case-control studies, may be an important factor, even if it is 
not statistically significant. When population controls are considered, pooled-estimates are 
below 1 but the upper limit of the confidence interval is close to 1 (OR=0.73 with 95% C.I. 
0.51, 1.04). At the opposite, in case-control studies with hospital controls we have a 
significant protective effect (OR=0.68 with 95% C.I. 0.56, 0.82). This may suggest that 
studies less susceptible to selection bias indicate a less strong protective effect.  
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None of the two factor interactions between the 7 characteristics of the studies listed 
in Table 3.5 was found to be statistically significant, although testing for interactions here has 
a low power.  
The number of categories used for the consumption classification  was also 
considered to see if this factor influences the results. Studies were separated into two groups: 
those that consider 3 or less levels and the ones that consider 4 or more levels. This factor did 
not seem to be relevant to explain variability between studies.  
 
3.3.4 Results from sensitivity analysis 
The largest case control study is Negri’s113 and no differences were observed in the estimates 
in Table 3.5 when this study was omitted, except that the estimates for case-control versus 
cohort studies became more similar. 
The decisions on  the indicator item selected, when an overall item (food group 
“vegetable” and food group “fruit”) was not presented, were checked. Estimates for “cooked 
vegetables” in Franceschi’s paper91, are not significantly below 1, whereas for “raw 
vegetables” the Odds Ratio is 0.73 (with 95% C.I. 0.60-0.88): therefore the decision was 
conservative. The estimate chosen from Hirose’s paper96 was the one from “green 
vegetables”, but when the estimate from “raw vegetables” (OR=1.05 with 95% CI 0.92-1.19) 
was included in its place the pooled estimate did not change (OR=0.74 with 95% CI 0.64-
0.85). In Hislop’s paper97 estimates for “yellow vegetables” and “other vegetables” where 
very similar (OR=0.8 with 95% CI 0.56-1.12 and RR=0.82 with 95% CI 0.55-1.22, 
respectively). The estimates in Richardson121 for “citrus fruits” and for “fruits rich in beta-
carotene” were exactly the same. The decision to choose “citrus fruits” instead of “other 
fruits” in Franceschi’s paper91 did not significantly modify the pooled estimate that became 
0.95 (with 95% CI 0.82-1.11). 
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The nine estimates excluded because the cut-off points were not indicated in the 
papers did not show any significant effect for the food groups and the micronutrient of 
interest. For vegetables, Van’t Veer127 and Ingram100 presented non-significant estimates 
greater than 1, whereas in Iscovich’s paper101 the OR was almost significant below 1. For 
fruits, all these three papers100;101;127 indicate a non-significant protective effect. The same 
results are indicated for Vitamin C in all the papers100;104;128 excluded and for beta-carotene in 
5105;117;119;127;128 out of 8 papers90;100;105;112;119;127;128 excluded. 
The results, shown in Table 3.6, obtained after inclusion of all possible studies (23 
for vegetables, 17 for fruits, 25 for beta-carotene and 16 for vitamin C) are very similar to 
those obtained previously with the first group of selected studies.  
 
3.3.5 Publication bias 
The existence of hypothetical unpublished data was considered and the influence that such 
data would have on my  results was studied. It was assumed that some more studies had data 
on fruit/vegetable consumption or micronutrients and breast cancer risk but that their results 
were not published because they were non-significant. To be conservative, it was postulated 
that the association with breast cancer for those studies was not protective. An average 
relative risk of 1.2 (with 95% CI 0.8; 1.8) was assumed, in order to have confidence intervals 
crossing one, because otherwise I  would expect to have seen reports on significant 
associations. The distortion analysis showed that even if I found  another seven studies with 
information on breast cancer and vegetable consumption, ten studies on breast cancer and 
beta-carotene, and another one on  Vitamin C, the hypothetical pooled estimates of the 
relative risk ratio would still be significantly below one.  
 
3.4 Discussion 
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The quantitative analysis of the published studies on the relationship between the risk of 
breast cancer and dietary habits suggests a moderate protective effect due to high 
consumption of vegetables and related micronutrients. For fruit intake, study results were less 
clear. Only two studies show a significant protective effect of high fruit intake for breast 
cancer.107;126 If the consumption pattern for  fruits is more homogenous than for vegetables, or 
vice versa, in any given population, and both groups are equally protective per amount 
consumed, then the food group with the wider range of exposures is more likely to yield a 
larger effect. From this point of view, vegetables might better discriminate between cases and 
controls. For many cancers the evidence for a protective effect of vegetables is rather stronger 
than that for fruits, perhaps reflecting the fact that vegetables are generally consumed in 
greater quantities than fruits, and thus in more variable quantities within populations.85 
Furthermore many yellow-orange vegetables such as carrots, squash and sweet potatoes, and 
dark green vegetables, such as broccoli and spinach are very good sources of nutrients such as 
vitamin C and carotenoids.144  
Forest plots are not used in this thesis because I agree with Charles Poole who 
commented a paper on Forest plots143. This Professor of the Department of Epidemiology, 
University of North Carolina, explained in the Education and Debate section of BMJ his 
aversion to the sizing of symbols for point estimates in proportion to their meta-analytic 
weight, writing that: “The expressed motivation for this special effect is to counteract a 
presumably irresistible urge for the proverbial clinician's eye to be drawn to the widest 
confidence intervals and thus to the least precise estimates. To my admittedly jaded meta-
analytic eye, however, the distended blobs representing the low-variance estimates in these 
displays connote not precision but its opposite. […]” Furthermore forest plots came from 
specially produced computer programs. Most standard statistical packages cannot easily 
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produce such a plot. Important information on the papers is available on the tables presenting 
all the main study features. 
The distributions of consumption of fruit/vegetable and intake of micronutrients 
extracted from the papers are partitioned into different percentiles: median, tertiles, quartiles 
or quintiles. Unlike pooled meta-analyses, I was not able to repartition vegetables and fruit 
consumption and micronutrients intake, but I have based the analysis on the partitions 
selected by the authors of the original reports. The pooled estimate that compared the highest 
with the lowest category of intake found in the papers was considered in order to reduce 
misclassification. This method of examining the associations addresses only the question 
whether a difference in risk exists between extreme categories of exposure. An important 
consideration is that a woman is not likely to change her diet from that of the highest to that of 
the lowest quintile, and the present estimates are intended primarily to reflect the strength of 
an observed association – an important criterion of causality. One limitation of this approach 
it that it may attenuate the summary relative risks because I have to pooled together estimates 
related to different percentiles. In fact if the intake is related to breast cancer risk the relative 
risk generated by a study that partitions fat intake into quintiles will generate a larger relative 
risk between the highest and the lowest categories of intake than does a study that partitions 
according to tertiles.  
Only few prospective studies offered information on breast cancer and 
vegetable/fruit consumption.99;122;130 Cohort studies offer the advantage of collecting data 
before the onset of the disease and are less likely to be biased. A protective effect for high 
fruit and vegetable intake was detected in each of the mentioned studies, but this effect was 
not statistically significant.   
A large heterogeneity due to mode and quality of dietary assessment has to be 
considered as well. The studies mentioned in this review assessed dietary intakes at a range of 
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different time periods (current diet, 1, 2, 5 years prior to the interview). A high correlation, 
however, exists between recalled past diet and current diet145, partly because recalled diet is 
heavily influenced by current diet and partly because diet tends to remain relatively constant 
over time. Heterogeneity due to the various time frames it is not likely to account for the 
overall  heterogeneity.  
Food Frequency Questionnaires (F.F.Q.) were used by all the studies included in this 
meta-analysis. This kind of questionnaire is characterised by several inaccuracies.142 In order 
to improve data quality, two criteria are important to be evaluated: Validity and Reliability. 
Most of the included studies presented information on Reproducibility and/or Validity. Only 
two studies96 103 provided very limited information on the dietary assessment instrument. 
Furthermore they used reduced questionnaires, which might not be able to detect variability in 
food intake within the study population. However, when these two studies were eliminated 
from the analysis, the conclusions remained the same.  
A comparison between Mediterranean countries and other European countries, with 
respect to cancer mortality rates and food availability patterns, suggests that low consumption 
of animal fat and high consumption of fruits and vegetables may contribute to a low incidence 
of coronary heart disease and several forms of cancer. Several studies105-107 in the 
Mediterranean area indicated that vegetable intake or related dietary factors may protect 
against breast cancer. 
I would wexpect that the beneficial effects of vegetables and fruit consumption were 
higher in populations who had lower baseline vegetables intakes, but in the heterogeneity 
analysis, high vegetables consumption seems to have a comparable protective effect in 
geographical areas where a “Mediterranean diet“ is prevalent (Italy, Greece and Spain) 
compared to “non-Mediterranean areas“ (USA, Argentina, Japan, Sweden, Denmark, Poland, 
Switzerland and Canada). Looking at the few papers that presented the values of the cut-off 
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points considered for the frequencies of vegetables consumption, it was not found a difference 
in the two groups: highest and lowest cut off points are similar (7 times per week vs 0-2 per 
week), but obviously the quantities could be different. 
In mediterranean countries it was observed that breast cancer rates are usually 
relatively low compared with most other Western countries. The reason for this pattern has 
not been clearly understood. A “Mediterranean diet“ is characterised by a high intake of 
vegetables and fruits in parallel with a high consumption of total fat,146 a low intake of animal 
fats and a higher consumption of olive oil compared with non-Mediterranean countries. Olive 
oil is high in monounsaturated fats and relatively low in saturated fats, as well as linoleic acid, 
and contains a relatively high amount of antioxidants, including alpha-tocopherol. 
Furthermore, a diet rich in monounsaturated fats presumably yields tissue structures that are 
less susceptible to oxidative damage than would be the case in high polyunsaturated diets.147 
For this reason a protective effect of vegetables and fruit consumption on breast cancer could 
be confounded by factors biologically independent of their content in beta-carotene or vitamin 
C.  
Many studies on diet and breast cancer risk investigated the relevance of a high fat 
intake as a risk factor for breast cancer, but the results are not consistent.145 The food pattern 
may be of special interest as high fat or energy intake is often associated with a low 
consumption of fruits and vegetables. Therefore, it is possible that a high fruit and vegetable 
consumption simply implies a lower intake of fat. An adjustment for energy-intake to address 
the issue of diet composition rather than absolute intake can be conceived.91;92;122;125-127;130 
However, there seems to be no particular influence on the estimated relative risks due to 
energy adjustment. 
The confounding issue is particularly a problem in the epidemiology of weak 
associations; the majority of breast cancer risk factors being rather weak with estimates not 
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exceeding 2. At this level, confounding by some yet unrecognised factors cannot be ruled out. 
Specific dietary habits might reflect education and consequently socio-economic status, which 
in turn, may be closely related to reproductive history. Adjustment for parity did not 
significantly explained between-study heterogeneity (p=0.33), however, when I looked at the 
pooled estimates of vegetables consumption in the two subgroups (adjusted vs not adjusted), I 
could verify that RRs not adjusted for parity indicate a significant protective effect (RR=0.68; 
95% C.I.: 0.61; 0.76) wereas the pooled estimate from RRs adjusted for parity was not 
significant (RR=0.79; 95% C.I.: 0.55; 1.14). These findings are only indicative because the 
number of studies was too small to have enough power to test the relevance of all possible 
confounding factors.     
Meta-analysis has to date been applied mainly to the results of randomised trials 
therapy. Although examples of meta-analysis directed at risk factors for disease exist there is 
no general agreement on whether studies with heterogeneous results should be combined, how 
differences in study quality should be taken into account, and whether studies with 
heterogeneous design carried out in different countries should be combined. However, in a 
sensitivity-analysis, none of these considerations weakened the conclusion drawn from this 
meta-analysis. There might be a moderate protective effect for breast cancer due to a higher 
consumption of fruit and vegetable. A meta-analysis cannot replace a well-conducted study, 
but in combination with narrative and quantitative methods a meta-analysis can be a useful 
tool for preliminary investigation. 
Finally, greater attention needs to be given to the problem of colinearity between 
antioxidants and the confounding effect caused by antioxidants. Confounding by antioxidant 
micronutrients is of particular concern, as intakes of these nutrients tend to be positively 
correlated. In addition, measurement of dietary intake does not in any way eliminate the 
possibility that some other factor in fruits and vegetables is responsible or that it simply 
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reflects evidence of a protective effect of vegetarianism for breast cancer. Either measure may 
be a marker for other substances. Dietary fibres  are found in vegetables and fruits, but  they 
also derive from legumes and unrefined grains. Among the studies  considered for this review 
only two presented risk estimates that differentiate between fibres derived from fruits and 
vegetables and fibres from other sources.92;131 Both investigators showed a significant 
protective effect for fibres derived from fruits and vegetable sources, but not for grain fibres. 
These results emphasise once more the possible role of  fruits and vegetables as a food group 
in breast cancer prevention. 
The exclusion of the pubblications92;96;109 which presented analyses separately for 
menopausal status does not change the results because they obtained results consistent with 
this meta-analysis: significantly protective values for high vegetable consumption and beta-
carotene intake, and not significantly protective effect for fruit consumption. 
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3.5 Tables 
Table 3.1. List of studies with indication of which estimates were excluded from 
meta-analysis and reasons for exclusion. 
Veg. Fr. Betac. Vit. C First Author Year 
of pub.
N. of 
cases 
N. of 
controls 
Main reasons 
for exclusion  
N.I. N.I. Exc. Exc. Ambrosone88   1995 336 413 No indep.  
N.I. N.I. Exc. N.I. Cooper89 1989 451 451 No indep. 
Exc. Exc. Exc. Exc. Freudenheim92 1996 297 311 Only pre-menop. 
Exc. Exc. Exc. Exc. Hislop97 1990 398 398 Benign breast 
disease 
Exc. Exc. Exc. Exc. Ingram100 1991 99 209 Not com. and no 
inf. 
Exc. Exc. Exc. Exc. Iscovich101  1989 150 150 No inf., no var.  
N.I. N.I. Exc. Exc. Jarvinen102 1997 88 4697* No var. 
N.I. N.I. Exc. Exc. Katsouyanni104 1988 120 120 No inf. 
N.I. N.I. Exc. N.I. Lee109 1991 200 120 Only pre-menop.
N.I. N.I. Exc. N.I. Marubini112 1988 214 215 No inf. 
N.I. N.I. Exc. N.I. Paganini-
Hill117 
1987 123 10473* No inf. 
N.I. N.I. Exc. N.I. Potischman119 1990 83 113 No inf. 
Exc. N.I. N.I. N.I. Simard124 1990 68 343 No indep. 
Exc. Exc. N.I. N.I. Toniolo125 1989 250 499 No var. 
Exc. Exc. Exc. N.I. Van't Veer127 1990 133 238 No inf. and No 
comp. 
N.I. N.I. Exc. Exc. Yuan131  1995 834 834 Continuous 
estimates and No 
comp. 
N.I. N.I. Exc. Exc. Zaridze128 1991 139 139 No inf. 
Exc. N.I. N.I. N.I. Zemla129 1984 328 585 No FFQ  
N.I., No information to obtain the estimate; Exc., excluded from the meta-analysis;. No 
indep, Not independent from other studies; No inf, No information on cut-off points, No 
comp, Not comparable categories, No var, No estimate of variance; No FFQ, No Food 
Frequency Questionnaire; (*) Number refers to the cohort size 
 
Table 3.2. List of studies included with indication of which estimates were included 
and excluded from meta-analysis and reasons for exclusion. 
Veg Fr. Betac Vit. C First Author Year 
of 
pub 
Type 
of 
study 
Country N. of 
cases 
N. of 
control 
Main 
reasons 
for excl 
Inc. N.I Exc. N.I. Ewertz 90  1990 CC Denmark 1474 1336 No inf. 
Inc. Inc N.I. N.I. Franceschi91  1995 CC Italy 2569 2588  
Inc. N.I N.I. Exc. Graham93 1982 CC USA 2024 1463 No com. 
N.I. N.I Inc. Inc. Graham94 1991 CC USA 439 1463  
N.I. N.I Inc. Inc. Graham95 1992 Co USA 344 18586*  
Inc. Inc N.I. N.I. Hirose96 1995 CC Japan 1186 23163  
Inc. N.I N.I. N.I. Hislop132 1986 CC Canada 846 862  
Inc. Inc
. 
Inc. N.I. Holmberg132 1994 CC Sweden 380 432  
Inc. N.I Inc. Inc. Hunter99 1993 Co USA 1439 89494*  
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Table 3.2b. List of studies with indication of which estimates were included and 
excluded from meta-analysis and reasons for exclusion. 
Veg Fr. Betac Vit. C First Author Year 
of 
pub 
Type 
of 
study 
Country N. of 
cases 
N. of 
control 
Main 
reasons 
for excl. 
Inc. N.I. N.I. N.I. Kato103 1992 CC Japan 908 908  
Inc. Inc. N.I. N.I. Katsouyanni105 1986 CC Greece 120 120  
N.I. N.I. Inc. Inc. Kushi106 1996 Co USA 879 34387*  
Inc. Inc. N.I. N.I. Landa107 1994 CC Spain 100 100  
Exc Exc Inc. N.I. La Vecchia108 1987 CC Italy 1108 1281 No indep.
Inc. Inc. Exc. N.I. Levi110 1993 CC Switzerland 107 318 No comp.
N.I. N.I Inc. N.I. London111 1992 CC USA 402 403  
Inc. Inc. N.I. N.I. Negri113 1991 CC Italy 2860 6147  
N.I. N.I Inc. Inc. Negri114 1996 CC Italy 2569 2588  
Inc. Inc. Inc. Inc. Nunez115 1996 CC Spain 139 136  
N.I. Inc. N.I. N.I. Nunez-Martin 116 1995 CC Spain 30 30  
Inc. N.I. N.I. N.I. Pawlega118 1992 CC Poland 127 250  
Inc. N.I N.I. Inc. Qi120 1994 CC China 244 244  
N.I. Inc. Exc. N.I. Richardson121 1991 CC France 409 515 No comp.
N.I. N.I. Inc. N.I. Rohan123 1988 CC Australia 451 451  
Inc. Inc. Inc. Inc. Rohan122 1993 Co Canada 519 56837*  
Inc. Inc. N.I. N.I. Trichopoulou126 1995 CC Greece 820 1548  
Inc. Inc. Exc. Inc. Verhoeven130 1997 Co Netherlands 650 62573* No comp.
Veg., Vegetables; Fr., Fruits; Vit. C., Vitamin C; Betac., Beta-carotene; 
Year of pub., Year of publication; Exc., Estimates excluded from the meta-analysis;  
Inc., Estimate included in the meta-analysis; N.I., No Information to obtain the estimate. 
CC, Case-control study; Co, Cohort study; No indep., Not independent from other 
studies; No inf., No information on cut-off points; No comp., Not comparable 
categories; No var., No estimate of variance 
(*) indicates that the number refers to the cohort size. 
 
Table 3.3. Estimates from meta-analysis of the RR of getting breast cancer. 
Food groups, micronut. N. of 
studies 
RR Low 
95%CI 
Up 
95%CI 
Heterog. 
Random effects model 
Vegetable 17 0.75 0.66 0.85 p<0.001 
Fruit 12 0.94 0.79 1.11 p<0.001 
Vitamin C 9 0.80 0.68 0.95 p=0.02 
Fixed effects model 
Beta-carotene 11 0.82 0.76 0.91 p=0.51 
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Table 3.4. Dose-response estimates from meta-analysis. 
Vegetables: Random effects model. Heterogeneity p<0.001 
Consumption/Intake N of studies RR Low 95% CI Up 95% CI 
3 vs 1 portions/ week 16 0.91 0.89 0.93 
4 vs 1 portions/ week 16 0.87 0.85 0.88 
5 vs 1 portions/ week 16 0.83 0.81 0.84 
6 vs 1 portions/ week 16 0.79 0.77 0.80 
Fruits: Random effects model. Heterogeneity p<0.001 
3 vs 1 portions/ week 11 0.93 0.88 0.97 
4 vs 1 portions/ week 11 0.89 0.85 0.93 
5 vs 1 portions/ week 11 0.86 0.82 0.90 
6 vs 1 portions/ week 11 0.83 0.79 0.87 
Vitamin C: Random effects model. Heterogeneity p=0.013 
100 vs 50 mg/ day 9 0.96 0.90 1.03 
200 vs 50 mg/ day 9 0.89 0.84 0.96 
300 vs 50 mg/ day 9 0.83 0.78 0.89 
400 vs 50 mg/ day 9 0.77 0.72 0.83 
Beta-carotene: Fixed effects model. Heterogeneity p=0.77 
2000 vs 1000 μg/ day 11 0.98 0.97 0.99 
3000 vs 1000 μg/ day 11 0.96 0.94 0.97 
4000 vs 1000 μg/ day 11 0.93 0.92 0.95 
5000 vs 1000 μg/ day 11 0.91 0.90 0.93 
 
Table 3.5. Estimates from meta-analysis, for breast cancer risk and vegetable 
consumption for sub-groups of studies.  
Possible heterogeneity factors N of 
studies 
RR Low  
CI 
Up 
CI 
Significance 
of factors 
<= 3 categories of consumpt. 7 0.76 0.63 0.91 p=0.98 
> 3 categories of consumption 10 0.73 0.60 0.89  
Case-control studies  14 0.71 0.60 0.81 p=0.30 
*Cohort studies 3 0.86 0.73 1.01  
Validated questionnaire 6 0.85 0.71 1.01 p=0.09 
Non-validated questionnaire 11 0.66 0.55 0.81  
Energy adjustment 5 0.73 0.64 0.83 p=0.56 
No energy adjustment 12 0.72 0.61 0.84  
Adjustment for confounders 10 0.68 0.56 0.83 p=0.22 
*No adjustm. for confounders 7 0.86 0.77 0.97  
Mediterranean countries 6 0.67 0.54 0.87 p=0.48 
Non Mediterranean countries 11 0.77 0.66 0.92  
<=50 items in FFQ 7 0.79 0.67 0.93 p=0.71 
>50 items in FFQ 10 0.71 0.57 0.87  
Popul. controls (CC studies) 4 0.73 0.51 1.04 p=0.76 
Hospital controls (CC studies) 10 0.69 0.57 0.82  
*Except for this estimate, Random effects models were used. 
Published erratum in European Journal of Cancer 2000, 36(5), 636-646 
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Table 3.6. Estimates from meta-analysis, from random effects models, when all 
possible studies are included. 
Food groups, and micronutrients N of 
studies 
RR Low 
95% CI 
Up 
95% CI 
Vegetable 23 0.74 0.65 0.84 
Fruit 18 0.91 0.79 1.05 
Vitamin C 16 0.78 0.66 0.93 
Beta-carotene 26 0.79 0.71 0.89 
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3.6 Figures 
Figure 3.1. RR estimates and CI of breast cancer and vegetables  
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Figure 3.2. RR estimates and CI of breast cancer and fruit.  
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Figure 3.3. RR estimates and CI of breast cancer and Beta-carotene.  
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Figure 3.4. RR estimates and CI of breast cancer and Vitamin C.  
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Legend of Figures 
RR, Relative Risk of “high consumption” compared to “low consumption” (for food 
groups representing “greater than 1 portion per day” versus less than 3-4 portions per 
week”, about “400 milligrams per day or more” of vitamin C compared with “70 
milligrams per day or less” and intake of “7000 micrograms per day or more” of 
carotene compared with “1100 micrograms per day or less”); CI, Confidence Intervals. 
Published in European Journal of Cancer 36(2000) 1588, Published erratum in Eur J 
Cancer 2000, 36(5), 636-646) 
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CHAPTER 4. MELANOMA AND PIGMENTED LESIONS 
 
4.1 Introduction 
Skin cancer is the most common form of cancer, affecting nearly one million people each year 
in USA. Non-melanoma skin cancers, including basal cell (BCC) and squamous cell 
carcinomas (SCC), account for the vast majority of all new skin cancers. Cutaneous malignant 
melanoma is the least common form of skin cancer but the most serious and account for about 
three-quarters of all skin cancer deaths.148  
The outcome of this systematic meta-analysis was histological confirmed cutaneous 
malignant melanoma (CMM), which is commonly divided into four histological types. These 
are superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma and acral 
lentiginous melanoma. The majority of melanomas (around 90%) are cutaneous lesions 
(superficial spreading and nodular melanomas). Melanomas also occur in the pigmented cells 
of the retina and on the mucous membranes of the nasopharyngeal sinuses, vulva, and anal 
canal. Mucosal melanoma and melanomas located on the palms, digits, soles, and nail beds 
(where acral lentiginous melanoma is found) are unique because they cannot be directly 
attributable to sun exposure and a different aetiology has to be invoked.149;150 Acral 
lentiginous melanoma was not studied from an epidemiological point of view because it is 
very rare in white-skinned populations. Lentigo maligna melanoma, that is the invasive form 
of lentigo maligna, clinically resembles other pigmented lesions such as solar lentigo or a 
superficial malignant melanoma. The data related to lentigo are consistent with very heavy 
repeated exposures over many years. 
Although cutaneous malignant melanoma is still a relatively rare neoplasm in many 
populations, incidence of cutaneous malignant melanoma was increasing world-wide in 
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Caucasian populations for several decades; between the early 1960s and the late 1980s annual 
increments of 3 to 7% were observed in 24 populations of mainly European origin,151 making 
melanoma the most rapidly increasing cancer in white populations, except for lung cancer in 
women.152 However, recent trends showing a deceleration or levelling off of the rate of 
increase in melanoma risk in cohort born after 1950 in some of those populations.153-157 As a 
result of the increasing incidence, CMM is now one of the more common cancers in white 
populations. It ranks 4th in man and 3rd in women in high incidence areas such as Australia 
and New Zealand (non-Maoris) and about 6th in medium incidence areas like the U.S. 
(whites), Scandinavia and parts of Canada.156 Another important point concerning disease 
burden is that in the U.S. it is the most common cancer in the 25-29 age group in females, and 
the second most common cancer (after breast cancer) in the 30-34 age group.158 
Earlier detection, resulting mainly from increased awareness by health providers and 
the general public, had an impact, as seen in the higher rate of increase in localized tumours. 
However there is supporting evidence that the trends reflect real changes more than increased 
diagnosis: in the U.S. from 1974-1997, all stages increased by comparable amounts and a 
decrease in the incidence rates of thick lesions shortly after the increase in thin melanoma in 
U.S., Australia and Scotland was not observed.153;156;159 Furthermore models taking into 
account a birth cohort effect proved to explain the observed trends more than those with a 
period effect.160 The steadily increasing incidence in all countries over the past 40 years 
cannot be associated with the increased awareness resulting in attention in melanomas that 
may have started to develop 10-20 years previously. Most important, mortality increased for 
decades in most fair-skinned populations,159 although there is evidence that CMM mortality 
rates are levelling or beginning to fall in recent generations in the U.S., Australia, Canada, 
Scandinavian countries and U.K.161 
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Melanoma is very rare in black people and we know very little about risk factors for 
cutaneous melanoma in more pigmented ethnic groups and in Asians. Epidemiological studies 
summarized by this meta-analysis concern Caucasian populations. Among people who are not 
black, melanocytic naevi (both common acquired and dysplastic or atypical) were identified 
as the most important phenotypic risk factor and there was recent activity directed at a better 
epidemiological understanding of this topic.150;152;162-165  
Benign naevi (moles) are non-malignant aggregations of melanocytes. Melanocyte 
density varies with different anatomical sites of the skin, increasing in density from trunk to 
extremities, head, and foreskin. In white populations, benign naevi are uncommon in the 
newborn, and increase during childhood and particularly after adolescence, reaching a peak in 
early adulthood; the prevalence falls thereafter.  
Because two-thirds to three-quarters of patients with melanomas report previous 
lesions and 25-50% have histological confirmation of an associated nevus, at least some naevi 
are probably precursors of melanoma.166 Hence, the study of acquired melanocytic naevi may 
tell us a great deal about the origins of malignant melanoma. A fairly large body of evidence 
suggests that the number of melanocytic naevi represents the best predictor for cutaneous 
malignant melanoma and that large atypical naevi may play an independent role.167-173 Risk of 
melanoma rises with increasing number and clinical atypia of naevi, from small risk in those 
with few small non dysplastic naevi, to higher risks with larger non dysplastic, to very high 
risk in those with multiple clinically dysplastic naevi.174;175 
Atypical naevi, present in 2 to 5% of Caucasian adults, are usually larger with a more 
variegated appearance, in comparison to ordinary naevi. The term “atypical nevus” is 
frequently used clinically raising the suspicion of naevi likely to be hiding underlying 
dysplasia from benign congenital or acquired naevi, whereas dysplasia is a pathologic 
diagnosis.  
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Sun exposure is the principal environmental risk factor implicated in naevi 
development and in melanoma occurrence.172;176 Number of naevi seems to be higher in those 
with high propensity to burn and light skin colour. Solar ultraviolet radiation may be 
important at two stages, in the production of benign acquired naevi, and in the transformation 
or promotion of such naevi into malignant melanoma.177 The biological correlates of such 
associations are still poorly understood, but it is plausible that factors that affect the density of 
melanocytic naevi may also influence the development of malignant melanoma later in life.  
 
4.2 Materials and methods 
4.2.1 Data sources and search strategy 
Two bibliographic databases were screened until September 30, 2002:  
• the online MEDLINE (National Library of Medicine, Bethesda, MD, USA 
(http://www.nlm.nih.gov/) using PUBMED (http://www.nlm.nih.gov/PubMed/) as 
system of querying from January 1966. 
• Elsevier Science online EMBASE (http://www.ovid.com/) from January 1988. 
No language restrictions were applied. The MEDLINE search was conducted using 
the following KEY-WORDS for titles and abstracts: nevi*, naevi*, nevo*, naevo*, nevu*, 
naevu*, mole*, pigmented lesion*, skin lesion*, cutaneous lesion*, melanocytic lesion*, in 
combination with melanoma and case control*, case-control*, cohort*, cross section*, cross-
section*, follow up*, follow-up*, followup*, prospective.  
A possible search strategy on Text Word in PUBMED cound be: (nevi*[Text Word] 
OR naevi*[Text Word] OR nevo*[Text Word] OR naevo*[Text Word] OR nevu*[Text 
Word] OR naevu*[Text Word] OR mole*[Text Word] OR moles*[Text Word] OR pigmented 
lesion*[Text Word] OR skin lesion*[Text Word] OR cutaneous lesion*[Text Word] OR 
melanoc* lesion*[Text Word]) AND (melanoma*[Text Word]) AND (case control*[Text 
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Word] OR case-control*[Text Word] OR cohort*[Text Word] OR cross section*[Text Word] 
OR cross-section*[Text Word] OR follow up*[Text Word] OR follow-up*[Text Word] OR 
followup*[Text Word] OR prospective*[Text Word]) NOT (uveal*[Text Word] OR 
ocular*[Text Word] OR animal*[Mesh]) AND ("1966"[PDat] : "2002"[PDat])  
Similar search strategies were used with the following MESH TERMS: nevus, moles 
associated with melanoma and case-control studies, cohort studies, cross-sectional studies, 
and prospective studies. The final search strategy was carried out combining the search 
strategy for “text word” and “mesh terms”. Similar search strategies were used to search 
EMBASE. The search was limited to human studies only. 
Other sources were the references of the retrieved articles and preceding reviews on 
the topic. All the retrieved references were entered into the bibliography management 
software Reference Manager 9,178 to facilitate the search for duplicate references. 
 
4.2.2 Selection of studies 
Primary inclusion criteria were developed for the selection of all relevant articles: case-
control, cohort or cross-sectional studies published as an original article. Ecological studies, 
case reports, reviews, editorials, were not considered eligible. On the basis of primary 
inclusion criteria the initial relevance of all retrieved articles was evaluated on the basis of 
title and abstract.  
As a second step, some inclusion criteria were identified, to obtain a subset of 
studies, with at least minimal information and comparable results. The following inclusion 
criteria were used: 
1. The studies have to provide sufficient information to estimate the relative risk and 
95% confidence intervals (i.e. they have to publish the Odds Ratios or Relative Risks 
or crude data and standard errors, variance, confidence intervals or p-value of the 
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significance of the estimates). An estimate and its variance are required to calculate a 
weighted pooled estimate of the RR. 
2. The studies have to be independent in order to avoid giving double weight to some 
studies. 
3. For the naevi counts the results reported have to be comparable. For this reason naevi 
counts must not be restricted only to the presence of large naevi, which have probably 
a special aetiology. Congenital naevi have not been considered in this meta-analysis 
because presence of large congenital naevi is associated to a very high risk of 
melanoma and those patients already need to be watched over with particular care, 
whereas there are many anamnestic difficulties to find small congenital naevi.20;179 
4. The populations studied should be homogeneous, at least for the main risk factor for 
melanoma. Studies could not include only cases of plantar foot, soles and vulva, 
because a distinct aetiology for non sun-exposed sites was suggested.180 Studies 
conducted exclusively on infant melanoma were excluded because they are not many 
and melanoma on infants is very rare.181 Furthermore very often infant melanoma may 
be indicators of a different pathology, as for example children with pigmentous 
Xeroderma,182 or completely different risk factors, mainly genetic.181  
 
4.2.3 Extraction and unification of the data 
A questionnaire was developed to collect some information about each study: 
• General information: year of publication, study design, study location, latitude of the 
region, mean age of study population;  
• Exposure information: definition of common naevi used, body district where the 
naevi were counted, number and profession of observers, categorization;  
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• Case information: inclusion or exclusion of specific histological types of melanoma, 
inclusion of cases with family history of melanoma, number and source of cases, 
participation rates of cases, percentages of fair skinned people in cases and in 
controls;  
• Case-control study information: source controls, matching design, blinding of case 
status, blinding of interviewers, response rates of controls;  
• Follow-up information: source study population, years of follow-up, blinding on 
exposure status and completeness of follow-up;  
• Statistical information: statistical methods used, adjusting for confounding variables 
(demographic factors, such as age and sex, baseline host characteristics such as hair, 
eye and skin colour and inherent tendency to burn or tan easily, atypical moles, sun 
exposure…), type of effect estimates (odds ratio, relative risk, standardized incidence 
ratio) with corresponding measures of precision, according the specific exposure 
category.  
Preparation of the data of the original studies for the meta-analysis was carried out 
according to a two-step procedure.  
First, since the number of common naevi was given by a range, to each class was 
assigned the number of naevi corresponding to the midpoint of the range. Highest categories 
of naevi count are often open, therefore, a value for the maximum number of naevi had to be 
specified in order to calculate numeric assignments to the categories. When no information 
about distribution of common naevi was available a fix value of 120 was set as the maximum 
value for the open-end categories. This choice was done investigating the distributions of 
naevi, looking at lower and upper limits for naevi density categories, in all included studies, 
and corresponding rough variation of number of controls and ORs. The analysis is not 
straightforward because the number of categories published varies from 2 to 6. It was seen 
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that the percentages of controls in classes with more than 100 naevi are very low (from 2% to 
7%). The studies with three categories, where the mean lowest limit for the highest category is 
53, present a mean percentage of controls in the upper categories of 18. The studies which 
consider four categories, and mean lowest limit for the highest category is 87, show that the 
mean percentage of controls in the upper category decreased to 8; the two studies that 
published six categories, and the mean lowest limit for the highest category is 110, the 
percentages of controls in the upper categories is only 4.5. In total eight studies consider 100 
as lowest limit for the upper category. Thus an upper limit for the highest categories of 120 
was considered as a reasonable value because it includes all possible situations. Effect of this 
assignment on this estimate was evaluated in the sensitivity analysis. 
For the upper categories of atypical naevi it was assigned the same amplitude as the 
preceding category, because the risk estimate is more sensitive to changes of small numbers 
of atypical naevi. A dichotomous categorization has also been evaluated. 
Secondly, the distinction among various measures of relative risk (e.g. odds ratio, 
rate ratio, risk ratio) was ignored assuming that melanoma is a rare disease. Consequently, 
every measure of association, adjusted for maximum number of confounding variables 
concerning each level of naevi count, and the corresponding confidence interval, was 
translated into log relative risk and corresponding variance with the formula proposed by 
Greenland.133 When estimates are not published, they will be calculated from crude data. To 
obtain the standard error of the log odd ratio from crude data, Woolfe’s formula was 
implemented. For Standardized Incidence Rates (SIR) the number of cases can be used to 
estimate the standard error of the log(SIR). If only the p-value is published then a “test-based” 
estimate is considered.133  
MacKie183 reported adjusted odds ratio separated for males and females and they 
were considered as two independent estimates. 
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Tucker172, Rodenas184 and Grob170 published odds ratios for common naevi with 
diameter smaller and greater of 5 mm separately; the first estimate was included in the meta-
analysis.  
Bain185 showed two estimates of risk for palpable and total self-reported nevus 
count; first one was considered for the meta-analysis. 
Marrett186 used a self administered whole-body diagram to assess nevus density with 
qualitative indications and the four categories “none”, “few”, “moderate” and “many” were 
transposed into the following numerical categories: “0”, “1-24”, “25-49” and “50+”, 
respectively. 
As for the meta-analysis on vegetables and fruit, it was decided to choose results 
from population controls if data from case-control studies were presented separately for 
hospital and population controls. As was said previously, patients who are hospitalised even 
for other diseases may be unrepresentative for the exposure distribution in the source 
population.136 However we have to take into account that population-based study requires full 
coverage of cases occurring in the population being studied and this is not always assured. 
Furtheremore sometimes in population-based studies there is low rate of response among 
controls. In these cases hospital-based estimates have to be preferred.  
In this meta-analysis two papers presented a single RR calculated considering 
hospital together with population controls, thus there was not need to make a choice. 
 
4.2.4 Data analysis strategy 
The data thus obtained were used for the statistical analysis performed with a six-step 
procedure. Details of statistical methods are reported in Chapter 2.  
In the first-step, a linear model was fitted, within each study, to estimate the relative 
risk, per one nevus of increase. The model was fitted according to the method proposed by 
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Greenland and Longnecker, which provides an estimator of the natural logarithm of RR, and 
of its standard error, requiring the estimates and the number of subjects at each category of 
naevi count. This dose-response model takes into account that the estimates for separate naevi 
categories depend on the same reference group. When number of subjects at each category of 
naevi count was not available from the papers, coefficients were calculated ignoring the 
correlation between the estimates of risk in the separate exposure levels.  
In the second step, the summarized RR was estimated pooling the study-specific 
estimates by the classical fixed effects and random effects models.70;133 The homogeneity of 
the effect across studies is assessed using the large sample test based on the Chi-squared 
statistic.70 In the third step a further analysis was carried out estimating pooled RR for 
common and atypical together, through the bivariate approach proposed by Houweling.29 
Covariance between common and atypical naevi risk estimates was not available, and 
independence was assumed in the model. An estimate of the covariance was obtained from 
the model. Log(RR) was fitted with PROC MIXED.74  
In the fourth step, possible sources of heterogeneity were investigated; sub-groups 
analyses and analysis of variance models were carried out to investigate between-study 
heterogeneity. Factors that were investigated are: publication year, country of origin, latitude, 
type of study design, matching design, sources of cases and controls, family history of cases, 
adjustment for confounding, type of naevi categorization, self count of moles. Main effects 
and interactions between the factors were explored by analysis of variance model. SAS Proc 
GLM was used to fit the random effect models on the log(RR).74 
In the fifth step, sensitivity analysis was carried out to evaluate if violations of the 
inclusions criteria, variation in assignments for mid points and upper limits, or changes on 
subgroups heterogeneity analysis may affect the results. The influence of single papers was 
also assessed. 
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Finally, in the sixth step, hypothesis that publication bias might affect the validity of 
the estimates was tested by a funnel-plot-based approach using the adjusted rank correlation 
method (Begg’s method)48 and linear regression analysis (Egger’s method)46. “Trim and fill” 
and Copas and Shi52 methods were applied. Estimates of the likely number of missing studies 
and of the adjusted RRs, calculated by imputing suspected missing studies, are provided. 
However, the adjusted results are not intended to give “better” estimates, but they can be used 
as a form of sensitivity analysis for estimating the likely impact of publication bias in the 
meta-analysis.  
 
4.3 Results  
4.3.1 Literature search and selection 
Five hundred and twenty-six articles were identified from MEDLINE, one hundred and forty 
from EMBASE (with seventy-six references found in both databases). After elimination of 
duplicates, I obtained five hundred and ninety studies. On the basis of title and keywords, 
references were evaluated using primary inclusion criteria. Of those, fifty-five articles were 
identified as potential for meta-analysis; other thirteen articles were identified checking the 
reference list for a total of sixty-eight articles. Of those forty-six were identified as fulfilling 
the secondary inclusion criteria, for a total of forty-seven datasets.  
 
4.3.2.Study characteristics 
An overview of the forty-seven datasets included in the selected groups is given in Tables 4.1. 
These forty-seven datasets included a total of 10499 cases and 14256 controls. Among the 
thirty-eight datasets dealing with common naevi, twenty-six presented the risk estimates for 
the whole body nevus count and seventeen for naevi count on arms. Twenty-seven datasets 
published the risk estimates for atypical naevi. Twenty-four studies were carried out in 
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European countries, fourteen in North America, seven in Australia and one in Argentina. I 
finally arrived at eight cohort studies, all dealing with atypical naevi, thirty-seven case-control 
studies and two nested case-control studies. 
Seventeen case-control studies used controls were population based, seven of them 
had cases from hospitals and controls drawn from the population. Eleven studies had both 
cases and controls from hospitals, five wrote cases from population (registries) and controls 
from hospitals. Among the studies with cases drawn from hospitals, two used controls drawn 
from visitors to the hospitals and one controls from neighbourhood. Two case-control studies 
used both, population and hospital-based controls. For one study information on source of 
cases and controls was not available. (Table 4.1)  
Of the thirty-eight datasets dealing with common naevi, nine presented estimates of 
risk based on self-assessment of the naevi count, while for all the twenty-seven datasets on 
atypical naevi assessment of naevi count was performed by physicians. 
 
4.3.3 Pooled RR estimates 
Relative risk estimates, and corresponding 95% confidence intervals, for the increase of one 
common nevus on whole body and arms, are presented in Figures 4.1 and 4.2, respectively. 
Relative risks for one atypical nevus are presented separately for case-control studies and 
cohort studies in Figures 4.3a and 4.3b, respectively. 
Fixed-effect model is quite unreasonable as it implies that only sampling error is 
associated with differences among estimates from studies with identical measured 
characteristics. Actually Chi-squared estimates, which evaluate between-study heterogeneity, 
are all significant (Chi=181.970, d.f.=25, p<0.001, for common naevi on whole body; 
Chi=111.738, d.f.=16, p<0.001, for common naevi on arms; Chi=390.148, d.f.=27, p<0.001, 
for atypical naevi). This is an indication that homogeneity assumption, at the base of the fixed 
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effects model, is probably not correct. Random effects models were performed for common 
naevi on whole body, common naevi on arms and atypical naevi, to take into account the 
variation among studies.  
Pooled Relative Risks (RR) and Confidence Intervals (C.I.), calculated from dose–
response models, for common naevi (whole body and arms) and atypical naevi are presented 
in Table 4.2 and Table 4.3. Statistically significant associations were found between naevi 
(common and atypical) count and melanoma. Summary estimates for common naevi, counted 
on whole body, indicate a significant risk for melanoma even for a medium-low density of 
naevi, indicated by the category “16 to 40” naevi compared to “0 to 15” naevi (pooled 
RR=1.47; 95% C.I.: 1.36, 1.59). The increase in the number of naevi is clearly associated with 
an increase in risk. People with very high naevi density (“100+” naevi) present a highly 
significant risk, almost 7 times greater (pooled RR=6.89; 95% C.I.: 4.63, 10.25) than people 
with very few naevi (“0-15” naevi). 
The count on a district (arms) confirms the association between common naevi and 
melanoma. Risk for people with more than 10 common naevi on arms is almost five times 
greater than risk for people with no naevi on arm (pooled RR=6.82; 95% C.I.: 3.05, 7.62). 
Atypical naevi count confirms to be a highly significant risk factor for melanoma. 
Presence of any atypical nevus increased the risk of 10 times compared to absence of atypical 
naevi (RR=10.12; 95% C.I.: 5.04, 20.32). Summary relative risks for having only one atypical 
nevus are already considerable (RR=1.60; 95% C.I.: 1.38; 1.85), rising up to 10.49 (95% C.I.: 
5.05; 21.76) for 5 atypical naevi (Table 4.3). 
To make a more reliable comparison between the two types of naevi, a further 
analysis was conducted on the thirty-eight studies that published both estimates only, on both 
common and atypical naevi. This analysis gives us an indication of a substantial correlation 
(R=0.36), suggesting that common and atypical naevi are not independent. I obtained similar 
 70
results to the ones obtained in the univariate analysis: pooled estimate for the increase of one 
atypical nevus (RR=1.515 and 95% C.I.: 1.372, 1.674) is much higher (p<0.001) than that for 
the increase of one common nevus (RR=1.016 and 95% C.I.: 1.012, 1.021). 
 
4.3.4 Heterogeneity analysis 
Studies included in this work vary in a number of aspects of their design and analysis. As 
previously stated, several factors that may have induced differences in outcomes were 
investigated with sub-group analyses and analysis of variance models. RR estimates, for one 
common (on whole body) and atypical nevus, by sub-group factors are shown in Table 4.4 
and Table 4.5. One study187 did not publish much information on the study design and was not 
included in several sub-groups examined for heterogeneity analysis. 
Within-subgroup heterogeneity remains highly significant for all subgroups 
identified by all possible factors (data not shown). 
Heterogeneity may be investigated in several ways. If we look at the Chi-squared 
that evaluates any differences among groups (it compares pooled estimates of each subgroup 
with the overall pooled estimate)133 it can be observed that all, but few factors, explain 
between-subgroup heterogeneity. Among studies considering common naevi in all body, only 
“dichotomization of exposure” and “adjustment for chronic sun” do not explain any between-
study variability (Chi-squared p=0.502 and p=0.918, respectively). In publications analysing 
atypical naevi, “adjustment for acute sun exposure” and “adjustment for chronic sun 
exposure” do not seem to play a significant role (Chi-squared p=0.19 and p=0.715, 
respectively). (Data not shown).  
If we investigate between-study heterogeneity by meta-regression, we can notice that 
only source of cases is an important factor that significantly affects the estimates for common 
naevi on arms. Studies with cases drawn from hospitals presented estimates lower than the 
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ones from studies with cases drawn from population (See Figure 4.4). Pooled estimate, for the 
increase of one nevus in arms, for the former (RR=1.08, 95% C.I.: 1.036; 1.125) is 
significantly lower (p=0.05, Table 4.4) than the estimate for the latter (RR=1.172, 95% C.I.: 
1.117; 1.229). If I consider studies with cases drawn from hospitals and controls drawn from 
population the pooled estimate is even lower (RR=1.07, 95% C.I.: 1.02; 1.122). 
Similar results are obtained analysing studies on atypical naevi (Table 4.5 and Figure 
4.5): when controls are drawn from hospitals the pooled estimate, for one nevus of increase, is 
significantly (p=0.02) lower (RR=1.424, 95% C.I.: 1.306; 1.553) than the pooled estimate of 
studies with controls drawn from population (RR=1.64, 95% C.I.: 1.227; 2.192) or other 
sources (RR=1.625, 95% C.I.: 1.166; 2.264). If I consider the six studies with both, cases and 
controls drawn from hospitals, the pooled RR is even lower (RR=1.312, 95% C.I.: 1.253; 
1.375). 
Type of study is an important factor (p<0.001) explaining a lot of between-study 
variability on atypical naevi (Table 4.5). Actually Figure 4.6 shows that RRs, for one atypical 
nevus, in case-control studies are much lower and more precise than in cohort studies.  
Very likely type of study is related to the type of categorization used for the 
estimates, because cohort studies used dichotomous categories to evaluate whether atypical 
naevi are present. Actually type of categorization is a significant factor for atypical naevi. 
Thirteen out of twenty-eight studies, which investigate the association between 
atypical naevi and cutaneous melanoma, published the results for a dichotomous exposure, in 
terms of presence or absence of atypical nevus (Figure 4.7). The pooled estimate (RR=2.86; 
95% C.I.: 2.05, 3.99) that evaluates the risk for the presence of any atypical nevus 
(dichotomous categorisation) is significantly (p=0.010) higher than in studies that consider 
more categories for naevi count (RR=1.60; 95% C.I.: 1.38, 1.85) (See Table 4.5). A great 
difference was also found when I considered only studies that used dichotomization 
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(presence/absence) of atypical naevi (Table 4.6). Cohort studies showed a huge relative risk 
for the presence of any number of atypical naevi (RR=39.20; 95% C.I.: 23.61; 65.08) 
whereas, if we consider only case-control studies, the pooled RR for the presence of atypical 
naevi is much lower, even if it is still quite high and statistically significant (RR=4.54; 95% 
C.I.: 2.65, 7.80) (Table 4.6).  
When only case-control studies are considered, we can observe a considerable 
reduction also in the risk estimates from dose-response models (Table 4.7). Actually the RR 
for the increase of five atypical naevi (RR=6.36 95%; C.I.: 3.80, 10.33) is twice lower than 
the RR calculated considering all types of studies together (RR=10.48, 95% C.I.: 5.05; 21.76). 
Cohort studies did not publish estimates for common naevi and it was not possible to 
investigate this aspect as with atypical naevi. Some study features were investigated only on 
case-control studies, because it was not possible to extract much information from the papers 
on the cohort studies. 
Likelihood ratio test indicates that few two-factor interactions are statistically 
significant, in the subgroup of case-control studies analysing atypical naevi, but I was dealing 
with very sparse and zeros in the tables. Testing for interactions here has low power. 
 
4.3.5 Sensitivity analysis 
Number of naevi increases until the age of 30-50 and then it decreases, thus age was 
considered the most important confounding variable for the aetiology of melanoma. The 
estimates included in the analyses were adjusted for age or come from study with matching 
for age, except for Dabkowski.188 Excluding the latter, the pooled estimate for the increase of 
one common nevus (RR=1.02; 95% C.I.: 1.01; 1.02) and one atypical nevus (RR=1.99; 95% 
C.I.: 1.72, 2.29) do not significantly change. 
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The choice of an upper limit for the highest category is necessary to obtain a mean 
value for the highest category in the dose-response analysis. The decision to assign a value of 
120 common naevi to the upper category with open end, for count on whole body, was 
investigated. Pooled random effect estimates, obtained assigning alternative upper limits for 
the open-end categories, are shown in Table 7. As can be seen, pooled estimates are sensitive 
to changes in assignments. There is a clear decreasing trend in RR estimates with increasing 
numbers for the upper category. Furthermore if we estimate the RR for the upper category, 
“100+” naevi, considering only the studies that present as lower limit a value greater than 100 
we obtain a lower estimate (RR=5.73; 95% C.I.: 3.61; 9.10 ). Thus we should be careful in the 
interpretation of the estimates for the highest categories because, at it was seen previously, 
very few subjects belong to the upper categories and in this case the RRs are not very 
stable.189  
Impact of inclusion criteria was analysed. Three studies were excluded for different 
reasons not related to dependence from other studies: Cockburn190 was non considered 
because only the risk for large nevus (larger than a pencil eraser) was estimated, while 
Green191 and Rolon192 were not included because only acral melanomas were considered in 
their studies. The pooled random effects estimate for the increase of one common nevus does 
not change appreciably (the RR without Green was RR=1.02; 95% C.I.: 1.01, 1.02) when 
Green191 was included in the analysis (RR=1.02; 95% C.I.: 1.01, 1.02). Only a slight 
difference was observed in the RR, for the increase of one common nevus on arms, when 
Rolon192 was included in the analysis (RR=1.13 with 95% C.I.: 1.09, 1.17; and RR=1.12 with 
95% C.I.: 1.08; 1.16; with and without Rolon192, respectively). If we consider large naevi 
(larger than a pencil eraser), defined in the Cockburn paper190 as atypical naevi and we 
included in the analysis the estimate published for dyzygous twins, a very slight decrease was 
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observed (RR=1.95; 95% C.I.: 1.70; 2.23; whereas the overall estimate is RR=1.96 with 95% 
C.I.: 1.71; 2.26 for each atypical nevus). 
Following considerations by some authors,193;194 the method of assessment of naevi 
would be an important aspect in study design, to be considered for the inclusion criteria. 
Actually self-assessment of the number of melanocytic naevi is difficult to perform 
accurately, and people severely underestimate the actual number. Although, the pooled RR, 
for common naevi on whole body (RR=1.020; 95% C.I.: 1.015, 1.025), from the studies (n=5) 
with self assessment of naevi count, was found very similar to the estimate obtained from 
studies (n=20) with assessment of naevi count by physician (RR=1.018; 95% C.I.: 1.013, 
1.023). For naevi count on arms, similar results were found. The pooled estimate from the 
studies (n=4) with self-assessment (RR=1.081; 95% C.I.: 1.023; 1.143) is not significantly 
different from the pooled RR from the studies (n=13) with assessment by physician 
(RR=1.144; 95% C.I.: 1.098, 1.193)  
 
4.3.6 Publication bias 
Investigation of publication bias, for common naevi counted in whole body, gives us some 
indications that probably some studies with no significant results were not published. Rank 
correlation analysis (Begg’s method48) of the funnel plot (Figure 4.8), indicates that smaller 
studies tend to report greater relative risk than greater studies (p=0.008). Similarly linear 
regression analysis (Egger’s method46) also indicates a general trend towards asymmetry of 
the funnel plot (p=0.004). The “Trim and fill” analysis suggested that the number of missing 
studies may be five and their inclusion would lead to a slightly lower pooled estimate 
(RR=1.016; 95% C.I.: 1.012, 020). 
Exploration among studies on atypical naevi (Figure 4.9) also shows that smaller 
studies tend to report greater relative risk than in general (p=0.019). Similarly linear 
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regression analysis (Egger’s method) indicates a trend towards asymmetry of the funnel plot 
(p<0.001). Using the “Trim and fill” analysis, four studies were identified in order to achieve 
symmetry of funnel plot. When the analysis was restricted to case-control studies no missing 
studies were identified.  
Lastly, no asymmetry on the funnel plot (Figure 4.10) were observed for common 
naevi counted on arms with Begg’s method (p=0.387) and linear regression analysis on the 
funnel plot (Egger’s method) (p=0.241).  
Using sensitivity analysis for publication bias proposed by Copas and Shi52 a strong 
positive trend in the funnel plot was found only for common naevi in whole body. Figure 4.11 
shows the relative risks from the included studies plotted against a measure of the uncertainty 
(standard error of the relative risk) in that relative risk. This uncertainty decreases as the size 
of the study increases, so that large studies are on the left of the plot and small studies on the 
right. The plot shows a trend for smaller studies to give more positive results than the larger 
studies. The basic idea of this method is that there should be no relation between study 
outcome and study size; the relation that we observe is simply an artefact of the process of 
selecting these studies. As the number of unpublished studies increases the estimates of the 
relative risk fall sharply.  
As was seen with Egger and Begg methods, for common naevi counted in arms there 
is no big evidence for the presence of publication bias. For atypical naevi Copas and Shi 
method give an indication for a continuous estimate less than 2 as reasonably consistent with 
the data. For example, with a RR=1.54 (95% C.I.: 1.29; 1.84) I get a p-value for the 
asymmetry of the funnel plot equal to 0.09. 
 
4.4 Discussion 
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One of the main problems with studies on naevi is to ensure valid counts. Naevi counts, 
published in even the most detailed studies, cannot be confirmed using biopsies. In 1990, the 
International Agency for Research on Cancer proposed a detailed protocol to standardize 
methodologies in nevus studies. However, even with a greater degree of standardization, 
problems arise in the inter-observer variation: up to about 10% of the variation in full body 
counts by different counters may be due to this.177 In our analysis, self-assessment of the 
number of common melanocytic naevi does seem to have significantly affected the estimates. 
The pooled estimate from the studies with self-assessment of naevi count was found very 
similar to the estimate obtained from studies with assessment of naevi count by physicians. 
Moreover as long as the error rates in counting are similar in different phenotype or sun 
exposure groups, this will not be a source of error in determining the aetiology of naevi. For 
atypical naevi none of the studies presented estimates obtained with self-assessment because 
trained personnel is needed to define clinically atypical naevi. 
In heterogeneity analysis it was seen that studies with controls are drawn from 
hospitals presented lower estimates than studies with controls drawn from population. These 
works probably published the most reliable estimates because usually assessment of naevi 
was much more precise in hospital-based studies. Population-based studies used weak and 
over-simplified measures of nevus count, such as self-assessment by the subjects or a very 
limited examination, and overall the data may be deficient of the details given through skilled 
examination. Actually in cohort studies, broad naevi classifications, as “presence/absence”, 
are used largely, whereas cases-control studies presented estimates for more complex 
categorizations of naevi counts. This may be one of the reasons for the differences found in 
the estimates, classified by type of study. RRs extracted from cohort studies are much higher 
than ORs published in case-control studies. However there may be another important factor 
that could have influenced the results. The populations of the two types of studies are 
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probably particularly different. Several characteristics were analysed and it was noted that 
mean age in case-control studies and in cohort studies is significantly (p<0.001) different: 
50.9 and 34.9, respectively (fifteen case-control studies and seven cohort studies published 
information on age of subjects). Cohort studies include much younger subjects and this 
disparity may play a special role for large naevi. Actually, for the aetiology of melanoma and 
naevi, age was considered the most important confounding variable and the number of large 
naevi at younger ages is the main predictor of melanoma occurrence.  
Usually studies carried out in clinical situations, using short interviews by busy 
medical doctors, are usually of less value also because they include patients who are 
hospitalised for some diseases and, as I said previously, they may be unrepresentative for the 
exposure distribution in the source population.136 However in regard to the assessment of 
naevi, in studies with controls drawn hospitals information is likely to be much more 
consistent and unbiased. Thus the lower RR found, including only case-control studies with 
controls drawn from hospitals, may be more reliable than the RR calculated considering 
population-based studies. Actually even if hospital-based case-control studies use control 
groups drawn from several disease categories, the large majority exclude other skin diseases 
and other cancers.  
Some of the host factors, such as pigmentation, are clearly genetic. Others, such as 
the number of naevi, density of freckles and skin type, are considered a combination of 
genetic factors and the influences of sun exposure. In many epidemiological studies nevus 
density was consistently correlated with pigmentary traits, similar to those associated with 
malignant melanoma, and with intense sun exposure and history of sunburns.195-198 
Persons with many benign naevi have more cutaneous “naevomelanocytes” and 
therefore have more total melanocytes at risk of undergoing malignant transformation than 
people with few nevi. Numerous moles might also indicates a greater genetic tendency to 
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form melanoma. Recent progress in the genetics of melanoma has led to the identification of 
two melanoma susceptibility genes: the tumour suppressor gene CDKN2A and the CDK4 
gene. CDKN2A mutations have been detected in at most 50% of melanoma-prone families 
that have been examined in Europe, North America, and Australia and CDK4 mutations have 
been described in only three families. Therefore, other genes remain to be identified. These 
highly penetrant genes can explain the high incidence of melanoma in rare families while the 
familial clustering of few melanoma cases might result from low penetrant susceptibility 
genes and/or shared environmental exposures. To assess the patterns of familial aggregation 
of three melanoma risk factors (great number of naevi, light phototype and high degree of sun 
exposure) a recent study was carried out on 66 French families with at least two melanoma 
cases.199 It was found that melanoma may not only result from specific genetic and 
environmental determinants but also from those underlying melanoma-associated phenotypes 
with complex gene-gene and gene-environment interactions. Furthermore the majority of data 
suggest that dysplastic naevi are independent risk factors for melanoma. Presence of 
dysplastic naevi does not appear to co-segregate with mutation in CDKN2A or CDK4.200  
In the heterogeneity analysis of this work, adjustment for sunlight indicators and 
other phenotypic factors do not seem to play an important role in explaining variability in the 
estimates. However relationship among naevi, sun exposure and phenotypic factors is 
certainly quite complex. Actually individuals who are prone to burning (red hair, dense 
freckling, very sensitive skin) may avoid sun exposure and develop fewer naevi than might be 
expected.177 Moreover it was suggested that the relation between sun exposure and 
melanocytic naevi might have parabolic dose-response curve.201 
Autier and co-authors in a very recent publication on naevi202 suggest that UVB 
doses would represent the principal environmental determinant of the progression from small 
to larger naevi. However they found a total absence of influence of sunburns and of difference 
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in latitude on small naevi, suggesting that biological events giving rise to small naevi could be 
linked to a component of sunlight other than UVB doses.  
A very recent study suggests an interesting new hypothesis on sun exposure and 
naevi, based on a “divergent pathway” model for melanoma occurring in different body 
sites.203 They found that melanomas on the head and neck were more likely to arise in people 
with few naevi, many solar keratoses, and who presented high levels of occupational sun 
exposure. In contrast, melanomas of the same histological type arising on the trunk tended to 
occur among people with many naevi, few solar keratoses, and lower levels of occupational 
sun exposure. They suggest that after initiation by sunlight, melanocytes of nevus-prone 
individuals are induced to proliferate and become neoplastic with little (if any) further 
requirement for sun exposure. In contrast, people with a low tendency to develop naevi 
require ongoing exposure to sunlight to drive the development of melanoma, beyond that 
required for initiation. Among these people, melanomas will tend to be on sun exposed body 
sites and will be associated with chronic sun exposure. This work stimulates further analyses 
in this field to look more deeply into risk factors for different body sites. 
 
4.5 Appendix: Reasons for exclusion 
One study190 was not considered because the authors estimated the risk only for large nevus. 
Two papers191;192 were not included because considered only acral melanomas. Nineteen 
articles were excluded because they were not independent from other studies.  
The paper by Nordlung204 was not included and the one by Roush205 was preferred 
because the latter used unconditional logistic regression to compute the odds ratio and it 
eliminated cases and controls with family history of melanoma. 
Augustsson206 and Stierner207 were not included and the one by Augustsson208 was 
preferred because the latter used total body naevi counts, whereas the former presented 
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estimates for naevi counts calculated separately for body areas. For the same reason between 
Garbe (1994)165 and Rieger209 and between Garbe (1989)210 and Kruger211 the ones by Garbe 
were preferred. 
The 204 cases and 200 controls analysed by Weiss212 in 1990 were included in the 
multicenter case-controls study with 1079 cases and 778 controls presented by Weiss213 in 
1991. 
Between Dubin’s paper, published in 1986,164 and Dubin’s paper, published in 
1990,214 the last was analysed because it excluded patients with non-melanoma skin cancer 
from controls. 
A paper by Bataille173 was not included because it presented a comparison study of 
two case-control studies of melanoma in Australia and England using the same mole-counting 
protocol that examiners had previously reported in 1996.215 
Rodenas published two papers in 1996184 and in the 1997216 on the same collective of 
subjects. Out of the two, the 1996 one was chosen, where common naevi are better described, 
by categorizing separately common naevi with diameter 2-5 mm, common naevi with 
diameter greater than 5 mm and clinically atypical naevi. 
The 106 cases analysed by Carli in 1995217 and in 1996218 were included in a 
following case-controls study published in 1999219 with 131 cases and 176 controls. 
Weinstock (1989)220 and Bain (1988)185 reported the same nested case-control study 
with self-reported nevus count. The second one was chosen because it published the results 
also for raised self-reported nevus count.  
Between Westerdahl’s221 and Masback’s222 papers the former was analysed because 
it presented crude and adjusted odds ratios, while the latter presented a stratified analysis by 
several other factors. 
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Zaridze published in Vopr.Onkol223and the Int.J.Cancer224 results concerning the 
same case-control study. The first was chosen because it is in an English version. 
Osterlind (1990)225 and Green (1985)167 published the same estimates of odds ratio 
presented in Osterlind (1988)226 and Green (1985)167 respectively, with similar description of 
the same study. The choice between them was considered indifferent. 
Landi’s study published in 2002227 was not included because it analyses a subset of 
patients reported in 2001.228 
Schneider (1994)229and Moore (1997)230 analysed the same population of employees 
of the Lawrence Livermore National laboratory. The second was chosen because it reported 
the results for a greater number of cases, 69 versus 9. 
Rigel published in 1988231 was not included and the one published in 1989232 was 
preferred because in the estimates of risk it used only invasive melanomas, while the first 
paper reported two-thirds of in situ lesions of the prospectively diagnosed melanomas. 
Rationales behind the selection of a study, between two dependent papers, are 
summarised in Table 4.9. 
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4.6 Tables 
 
Table 4.1a. Characteristics of the studies on pigmented lesions. 
First author Year 
pub 
Country  Study 
design
N° 
cases
N° 
control
Case 
source
Control 
source 
Common 
naevi 
Atypical 
naevi 
        Body Arms  
Augustsson 208 1991 Sweden CC 121 378 Pop Pop Yes - Yes 
Autier233  1994 Belgium, 
France, 
Germany 
CC 420 447 Hosp Neigh. - Yes - 
Bain 185 1988 USA N CC 98 190 Pop Pop - Yes - 
Bataille215 1996 England  CC 426 416 Pop Hosp Yes - Yes 
Beral 162 1983 Australia  CC 287 574 Hosp Pop Yes - - 
Carli 219 1999 Italy CC 131 176 Hosp Pop Yes - Yes 
Chen 234 1996 USA) CC 548 494 Pop Pop - Yes - 
Cristofolini235 1987 Italy CC 103 205 Hosp Hosp Yes - Yes 
Dabkowski188  1997 Poland  CC 74 300 Hosp Pop Yes - Yes 
Dubin214  1990 USA CC 289 527 Hosp Hosp Yes - - 
Elwood236 1986 England CC 83 83 Pop Hosp Yes Yes - 
Elwood237 1990 England CC 195 195 Pop Hosp - Yes - 
Garbe 165 1994 Germany; 
Austria; 
Switzer.  
CC 513 498 Hosp Hosp Yes - Yes 
Garbe 210 1989 Germany CC 200 200 Hosp Hosp Yes - Yes 
Green167 1985 Australia CC 183 183 Pop Pop - Yes(1) - 
Grob 170 1990 France  CC 207 295 Hosp Pop Yes Yes(1) Yes 
Grulich171  1996 Australia CC 242 276 Hosp Pop Yes Yes Yes 
Halpern238  1991 USA CC 105 181 Hosp Pop Yes - Yes 
Halpern239  1993 USA Co 2 89 - - - - Yes 
Holly169  1987 USA CC 121 139 Hosp Hosp Yes - Yes 
Holman 150  1984 Australia CC 511 511 Pop Pop - Yes - 
Kang240  1994 USA Co 2 155 - - - - Yes 
Kelly241 1997 Australia Co 20 278 - - - - Yes 
Landi 228  2001 Italy  CC 183 179 Hosp Pop+ 
Hosp 
Yes(2) - Yes 
Loria 242  2001 Argentina CC 101 249 Hosp Hosp Yes Yes - 
MacKie 183 
(wom.) 
1989 Scotland CC 181 181 Pop Hosp Yes - Yes 
MacKie 183 
(men) 
1989 Scotland CC 99 99 Pop Hosp Yes - Yes 
MacKie 175 1993 Scotland Co 5 116 - - - - Yes 
Marghoob243 1994 USA Co - 124 - - - - Yes 
Marrett 186 1992 Canada CC 583 608 Pop Pop Yes - - 
Mastrangelo 
244 
2000 Italy CC 99 104 Hosp Pop - Yes - 
Moore 230 1997 USA N CC 69 69 Pop Pop Yes - Yes 
Naldi245  2000 Italy CC 542 538 Hosp Hosp Yes - - 
Osterlind226 1988 Denmark  CC 474 926 Pop Pop - Yes - 
Rhodes  1980 USA CC 138 217 N.A N.A - - Yes 
Rigel 232 1989 USA Co 1 281 - - - - Yes 
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Table 4.1b. Characteristics of the studies on pigmented lesions. 
First author Year 
pub 
Country  Study 
design 
N° 
cases
N° 
control
Case 
source
Control 
source 
Common 
naevi 
Atypic
al 
naevi
        Body Arms  
Rodenas 184 1996 Spain CC 105 138 Hosp Visitors to 
the hosp 
Yes - Yes 
Roush 205 1988 Australia  CC 246 134 Hosp Pop+Hosp Yes - Yes 
Snels 246  1999 Holland  Co 3 166 - - - - Yes 
Sorahan247 1985 England CC 58 182 Hosp Hosp - Yes(1) - 
Swerdlow168 1986 Scotland CC 180 197 Hosp Hosp Yes Yes - 
Tiersten 248 1991 USA Co 4 157 - - - - Yes 
Tucker172 1997 USA  CC 716 1014 Hosp Hosp Yes - Yes 
Weiss 213 1991 Germany  CC 1079 778 Hosp Hosp Yes - Yes 
Westerdahl221 1995 Sweden CC 400 640 Pop Pop - Yes(1) - 
White 249 1994 USA CC 256 273 Pop Pop - Yes - 
Zaridze 224 1992 Russia  CC 96 96 Hosp Visitors to 
the hosp 
- Yes - 
N.A.=not available; Pop=population; Hosp=Hospital; Neig=Neighbourhood; 
CC=Case Control study; Co=Cohort study; N CC=Nested Case-control; (1) Only one 
arm; (2) Only back 
 
Table 4.2. Estimates from meta-analysis for common naevi.  
Whole body 
N° nevi RR Low 95% CI Up 95% CI 
0-15 1.00   
16-40 1.47 1.36 1.59 
41-60 2.24 1.90 2.64 
61-80 3.26 2.55 4.15 
81-100 4.74 3.44 6.53 
101+ 6.89 4.63 10.25 
Arms 
N° nevi RR Low 95% CI Up 95% CI 
0 1.00   
1-5 1.44 1.29 1.60 
5-10 2.48 1.90 3.23 
11+ 4.82 3.05 7.62 
For whole body N° of studies = 26 Heterogeneity Chi = 181.970 p < 0.001 
For arms N° of studies = 17 Heterogeneity Chi = 111.738 p < 0.001 
 
Table 4.3. Estimates from meta-analysis for atypical naevi. 
Nevi N. RR Low 95% CI Up 95% CI Heterog Chi p-value 
Absent 13 1.00   85.340 <0.001 
Present  10.12 5.04 20.32   
0 15 1.00   221.876 <0.001 
1  1.60 1.38 1.85   
2  2.56 1.91 3.43   
3  4.10 2.64 6.35   
4  6.55 3.65 11.75   
5  10.49 5.05 21.76   
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Table 4.4. Sub-groups analysis for common naevi.  
Common naevi (whole body) Common naevi (arms)  
Variables N° of 
studies 
RR Low 
95% CI
Up  
95% CI
P- 
value
N° of 
studies
RR Low 
95% CI 
Up  
95% CI 
P- 
value
Country            
Australia 3 1.013 1.005 1.022  3 1.147 1.065 1.235  
North America 6 1.016 1.010 1.022  3 1.117 1.041 1.198  
North Europe 6 1.027 1.013 1.041  6 1.178 1.084 1.281  
Mediterr. Europe 7 1.017 1.008 1.027  3 1.045 0.993 1.101  
Central Europe 4 1.022 1.017 1.028 0.594 2 1.146 0.999 1.315 0.485
Public. year            
83-89 9 1.023 1.012 1.034  7 1.168 1.107 1.232  
90-01 17 1.018 1.013 1.022 0.383 2 1.100 1.051 1.152 0.163
Matching            
Individ. matching 9 1.026 1.018 1.035  9 1.153 1.096 1.214  
Freq. Matching 8 1.017 1.013 1.021  7 1.109 1.051 1.17  
No matching 8 1.012 1.005 1.019 0.103 1 1.078 1.006 1.154 0.602
Source of Cases            
Hospital 19 1.019 1.015 1.024  8 1.08 1.036 1.125  
Population 7 1.018 1.010 1.025 0.738 9 1.172 1.117 1.229 0.052
Source of Controls           
Hospital 14 1.022 1.016 1.028  5 1.125 1.049 1.207  
Population 8 1.018 1.011 1.026  10 1.143 1.086 1.202  
Other 4 1.011 1.004 1.018 0.259 2 1.08 1.055 1.106 0.726
Dichotomous exp.           
No 16 1.018 1.013 1.023  14 1.146 1.095 1.199  
Yes 10 1.021 1.014 1.028 0.485 3 1.039 1.011 1.068 0.095
Self count of moles           
No 20 1.018 1.013 1.023  13 1.144 1.098 1.193  
Yes 5 1.020 1.015 1.025 0.434 4 1.081 1.023 1.143 0.277
Adjusted for phenotype charact.         
No 12 1.016 1.011 1.022  6 1.082 1.021 1.147  
Yes 14 1.021 1.015 1.027 0.355 11 1.155 1.105 1.207 0.145
Adjusted for chronic sun exposure        
No 22 0.015 0.013 0.016  14 0.278 0.222 0.306  
Yes 4 0.015 0.012 0.018 0.918 5 0.265 0.244 0.344 0.716
Adjusted for acute sun exposure         
No 17 1.017 1.012 1.022  8 1.157 1.100 1.218  
Yes 9 1.023 1.015 1.031 0.254 9 1.103 1.049 1.158 0.258
Adjusted for atypical naevi          
No 15 1.022 1.016 1.028        
Yes 11 1.015 1.010 1.020 0.229           
 p-values: for Significance of factor; RR, Relative risk estimates for one common nevus 
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Table 4.5. Sub-groups analysis for atypical naevi.  
Variables N° of
studies 
RR Low 95% CI Up 95% CI P-value 
Type of study      
Case-control 20 1.56 1.41 1.72  
Cohort 8 4.35 2.82 6.69 <0.001 
Dichotomous exp.      
No 15 1.60 1.38 1.85  
Yes 13 2.86 2.05 3.99 0.01 
Country      
Australia 3 1.77 1.14 2.76  
North America 10 2.52 1.94 3.26  
North Europe 6 2.09 1.58 2.76  
Mediterr. Europe 5 1.72 1.37 2.15  
Central Europe 4 1.44 1.24 1.69 0.45 
Publication year      
80-89 8 1.76 1.42 2.18  
90-94 10 2.63 1.85 3.76  
96-01 10 1.69 1.38 2.07 0.22 
Matching Case-control studies only 
Individ. matching 5 1.40 1.18 1.65  
Freq. matching 6 1.47 1.28 1.70  
No matching 7 1.74 1.45 2.08 0.302 
Source of Cases      
Hospital 14 1.52 1.37 1.69  
Population 5 1.51 1.18 1.92 0.179 
Source of Controls      
Hospital 9 1.42 1.31 1.55  
Population 6 1.64 1.23 2.19  
Other 3 1.63 1.17 2.26 0.023 
Family history of melanoma    
No 6 1.75 1.39 2.20  
Yes 13 1.46 1.31 1.62 0.265 
Adjusted for phenotype charact.    
No 8 1.59 1.36 1.86  
Yes 11 1.46 1.31 1.62 0.517 
Adjusted for chronic sun exposure    
No 14 1.55 1.37 1.76  
Yes 5 1.43 1.21 1.67 0.716 
Adjusted for acute sun exposure    
No 11 1.59 1.36 1.85  
Yes 8 1.42 1.29 1.56 0.494 
Adjusted for common nevi    
No 8 1.509 1.216 1.872  
Yes 11 1.513 1.362 1.681 0.830 
 P-values: for Significance of factor; RR, Relative risk estimates for one atypical nevus 
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Table 4.6. Estimates from studies that used dichotomization of atypical naevi number, 
by type of study. 
 N of 
studies 
Naevi RR Low  
95% CI
Up  
95% CI
Heterogeneity 
Chi- squared 
p-value 
for Chi 
Absent 1.00     Only case-
control 
7 
Present 4.54 2.65 7.80 19.766 0.003 
Absent 1.00     Only cohort 
studies  
6 
Present 39.20 23.61 65.08 4.81 0.440 
 
Table 4.7. Estimates from meta-analysis for atypical naevi from case-control studies.  
N° naevi RR Low 95% CI Up 95% CI 
0 1.00   
1 1.45 1.31 1.60 
2 2.10 1.71 2.54 
3 3.03 2.23 4.06 
4 4.39 2.91 6.47 
5 6.36 3.80 10.33 
 N° of studies = 13 Heterogeneity Chi = 64.694 p < 0.001 
 
Table 4.8. Estimates from meta-analysis for common naevi on whole body.  
Sensitivity analysis.  
Last category was calculated  
assigning 100 to the upper value 
N° naevi RR Low 95% CI Up 95% CI 
0-15 1.00   
16-40 1.56 1.42 1.72 
41-60 2.55 2.09 3.11 
61-80 3.95 2.95 5.27 
81-100 6.10 4.16 8.94 
101+ 13.08 7.59 22.53 
Last category was calculated  
assigning 150 to the upper value 
N° naevi RR Low 95% CI Up 95% CI 
0-15 1.00   
16-40 1.40 1.31 1.50 
41-60 2.02 1.76 2.33 
61-80 2.81 2.28 3.46 
81-100 3.90 2.96 5.13 
101+ 6.92 4.69 10.21 
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Table 4.9. List of studies excluded with reasons for exclusion. 
Articles Main reasons for exclusion 
Augustsson, 1991 206 Not independent from Augustsson ,1991 208 
Bataille, 1998 173 Not independent from Bataille, 1996 215 
Carli, 1995 217 Not independent from Carli, 1999219 
Carli, 1996 218 Not independent from Carli,1999219 
Dubin, 1990214 Not independent from 164 
Green, 1986 250 Not independent from Green, 1985167 
Green, 1999 191 Only acral melanoma 
Kruger, 1992211 Not independent from Garbe, 1989210 
Masback, 1999 222 Not independent from Westerdahl, 1995221 
Osterlind, 1990225 Not independent from Osterlind, 1988226 
Rieger, 1995209 Not independent from Garbe, 1994165 
Rodenas, 1997216 Not independent from Rodenas, 1996184 
Rolon, 1997192 Only acral melanoma 
Nordlung, 1985204 Not independent from Roush, 1988205  
Stierner, 1992207 Not independent from Augustsson, 1991208 
Weinstock, 1989220 Not independent from Bain, 1988185 
Weiss, 1991213 Not independent from Weiss, 1990212 
Zaridze, 1992223 Not independent from Zaridze, 1992224 
Landi, 2002227 Not independent from Landi, 2001228 
Schneider, 1994229 Not independent from Moore, 1997230 
Cockburn, 2001190 Estimates of risk only for large naevi 
Rigel, 1988231 Not independent from Rigel, 1989232 
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4.7 Figures 
 
Figure 4.1. RR and CI for the increase of one common nevus on whole body. 
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Figure 4.2. RR and CI for the increase of one common nevus on arms. 
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Figure 4.3a. RR and CI for the increase of one atypical nevus in case-control studies.  
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Figure 4.3b. RR and CI for the increase of one atypical nevus in cohort studies. 
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Figure 4.4. RR and CI for one common nevus on arms by source of cases. 
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Studies with cases drawn from hospitals are indicated with dark bars, drawn from 
population with grey bars.  
 
 
 
 
Figure 4.5. RR and CI for one atypical nevus by source of controls. 
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Hospital base studies are indicated with dark bars, Population–based studies with grey 
bars and Other sources for controls with dashed lines. 
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Figure 4.6. RR and CI for one atypical nevus by type of study.  
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Case-Control studies are indicated with dark bars and Cohorts with grey bars. 
 
 
 
 
Figure 4.7. RR and CI for one atypical nevus by type of categorization. 
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Estimates on naevi categorized in a Dichotomous variable are indicated with dark bars 
and in a variable Not Dichotomous with grey bars. 
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Figure 4.8. Funnel plot for common naevi on whole body.  
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Figure 4.9. Funnel plot for atypical naevi. 
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Figure 4.10. Funnel plot for common naevi on arms. 
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Figure 4.11. Log Relative risk (y) vs its Standard error (s) for common naevi. 
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CHAPTER 5. MELANOMA AND THE OTHER RISK FACTORS 
 
5.1 Introduction 
A systematic meta-analysis on all published studies from January 1984 to December 1999 is 
performed in this Chapter. All main risk factors for melanoma are investigated, except for the 
naevi count that was evaluated in the previous Chapter.  
The published literature shows strong associations of melanoma with several factors. 
Highly renowned groups such as the International Agency for Research on Cancer have 
accepted sun exposure as the main cause of cutaneous melanoma in humans.176 However 
complete or more convincing answers are still needed to many questions on sun exposure. 
They include whether the pattern of sun exposure is really important and acts independently 
of amount of sun exposure and whether sunburn makes a specific contribution to the risk of 
skin cancer. It is often difficult to separate the interrelations between sunburn history, sun 
exposure habits, ability to tan and other phenotypic factors. UV radiation may act as both an 
initiator through sunburn, for example, and a promoter, producing naevi and promoting action 
on them.251  
Assessment of sun exposure has been investigated in this chapter looking also at 
differences between intermittent and chronic patterns of exposure and a possible association 
with sunburns. Several phenotypic characteristics are also analysed (hair colour, eye colour, 
skin colour, presence of freckles and phototype), trying to investigate interrelationships and 
associations with the influence of adjustment.  
Most of the evidence relevant to the effects of different patterns of sun exposure 
comes from epidemiological studies and it is not easy to separate the effects of different 
patterns of exposure with epidemiological methods. The evidence for the association between 
sun and melanoma is often conflicting and the mechanism remains unclear. Several 
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methodological problems may bias the association between sunlight exposure and melanoma 
risk.26 A deep exploration of between-study heterogeneity and possible sources of bias has 
been carried out searching for significant differences by study features, definitions adopted, 
characteristics of the populations and of the types of analyses. 
In 1992, IARC concluded that there is limited evidence for the carcinogenicity of 
exposure to ultraviolet radiation from sunlamps and sun-beds and that there is inadequate 
evidence in humans for the carcinogenicity of fluorescent lighting.176 Most of the studies on 
sources of ultraviolet radiation, other than the sun, have several methodological 
limitations.252;253 Furthermore the power of these studies cannot be very high because of the 
presumed lag time between the relevant exposure and diagnosis of melanoma generated by 
this exposure. At the moment there is not enough evidence of any effect of other sources of 
ultraviolet radiation. Thus these factors are not included in this meta-analysis. 
It was decided not to evaluate risk factors mentioned in certain publications where 
highly contradictory evidence of an effect was reported, such as sunscreen254 and oral 
contraceptives22;255 These two risk factors were investigated in two recently published meta-
analyses256;257 where no association with melanoma was found. Diseases, therapies or 
situations that may become big risk factors for melanoma and were studied only on very small 
populations such as immunosuppressors and PUVA therapy258 or ionising radiations259 are not 
considered for the meta-analysis.  
Cutaneous lesions, which may be considered indicators of acute and chronic 
exposure to UV radiations, are included as photodamage indicators. In particular, in this 
chapter I analysed solar lentigo, actinic keratosis, solar elastosis and presence of epithelioma. 
Risk associated with family history of melanoma is evaluated by looking at this 
factor alone, in the absence of other contemporaneous risk factors. Those with a family 
history of melanoma and dysplastic naevi and/or who have a large number of naevi 
 96
themselves, are at a very high risk of developing a melanoma over their lifetime.27 The risk 
associated with this situation, called atypical mole syndrome,260;261 can be estimated as the 
product of the risk associated with the number of naevi and with family history of melanoma.  
Personal history of melanoma has not been included in the meta-analysis because 
some studies estimated a very high risk of melanoma associated with a previous 
melanoma.20;262 Such individuals are well known to be at high risk. 
Socio-economic level is regarded by some authors237;263;264 as a risk factor of 
melanoma. There is a strong social class gradient in risk: melanoma is much more common in 
higher socio-economic groups, and some studies showed that this is a social rather than a 
specific occupational factor. However it was decided not to include socio-economic level in 
the meta-analysis because there is evidence that at least a large proportion of this socio-
economic gradient can be explained by variations in sun exposure. 265 The increased risk for 
higher social classes may be due to greater opportunities for leisure and vacation activities 
involving sun exposure. Actually in several case-control studies the association is weakened 
adjusting for sun exposure.252 
Diet was not considered, although various associations with dietary factors were 
suggested for melanoma, because the available information is very limited.266 More work on 
dietary factors is needed and it would be particularly interesting to conduct this in a 
population where solar radiation is a less important feature. 
Age and sex are considered as confounding factors. They are interrelated and 
associated with different behaviours with sun exposure and they have a cohort effect on 
chronic sun exposure.267 In most societies, melanoma incidence rates are somewhat higher in 
women than in men during the reproductive age groups, being similar after the age of 60 
years.268  
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Identification of intermediate variables, that are dependent variables in causal chain 
of melanoma, is very important for the definition of disease model and consequent analysis of 
variables involved. High number of naevi is associated with cutaneous sensitivity to sun 
therefore we could consider pigmented lesions as an effect modifier. If naevi are considered 
precursors of melanoma, and their number is defined by sun exposure, the variable number of 
naevi is in the causal chain of sun exposure with melanoma, and adjusting for number of 
naevi would introduce a bias toward null effect. In Figure 5.1 a simplified disease model, 
which summarises some hypotheses on the main associations and interactions between risk 
factors and melanoma, is presented. Interpretation of factors as effects modifiers or 
intermediate variables, and their possible interactions, are discussed in the heterogeneity and 
sensitivity analyses of next paragraphs. 
 
5.2 Methods 
A literature search was performed to identify publications that contain suitable information on 
the association between all risk factors (except for naevi) and melanoma, over the period 
January 1984 to December 1999. Four hundred ninety-eight papers in total were found, but 
only one hundred and ten were independent. 
A detailed description of data sources, search strategy and data collection can be 
found in Chapter 4, where the meta-analysis on naevi is presented. A detailed description of 
the statistical methods adopted can be found in Chapter 2. As previously, statistical 
significance for the heterogeneity Chi-squared is assumed at the p-value=0.1, given the low 
power of this test.71 A bivariate approach was used to compare intermittent versus chronic sun 
exposure and sunburns in childhood versus sunburns in adulthood. Conditional independence 
was assumed at the beginning of the model because estimates on the covariance, between the 
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two variables to be compared, were not available. However an estimate of the correlation was 
obtained from the bivariate model. 
In general the estimates extracted are the published Odds Ratios (OR), Relative Risk 
(RR) or Standardized Incidence Ratio (SIR), for the highest category compared to the lowest 
category of exposure, adjusted for the maximum number of confounders.  
Inclusion criteria adopted for all following analyses are the following: 
• The studies have to provide sufficient information to estimate the relative risk and 
95% confidence intervals (i.e. they have to publish OR, RR, SIR or crude data and 
standard errors, variance, confidence intervals or p-value of the significance of the 
estimates).  
• The studies have to be independent in order to avoid giving double weight to some 
studies. Rationales for the choice to include a particular study, among a set of 
dependent studies, can be seen in the previous Chapter on naevi. In general the 
publication with the widest sample size was chosen. 
• The populations studied had to be homogeneous, at least for the main risk factor for 
melanoma. Thus studies could not include only cases of lentigo maligna melanoma 
(LMM) and acral lentiginous melanoma (ALM), as there is evidence of a different 
aetiology for these lesions. 
Most results were for all subjects, combining sexes; some of them presented results 
separately for women and men with no combined data. They were used in that form, 
producing a number of independent datasets higher than the number of studies included in the 
meta-analysis.  
I finally obtained a total of seventy-four independent studies that presented the 
minimum information necessary for the analysis and satisfied all inclusion criteria. 
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Several methodological issues, that may have biased the results, and differences in 
study designs and in population features were explored as potential sources of variation 
between estimates: type of study, blinding of subjects and/or interviewers, sources of cases 
and controls, mean age of cases and controls, percentages of fair skin in cases and controls, 
inclusion among controls of subjects with any tumours or with dermatological problems, 
inclusion of subjects with family history, exclusion of maligna lentigo and acral melanoma, 
latency period considered, country, latitude, publication year and adjustment for some 
possible confounding factors (age, sex, naevi, phenotype, phototype, sunburns, chronic, acute 
and total sun exposure, family history…). 
Heterogeneity analysis looking at the influence of adjustment for several 
confounding factors was always evaluated on the estimates coming from saturated models 
(including naevi for sun exposure analysis).  
For each risk factor, a table describing some general features of each study included 
in the analysis, graphs of ORs extracted from the papers, with corresponding confidence 
intervals, and funnel plots are presented. Sometimes further graphs are used to present relative 
risks included in the analysis, to obtain more readable estimates. When variation among 
definitions and methods of assessment of exposures are a matter of concern a further table 
with some brief descriptions is included. When some features significantly explain between-
study heterogeneity, more figures are presented to show differences among studies in terms of 
these characteristics. When publication bias is found to be significant, a plot, proposed by 
Copas and Shi52 investigating a trend between the estimates and their standard error, has been 
added.  
 
5.3 Ultraviolet radiations exposure: Introduction 
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The “Consensus Development Conference on Sunlight, Ultraviolet Radiation, and the Skin” 
in 1991 stated that the only established exogenous causal factor for cutaneous melanoma in 
white populations is sun exposure.269 Similar conclusions were reached by the International 
Association for Research on Cancer,176 which has reviewed in great detail the relation 
between melanoma and sun exposure. Several pieces of epidemiological evidence were found.  
Firstly, the closer to the equator one is, the higher the mortality and incidence rates 
of melanomas are. This has been reported in many areas such as North America and Australia. 
Melanoma is more common in the white population of Australia than any where in the world. 
Actually most Australians experience an average of seven hours or more of bright sunlight per 
day and the majority of the population lives closer to the equator. The relationship with 
latitude is less clear in Europe where melanoma incidence rates are higher in Scandinavia than 
they are in southern Europe, probably reflecting different skin pigmentation and the 
importance of recreational sunlight exposure and vacation habits.250 That trend did not apply 
in Europe as a whole but something similar was still seen within individual countries. 
Furthermore there is a relationship between the length of time that people have lived at lower 
latitudes and the risk of melanoma. Migrant studies have shown that people who move from 
less sunny places to countries such as Australia, New Zealand, Israel and California present 
lower rates than the native born population.252 
Secondly, the highest rates are seen in body sites that received the greater amount of 
sun exposure such as the face, ears, and shoulders. Per unit area of epidermis, the male ear has 
the highest incidence of melanoma of any part of the body.166 However the distribution of 
melanoma is unlike non melanoma skin cancers that occur almost exclusively on exposed skin 
areas and that are clearly more common in individuals with a great deal of outdoor exposure. 
Furthermore there is a difference in the distribution of melanoma between sexes that is 
consistent with different exposure habits. It was seen a considerable change, with time, in the 
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sites distribution, with marked increase for the trunk in males and in lower limb for 
females.160 
Thirdly, cutaneous malignant melanoma is a disease of Caucasian people (fair skin 
being more susceptible to the ill effects of sunlight) and is more frequent in sun-sensitive 
people. The risk was found higher in individuals with both phenotypic susceptibility and a 
history of sun exposure.152 
Fourthly, the incidence is higher in people with benign sun-related skin conditions. 
Patients with melanoma have a significant excess of solar elastosis, actinic keratoses, and 
non-melanoma skin cancers, which are considered measurements of cumulative sun 
damage.270  
Fifthly, even if the main evidence is based on analytical epidemiological studies, 
mutagenic and oncogenic activities of sun exposure are well documented in experimental 
animals and their role in skin ageing and the association with squamous cell carcinomas of the 
skin is well established.176 
Melanocytes are in the skin and their normal function is to respond to UVR by 
producing and distributing pigments. However melanoma does not simply increase with an 
increasing amount of accumulated exposure to ultraviolet radiation. This is illustrated by the 
fact that the incidence of melanoma is higher among indoor than among outdoor 
workers271;272  
Sun exposure is particularly difficult to assess as methods of recording and coding 
vary a lot between studies. The measurement of sun exposure is extremely complex, and no 
objective methods exist for assessment of different types of exposure, for definition of 
different categorizations of level of exposure or even consistency on the use of particular 
reference groups. Inadequate definitions result in non-differential misclassification, that is, 
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errors in the exposure classification that are independent of the case-control status and this 
may modify the results toward no effect.  
Biases may also be induced by inclusion of some histological types of melanoma. 
Actually superficial spreading melanoma and nodular melanoma are the only histological 
types relevant to test the intermittent sun exposure hypothesis. As lentigo maligna melanoma 
is strongly associated with the chronic sun exposure, and acral lentiginous melanoma occurs 
on the non-sun exposed site, their inclusion could modify the risk estimates for intermittent 
sun exposure.273  
The period in which sunlight exposure is measured is also important and the risk 
estimates are expected to vary according to induction period. However conflicting results 
have been reported, some274;275 indicating that events 20 years prior to diagnosis may 
contribute significantly, others276-278 relating melanoma risk to early childhood ultraviolet 
exposure and extending the, so called, latent period to 40-50 years prior to melanoma 
appearance. In this analysis definitions that considered widest induction periods were 
included.  
The physical dose of solar radiation, received from a given pattern of exposure, will 
vary with geographical location and latitude that define the background level of exposure. An 
hour of exposure at the latitude of, for example, Queensland gives about three times the UV 
exposure of an hour of exposure in mid latitude Europe. Elwood and Diffey279 showed that, 
for identical outdoor exposure patterns, an individual at higher latitude will receive a 
relatively lower amount of total ultraviolet dosage. The absorbed dose will vary with personal 
skin characteristics as well as clothing. The presence of constitutional factors (hair colour, eye 
colours...) may increase the sensitivity of the skin to sunlight and become important risk 
factors for melanoma.  
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For melanoma, the pattern of sun exposure several decades before diagnosis is the 
important factor, but this will be difficult to ascertain by a retrospective study. However the 
evidence implicating sun exposure in the aetiology of melanoma derives largely from case-
control studies. These types of studies have the major disadvantage that the information 
collected concerns events occurred in the past. Prospective studies, collecting exposure data 
before disease onset, would be better. In fact retrospective assessment of sun exposure implies 
potential for significant recall bias: if patients with melanoma or the interviewers are aware 
that sun light might be associated with the disease it is more likely that sun exposure will be 
reported.280 Many studies were conducted before the 1990s, and at that time much 
professional opinion was against the concept that melanoma could be related to sun exposure. 
21;281 Therefore (with the possible exception of Australia) there was little public knowledge 
about the dangers of sun exposure.  
Another crucial aspect of case-control studies is selection of representative controls. 
If they were recruited from inpatients of various hospital departments, it is unlikely that such 
controls would be representative of the case base, and thus results may be potentially biased.26 
In fact some of them use patients with other skin conditions, and even other skin cancers, as 
controls. At the opposite the response rates in studies with population based controls have in 
general been adequate. Comparisons with the source population give good evidence of 
comparability between the selected controls and their sources populations in general 
demographic features.252 Furthermore it is difficult to realize cohort studies because 
melanoma, even in high-risk countries, is still a rare disease and sun exposure is not recorded 
in any existing database. 
 
5.3.1 Extraction and homogenisation of the data on sun exposure 
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Results were classified as relating to intermittent, chronic (occupational) or total sun 
exposure. Intermittent sun exposure was generally assessed by posing questions about specific 
activities that would be likely to represent relatively severe intermittent exposure such as 
recreational activities: sunbathing, water sports, and vacations in sunny places. While 
occupational exposure to the sun is considered to be a more regular and chronic exposure. 
Total accumulation exposure is a sum of both types of exposures.  
Several studies presented more measures for the same pattern of exposure and it was 
decided to include the exposures concerning the periods of life that were widest and most 
recent. Regarding childhood exposure and adulthood exposure the second option was chosen 
because there is evidence that self-reported childhood sun exposure is less reproducible than 
sun exposure at older ages.282 This choice was checked in the heterogeneity analysis looking 
at the relevance of the latent period considered. When the decision about the most appropriate 
definition is not straightforward, the one that presented the highest prevalence among controls 
was chosen. 
The estimates adjusted for demographic factors, such as age and sex, and baseline 
characteristics, such as ethnic origin, skin pigmentation and inherent tendency to burn or tan 
easily, were favoured. Those who do not suffer when lying in the sun are likely to spend more 
time doing so, therefore an analysis looking at sun exposure without adequate adjustment for 
the sun sensitivity factors, skin pigmentation and tendency to burn will underestimate the true 
relationship. Such adjusted measures were used instead of measures adjusted for factors 
which themselves could be related to sun exposure, such as number of naevi. As was seen 
previously, melanoma risk is strongly related to the number of naevi and naevi are increased 
in individuals with high levels of sun exposure. Thus, naevi may lie in the causal pathway 
between sun exposure and melanoma and in this case the adjustment for naevi would be not 
appropriate because it would decrease the true association.283 The mechanism for the 
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association between sun exposure and melanoma may be related to the induction and/or 
transformation of naevi or the number of naevi could be considered as a potential confounder. 
There is no consensus on this issue, but I decided to treat the number of naevi not as 
confounders but as intermediates, investigating this choice in the sensitivity analysis. Relative 
risk estimates adjusted for the greater number of confounders, excluding naevi, were extracted 
from the papers. If all the published estimates were adjusted for naevi a crude estimate from 
published raw data was calculated.  
 
5.3.2 Total sun exposure 
5.3.2.1 Materials and methods 
Among the fifteen papers that investigated association between melanoma and total sun 
exposure, five164;236;251;284;285 were not independent, reporting results already described in 
other papers. I finally arrived at ten eligible independent case-control studies and eleven 
datasets because Graham286 only presented estimates separately for gender. All of them 
presented estimates referring to melanoma on all body. 
Details of all these studies, including number and sources of cases and controls, 
country of origin and assessment of exposure are given in Tables 5.1 and Table 5.2. In bold 
are indicated the definitions corresponding to the definitions for the estimates included in the 
analysis. As can be seen in Table 5.2 there are several measures of total sun exposure, which 
included a variety of definitions, measured with questionnaires, concerning all life or shorter 
periods. Definitions of total sun exposure range from a general indication of history of 
intensive sun exposure, to overall sun exposure, cumulative sun exposure in hours during the 
whole or mean hours during summer. Some of them used very sophisticated classifications 
with sun exposure indexes, or accurate calculations of the total number of hours of exposure 
or the number of hours per day, whereas some others used only broad categories. When it was 
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necessary to choose among different measures, the definitions that seem to indicate the 
highest levels of exposure were preferred, in order to decrease misclassification. 
 
5.3.2 2 Results 
Odd ratios extracted from the included papers were plotted, with their confidence intervals, in 
two figures (Figures 5.2a and 5.2b), grouping highest estimates together to be more readable.  
A random effects model was adopted because there is significant heterogeneity 
between published estimates (Chi squared=63.49 with 10 d.f.).  
Final pooled RR is not significantly greater than one (RR=1.29 with 95% C.I.: 0.82; 
2.02), suggesting no statistically significant association between total UV radiation and risk of 
melanoma. 
 
5.3.2.3 Heterogeneity analysis 
The lack of standardized measurements for sunlight exposure and the use of different baseline 
and exposure categories represent the first serious problem in assessing the effect of UV 
exposure. It is difficult to investigate heterogeneity looking at sun exposure definitions 
because they are described in a qualitative subjective way. Only induction period, considered 
in the descriptions of the total sun exposure, may be quantitatively evaluated: the majority of 
the studies considered “all life long” whereas two studies asked questions on last 20 year 
(Cristofolini 1987235) and last 10 years (White 1994249). The estimates are not significantly 
different from each other. 
Looking at all possible factors that may have induced differences in outcomes, not 
due to sampling variation, subgroup analysis shows that heterogeneity within subgroups of 
studies remains significant. However from meta-regression it was seen that three factors 
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explain some of the between-study heterogeneity: “sources of controls”, “adjustment of the 
estimates for phenotype” and “publication year”.  
Estimates with the indication of the source of controls are presented in Figure 5.3. As 
can be seen, the seven studies with controls not drawn from hospitals showed higher and more 
precise values compared to studies with controls drawn from hospitals. The pooled RR for 
studies with controls not drawn from hospitals indicates a slightly significant risk for total sun 
exposure (RR=1.78; 95% C.I.: 1.00; 3.17; Chi=35.83, d.f.=6, p<0.001). This estimate is 
different, at 8%, from the pooled relative risk of the subgroup of case-control studies with 
controls drawn from hospitals, which suggests a not significant effect of total sun exposure 
(RR=0.75 with 95% C.I.: 0.40, 1.40; Chi=14.97, d.f.=3, p=0.002). This finding may be 
explained by considering that recall bias can influence results because controls with diseases 
may be more aware of the effect of UV radiation and may more easily remember episodes of 
sun exposure. In fact three out of four estimates obtained from case-controls with controls 
based on hospitals, come from studies that include subjects with dermatological problems or 
any tumours (Graham 1985286, Dubin 1990214). All four studies with controls drawn from 
hospitals declared to have included subjects with family history. Thus recall bias was 
hypothesized as an important factor because it may modify the results towards a null effect. 
This hypothesis is also supported by the trend found by looking at publication years. As we 
have said, recall bias may be a problems for many studies performed after the 1990s. From 
Figure 5.4 it can be seen that studies published after 1990, when dangers of sun exposure 
became a public issue, showed an increased significant relative risk (RR=2.24 and 95% C.I.: 
1.27; 3.96; Chi=18.00, d.f.=4, p=0.001). Whereas studies published before 1990, when much 
professional and common opinion did not yet agree with the perception that melanoma could 
be related to sun exposure, indicated a significantly (p=0.05) lower risk (RR=0.77 and 95% 
C.I.: 0.54; 1.116; Chi=11.28, d.f.=5, p=0.05) than the studies published afterwards.  
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Investigating influence of adjustment for confounders on the fully adjusted estimates 
(see Figure 5.5), it can be observed that the four estimates adjusted for phenotype are higher 
than not adjusted. The pooled RR of the subgroups of studies for which we have estimates 
adjusted for phenotype indicates a significant risk for total sun exposure (RR=2.51, 95% C.I.: 
1.18, 5.27), with a reduction in the Chi-squared (Chi=10.6 with 3 d.f., p=0.013). The pooled 
RR for subgroups of estimates not adjusted for phenotype is lower and not significant 
(RR=1.00, 95% C.I.: 0.59, 1.71; Chi=32.71 with 7 d.f., p<0.001). Meta-regression gives a 
difference between the two groups significant at 9%. In fact adjustment for phenotype may 
influence estimate of exposure to the sun because fair people probably receive less sun 
exposure. If we do not take this into account we will obtain estimates that are lower not 
because of the sun effect but because of phenotype: fair people do not go in order to get 
suntanned. The fact that adjusted estimates are higher than unadjusted suggests that sun 
exposure may have a significant effect. 
Exclusion of lentigo maligna and acral melanoma do not have any significant effect 
on the results. Similarly, country and average latitude do not seem to have a significant effect 
in explaining between-study heterogeneity.  
It is important to notice that caution should be taken in the interpretation of these 
results because the number of studies included in the meta-analysis is not large and there may 
be a problem of multiple testing.  
 
5.3.2.4 Sensitivity analysis  
The choice to exclude from meta-analysis estimates adjusted for naevi was investigated and a 
new analysis was carried out including all relative risks adjusted for the maximum number of 
confounders. The results (RR=1.36 with 95% C.I.: 0.86, 2.16; Chi=55.92, d.f.=10, p<0.001) 
are very similar to the final RR calculated on estimates not adjusted for naevi. 
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Green published two papers on the same collective of subjects, in 1985 and 1986. 
Out of the two, I considered, as usual, the paper284 in which estimates of the relative risk are 
adjusted for the major number of confounder. This estimate is much greater than the other and 
it has very wide confidence intervals: RR=5.3 (95% C.I.: 0.9; 30.8). The RR adjusted for less 
confounders is lower (RR=1.7 and 95% C.I.: 0.4; 7.8) and it differs from the previous one 
because it does not take into account eye colour and inherent tendency to burn.250 A further 
pooled RR was calculated with the Green’s lowest estimate and a very similar value of the 
pooled RR was found: RR=1.31 (95% C.I.: 0.83, 2.03).  
Rodenas (1996)184 presented a very high estimate, but its weight is quite low 
(w=5.96) and it does not influence the pooled RR.  
It is interesting to note that there is a significant (p<0.001) difference between mean 
percentages of fair skin between cases (mean=41.65, s.e.=17.75) and controls (mean=23.72, 
s.e.=13.28), among the 9 studies that published this information. Green and Rodenas are the 
two studies with the lowest percentages of fair skin in the controls (6% and 5.8%, 
respectively) and with a big difference between cases and controls (percentages in cases are: 
13% and 36%, respectively). However they adjusted the estimates for phenotype. Meta-
regression shows that percentages of fair skin, in cases and in controls, do not seem to 
significantly explain the variability among the estimates, probably because the majority of the 
estimates are adjusted for phenotype or phototype. 
Investigation of the funnel plot (Figure 5.6) with Copas and Shi methods gives no 
indication of publication bias. 
 
5.3.3 Intermitted sun exposure 
5.3.3.1 Materials and methods 
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Forty-three papers provided information on association between melanoma and intermittent 
exposure to UV radiations, in terms of a specific recreational or vacation exposure. One of 
them (Sorahan 1985247) did not publish any information to calculate the standard errors of the 
estimates and seventeen164;212;219;222;224;225;233;251;284;285;287-294 of them were not independent. 
The twenty-five independent studies, included in the analysis, are all case-control studies 
(Moore 1997230 is a nested case-control). Herzfeld (1993)295 presented data on melanoma only 
on the trunk of males. Holly (1995)296 published data regarding a female population. Chen 
(1996)234 was not included for the calculation of the main pooled estimate because it was not 
possible to extract an estimate not adjusted for naevi. This decision was tested in the 
sensitivity analysis where further pooled estimate that includes fully adjusted estimates was 
calculated. 
Details of the studies are presented in Tables 5.3. 
The measures used to define intermittent sun exposure were recreational or vacation 
exposures, either in general or related to specific activities. Definitions adopted by different 
authors are summarized in Table 5.4. As can be seen there is a variety of different measures of 
intermittent exposure. Some of them include an indication of the amount of time spent 
outdoors during leisure and of the frequency of participation in sun-based activities such as 
sunbathing, swimming, boating skiing, gardening. Very sophisticated definitions are also 
used, with sun exposure indexes or accurate number of hours of exposure. When it was 
necessary to choose among different measures, the definitions that seem to indicate the 
highest levels of exposure were preferred, in order to decrease misclassification. “Sunbathing” 
was one of the activities favoured to represent the highest level of intermittent sun exposure, 
among the different situations evaluated by the studies (boating, skiing, gardening…). As 
mentioned at the beginning, when the decision about the most appropriate definition is not 
straightforward the variable with the highest prevalence in controls was chosen. However the 
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estimates of intermittent sun exposure, coming from the same study, were quite similar and 
the choice among them was considered not influential for the final pooled result. 
 
5.3.3.2 Results 
Estimates included for the calculation of the final pooled RR are plotted in two Figures 5.7, 
grouping highest estimates in the same plot to be more readable. As can be seen there is 
reasonably consistent evidence for a positive association between intermittent sun exposure 
and melanoma. The random effects model gives an indication of a significant risk: RR=1.58 
(95% C.I.: 1.26; 1.99).  
 
5.3.3.3 Heterogeneity analysis 
A considerable between-study heterogeneity was found (Chi-squared=133.36 with 23 d.f.; 
p<0.001). The variations in ORs and RRs is likely to be related to many factors and probably 
the considerable diversity among the definitions of intermittent sun exposure plays an 
important role. Latency period was evaluated quantitatively and it does not justify differences 
in the estimates. 
Meta-regression indicates that none of the considered factors seem to be statistically 
significant in explaining between-study heterogeneity. Heterogeneity within subgroups of 
studies remains highly significant. Nevertheless there are some similarities in the type 
variability among estimates found in total sun exposure. Pooled RR of the subgroups of 
studies with controls not coming from hospital indicates a higher significant risk for 
intermittent sun exposure (RR=1.75; 95% C.I.: 1.34; 2.29), compared to the subgroup of 
studies with controls based on hospitals that suggests a lower and not significant effect of sun 
exposure (RR=1.12; 95% C.I.: 0.76, 1.65). Again this difference may be explained by the 
problem of recall bias (towards a null effect) because controls with diseases may be more 
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aware of the effect of UV radiation and may easily remember episodes of sun exposure. 
Actually four (Bell 1987297, Dubin 1990214, Weiss 1991213 and Wolf 1998298) out of five case-
control studies with controls drawn from hospitals included subjects with dermatological 
problems. 
Investigation of influence of adjustment for phenotype and/or phototype, which was 
carried out on fully adjusted estimates, indicates trends similar to the one found for total sun 
exposure. The pooled RRs of the subgroups of estimates, adjusted for these features, indicate 
a higher significant risk for intermittent sun exposure (RR=2.24; 95% C.I.: 1.70, 2.95 for 
phenotype and RR=2.53; 95% C.I.: 1.64, 3.91 for phototype). The pooled RRs of not adjusted 
estimates are lower and not significant (RR=1.08 with 95% C.I.: 0.82, 1.42 for phenotype and 
RR=1.21 with 95% C.I.: 0.96, 1.53 for phototype). These results are consistent with the 
previous considerations that if we do not take into account phenotype and phototype we will 
obtain estimates that are lower not because of the sun effect but because people with sensitive 
skin do not go for tanning.  
Few studies published percentages of fair phototype (12 out of 24) in cases and in 
controls, but where it was possible to investigate differences in prevalence of fair phototypes 
there was not seen to be a significant difference. 
As for total sun exposure, exclusion of lentigo maligna and acral melanoma do not 
have any significant effect on the results.  
The measurements which give the strongest associations for intermittent sun 
exposures were the ones obtained in the sixteen studies conducted in European countries 
(RR=1.92 and 95% C.I.: 1.41, 2.653; Chi=94.61, d.f.=15, p<0.001), where it is possible to 
clearly see the effect of sunny vacations. Positive results were also reported in sunnier 
countries as Italy and Spain (Rosso 1998299, Carli 1995217 and Rodenas 1996184). A less 
consistent pattern was seen in Australia and USA where the pooled estimate considering only 
 113
these two countries (9 studies) is not any more significant (RR=1.19 and 95% C.I.: 0.90, 1.56; 
Chi=26.86, d.f.=8, p<0.001). If we investigate the influence of intermittent sun exposure 
during vacations we do not always obtain very reliable estimates. In Australia, for example, 
people go to places which enjoy a lower rather than a higher level of sunshine exposure. The 
major study performed in Queensland (Green 1986250) does not show a significant association 
with intermittent sun exposure. Similar results were found in the other very detailed study 
carried out in Australia (Holman 1986300), which showed positive association with some but 
not all measures of intermittent sun exposure. In this analysis we have to take into account 
that in areas with very high levels of sunshine the effect of intermittent sun exposure may be 
seen more for some specific recreational activities. In a sunny environment, recreational 
activities should involve high frequency or intensity of sun exposure to result in an 
intermittent rather than a constant pattern. It is probably easier to study intermittent exposure 
in countries as Europe where many people have a little regular exposure and increase sun 
exposure during holidays and recreational activities.  
 
5.3.3.4 Sensitivity analysis 
The choice to exclude from meta-analysis estimates adjusted for naevi was investigated and a 
new analysis was conducted including relative risks adjusted for the maximum number of 
confounders, including naevi. The pooled estimate is very similar to the previous pooled 
relative risk (RR=1.58 and 95% C.I.: 1.27, 1.97; Chi=133.27, d.f.=25, p<0.001). 
Chen (1996)234 only presented estimates separately for the four body sites and 
adjusted for naevi and did not publish information to calculate the crude estimates. For this 
reason it was excluded from the main analysis and it was included in this phase of the work. 
The four estimates being very similar (Chi-squared for heterogeneity is 0.08 with 3 d.f., p-
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value=0.99) in order to not give to much importance to this study a weighted average of the 
four estimates was considered for the analysis on the fully adjusted estimates.  
The highest estimates were presented by Grob (1990)170 and Autier (1998)301 and it 
is interesting to note that they are the only two studies, included for the final pooled RR, that 
presented an estimate based on a sun exposure index and not looking only to a single activity.  
Looking at the funnel plot (Figure 5.8), Copas and Shi method gives no indication of 
publication bias for intermittent sun exposure 
 
5.3.4 Chronic sun exposure 
5.3.4.1 Materials and methods  
Thirty-nine papers were identified concerning association between melanoma and chronic sun 
exposure. Among those articles, eight164;212;225;236;251;290-292 presented results already described 
in other papers. I analysed twenty-eight independent case-control studies, plus one nested 
case-control study and two cohort studies. Two of them (Osterlind 1988302 and Pion 1994303) 
presented estimates separately for sex therefore I finally arrived at thirty-three eligible 
independent datasets. 
Herzfeld (1993)295 presented results on melanoma found only on trunk of male 
subjects. The estimate extracted from Graham (1985)286 concerned data on a male population 
and the estimate from Holly (1995)296 on a female population. 
Chen (1996)234 was not included for the calculation of the main pooled estimate 
because it was not possible to extract estimate not adjusted for naevi, as for the other two 
measures of sun exposure. This decision was tested in the sensitivity analysis where a further 
pooled estimate, which includes fully adjusted estimates, was calculated. 
Details of the studies included in the analysis and definitions of exposure, used to 
identify chronic or occupational sun exposure, are described in Table 5.5 and Table 5.6.  
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Regular outdoor activities through occupation are likely to give the best measure of 
chronic or regular, as opposed to intermittent, sun exposure. As can be seen, occupational 
exposures were assessed with differing degrees of detail. Several of the studies used only very 
general definitions, for example occupation being predominantly outdoors or predominantly 
indoor, which is likely to be inadequate. Some others were more accurate and gave detailed 
evaluation involving assessment of habits and a quantification of time that subjects spend 
outdoors. In general, chronic exposure should be easier to document than intermittent sun 
exposure.  
 
5.3.4.2 Results 
ORs and RRs, with their confidence intervals, are plotted in two Figures 5.9, grouping highest 
estimates in the same plot, to be more readable. As can be seen there are several studies that 
present estimates lower than 1, indicating a protective effect of chronic sun exposure, but the 
confidence intervals very often includes 1,indicating a not significant effect of chronic sun 
exposure on melanoma. Even if there is a problem of heterogeneity (Chi-squared=85.3, with 
31 d.f., p<0.001), a general suggestion of a protective effect is emerges from the analysis, 
even if not significant. In fact the majority (18 out of 31) of the estimates are below 1.  
The pooled RR, obtained from the random effects model, is: RR=0.93 (95% C.I.: 
0.84; 1.04).  
  
5.3.4.3 Heterogeneity analysis 
Results from meta-regression indicate that three study features are statistically significant in 
explaining variability between studies, even if heterogeneity within subgroups remains 
significant: “source of controls”, “inclusion of subjects with dermatological problems” and 
“country of the study”. Two-factors interactions were not significant.  
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For chronic sun exposure, the relationship between source of controls and sun 
exposure, in the evaluation of the risk of melanoma, is different from that obtained for 
intermittent and total sun exposure. From Figure 5.10 it can be seen that the majority of the 
studies (thirteen out of eighteen), with controls not drawn from hospitals, showed a protective 
effect (RR lower than one) and six of them were statistically significant. The pooled RR of 
this subgroup of studies (RR=0.84, 95% C.I.: 0.71, 0.99; Chi-squared=50.03, 17 d.f., 
p<0.001) is significantly different (p=0.06) from the one obtained considering the hospital-
based studies (RR=1.07, 95% C.I.: 0.92, 1.24; Chi-squared=33.51, 13 d.f., p=0.001).  
In Figure 5.11 a histogram presents studies with the indication of inclusion of 
subjects with dermatological problems. As can be seen, the fives studies, in which it was 
stated that these subjects had been included, showed all rates greater than one. The pooled RR 
of the twenty studies that did not include subjects with dermatological problems, or did not 
say anything about it, (RR=0.82; 95% C.I.: 0.69, 0.97; Chi-squared=42.99, d.f=20., p=0.001) 
is significantly (p=0.01) lower than the RR of the studies that declared to have included them 
(RR=1.39; 95% C.I.: 1.09, 1.76). For this latter sub-group of studies the fixed effects model 
was used because the Chi-squared was not any more significant (Chi=5.27, d.f.=4, p=0.26).  
Similar results are obtained considering the subgroup of twenty-two studies coming 
from Australia, USA or UK. The majority of them (fifteen) showed rates lower than one (See 
Figure 5.12). The Pooled (RR=0.87, 95% C.I.: 0.79, 0.96, with Chi-squared=43.2, d.f.=21 
p=0.003) is significantly lower (p=0.02) than the one obtained for the other countries 
(RR=1.32, 95% C.I.: 0.91, 1.92, with Chi-squared=30.63, d.f.=8, p<0.001). 
Studies conducted in these countries in general presented a better design: many had 
controls community based (13 out of 22 studies); all of them excluded subjects with 
dermatological problems; the majority presented quite detailed information on sun exposure. 
One of the reasons may be related to the fact that the USA and Canada present quite high 
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incidence of melanoma and for many years melanoma was a matter of concern. Much 
professional opinion maintained that melanoma could be related to sun exposure and many 
studies were planned to investigate this association.  
Thus the indication of a protective effect for chronic sun exposure comes from 
studies that presented a better design: population-based controls, which stated that subjects 
with dermatological problems had been excluded and which were carried out in “high 
incidence” countries. In fact, the pooled RR calculated on the four studies that have all these 
three features suggests a significantly protective effect for chronic sun exposure and a not 
significant heterogeneity (pooled RR=0.64, 95% C.I.: 0.51, 0.81, with Chi-squared=3.35, 
d.f.=3 p=0.34). 
Elwood arrived at similar conclusions, in a review published in 199621, where he 
found an agreement between western Australia and northern hemisphere studies in terms of 
low risk of melanoma seen with heavy occupational sun exposure. In the very detailed study 
published in 1985304 Elwood suggests that the association with occupational exposure may be 
non-linear, with an increase in risk related to small amounts of occupational exposure and a 
decrease in risk with long continued heavy exposure. This mixed overall pattern may explain 
the inconsistent results arising from many other studies that do not assess the chronic sun 
exposure in enough detail. Elwood21 looked at the ratio of the risk ratios for intermittent sun 
exposure compared to occupational sun exposure and he found that the ratios of intermittent 
to chronic exposure tend to be positive for the studies with control group drawn from the 
community, or hospital control group which excludes patients with skin diseases or other 
cancers. This finding suggests that in well-conducted studies it is easier to find a clear 
distinction between the two estimates and a lower protective effect for long continued chronic 
sun exposure.  
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Among the studies classified as non hospital-based there are four that have singular 
designs: Cooke (1984)305, Vagero (1986)306, Goodman (1995)307 and Freedman (1997)308. 
Three of them also have big weights with a vast quantity of cases and controls. Goodman’s 
paper compares incidence cases of melanoma, recorded by population-based registry, to 
incidence cases of all other forms of registered cancers, with respect to declared occupation. 
Cooke’s paper compares observed and expected number of incidence cases for several 
occupational unit groups, in the New Zealand cancer registry. Freedman’s paper compares 
deaths from melanoma with non-cancer deaths, drawn from a database supported by two 
American national health institutes. Potential sunlight exposure was assessed by usual 
occupation recorded on the death certificate. Vagero’s paper presented an analysis based on 
incidence cases obtained from an extended Swedish cancer registry, created from a linkage of 
the Swedish Cancer Registry to the population census. For each case, census information such 
as occupation was known.  
Their design being different from the others and obviously information about sun 
exposure not being very detailed, a further analysis was carried out looking at their influence 
on the results. After their exclusion, the subgroup of eighteen remaining studies in high 
incidence countries, provides an estimate indicating a clear significant protective effect of 
chronic sun exposure: RR=0.81 (95% C.I.: 0.72, 0.88) and heterogeneity was not any more 
significant (Chi-squared=23.485 with 17 d.f.; p=0.134). Similar results are found when these 
four studies are excluded from the subgroups of studies obtained looking at sources of cases 
and controls. The subgroup formed by population-based studies presents a heterogeneity Chi-
squared not any more significant (12.49 with 10 d.f.; p=0.23) and the pooled estimate 
obtained with the fixed effects model suggests a higher significant protective effect of chronic 
sun exposure (RR=0.76; 95% C.I.: 0.67; 0.85). These results provide good evidence against 
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there being a clear increase in risk at maximum levels of chronic exposure, and a protective 
effect is suggested. 
Results on adjustment for phenotype and naevi, on estimates coming from saturated 
models, are similar to those obtained for total and intermittent sun exposure. The pooled RRs 
of the twenty-three estimates not adjusted for phenotype (RR= 0.92; 95% C.I.: 0.85, 1.01) and 
of the twenty-eight estimates not adjusted for naevi (RR= 0.89; 95% C.I.: 0.80, 0.99) are 
lower than the pooled RRs of the estimates adjusted for phenotype (RR=1.23; 95% C.I.: 0.75, 
1.99) and for naevi (RR=2.33; 95% C.I.: 1.51, 3.62). 
Just few studies adjust for total sun exposure (Freedman (1997)308), intermittent sun 
exposure (Cristofolini (1987)235, Weiss (1991)213) or sunburns (Cristofolini (1987)235). 
Not many studies published percentages of fair phototype (14 out of 28), but where it 
was possible to investigate differences in percentages of fair phototypes between cases and 
controls a not significant influence of this difference on the estimates was observed. 
Twenty-two studies indicated that they had excluded lentigo maligna and acral 
melanoma but their estimates are not significantly different from the others. “Blinding of 
subjects” and “matching” are also not significant in explaining variability among the 
estimates.  
 
5.3.4.4 Sensitivity analysis 
The choice to exclude from meta-analysis estimates adjusted for naevi was evaluated and a 
new analysis was conducted including relative risks adjusted for the maximum number of 
confounders, including naevi. The pooled RR is very similar to the previous one calculated on 
all not fully adjusted estimates: RR=0.94 (95% C.I.: 0.84, 1.05), with a highly significant 
between study heterogeneity (Chi=98.65, d.f.=32, p<0.001). 
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As in the previous analyses on sun exposure, Chen (1996)234 presented only 
estimates separately for the four body sites and adjusted for naevi and did not publish 
information to calculate the crude estimates. For this reason it was excluded from the main 
analysis and it was included in the previous pooled RR, calculated on estimates adjusted for 
naevi.  
Analysis was repeated with exclusion of the four peculiar big studies (Freedman 
1997308, Goodman 1995307, Vagero 1986306 and Cooke 1984305). Results are very similar to 
the previous ones and no consistent significant protective effect of chronic/occupational UV 
exposure is suggested RR=0.93 (95% C.I.: 0.81, 1.09); heterogeneity Chi-squared test 
remains still highly significant (Chi=71.07 d.f.= 27, p<0.001).  
Two of them (Osterlind 1988302 and Pion 1994303) presented estimates separately for 
sex but their estimates are quite similar to the others and the difference by sex is not 
significant. 
No indication of publication bias was found (Figure 5.13). 
 
5.3.5 Discussion on intermittent and chronic sun exposure 
Interesting considerations come from the heterogeneity analysis looking at study design 
differences. Data from detailed studies with controls drawn from community are consistent 
with the intermittent sun exposure hypothesis: particularly intense exposure to sunlight 
increases the risk of melanoma, while more regular, chronic exposure has a neutral or even 
protective effect. Very similar results were found in Nelemans’s26 (RR=1.57 95%C.I.: 1.29-
1.91 for intermittent; RR=0.73 95%C.I.: 0.60-0.89 for chronic sun exposure) and Elwood’s280 
(RR=1.71 95%C.I.: 1.54-1.90 for intermittent; RR=0.86 95%C.I.: 0.77-0.96 for chronic sun 
exposure) meta-analyses that include holder studies.  
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Elwood did not investigate between-study heterogeneity looking at possible study 
features and he presented only a pooled estimates excluding different RRs. Whereas 
Nelemans clearly use a methodology quite similar to mine showing that an important function 
of a meta-analysis is the exploration of sources of variation in study results. The author found 
that when studies with some degree of blinding were combined only a small and non-
significant effect was evident for exposure to sunlight. Conversely, in studies without 
blinding, the effect was considerably greater and significant because differential recall of past 
exposures may have introduced bias. Meta-regression, which could have been useful to 
investigate interaction between factors, was not applied because the author considered the 
number of the studies available too low to produce reliable results. In fact the number of 
studies was lower than mine because Nelemans included only case-control studies and papers 
published in English.   
To make a comparison between intermittent and chronic sun exposure on more 
comparable estimates a further analysis was performed on the nineteen studies that published 
both estimates. In Figures 5.14 are presented, for each study, intermittent and chronic sun 
exposure RRs estimated. As can be seen, in the majority of the studies the RR for intermittent 
sun exposure is higher than the RR for chronic sun exposure, even if the differences are not 
always statistically significant. In fact meta-regression indicates a significant difference 
between the two estimates (p=0.015).  
Analysing intermittent and chronic sun exposure in a bivariate approach, I obtained 
an indication of a considerable correlation (R=0.46) between the two variables but the pooled 
estimates for intermittent and chronic are quite similar to the ones obtained previously: 1.66 
with 95% C.I. (1.23, 2.24) and 0.965 with 95% C.I. (0.76, 1.22), for intermittent and chronic 
sun exposure respectively. Looking at factors explaining heterogeneity, the inclusion in the 
model of the variable indicating presence of subjects with dermatological problems makes the 
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variables “sources of cases”, “source of controls” and “countries” not any more significant, 
suggesting an association between them. All these features represent a sort of indicator of a 
well-done study design, as I discussed in the heterogeneity analysis of the univariate 
approach.  
More than in other situations these analyses should be considered with caution 
because of two main problems concerning quantification of exposure and its association with 
melanoma: recall bias and a considerable variability among definitions and measures of 
exposure. However, differences in results relating to different types of sun exposure argue 
against significant recall bias. 
One study309 had the chance to evaluate publication bias because it found that the 
degree of tanning reported was lower in the second survey following the diagnosis of the 
melanoma. However the questions and the contexts in which they were administered were not 
identical. 
A case-control study performed in twins, from 1980 to 1991, showed contrasting 
results on the effect of a possible recall bias, which was suggested for sunbathing, mole and 
freckling frequency and not for burning and tanning.310 However, as we said before, in the 
1980s when some of the big studies were carried out, there was little public perception of the 
risks of sun exposure in regard to melanoma. The acceptance of sun exposure as a danger, 
something regularly commented on in the press, came later.  
Assessment of exposure by questionnaire in a way which will allow different types 
of exposure to be separated, is difficult and requires that an interview be conducted lasting 
between 30 and 90 minutes.252 Studies carried out in clinical situations often using short 
interviews by busy medical doctors are not very reliable.  
Obviously none of the studies had the opportunity to compare responses directly 
with any pre-recorded data on sun exposure, as such data do not form part of any medical or 
 123
employment record. The lack of cohort studies is actually related to the fact that melanoma is 
in absolute terms a rare disease, and that sun exposure is not systematically recorded in any 
existing database, in the way, as for example, drug use may be recorded by medical doctors. It 
has therefore been difficult, so far, to design retrospective cohort studies. Actually in the few 
nested case-control studies, data on sun exposure are very limited. On the other hand, major 
case-control studies are characterized by good study designs by counting all newly incidence 
melanoma cases in a defined population, completing interview data on a large proportion of 
cases and controls and using detailed interview techniques.  
The complexity of the relationship between solar exposure and melanoma should not 
be surprising, as sun exposure has a wide range of effects on the skin.176 In fact the effects of 
UV exposure are modified by skin responses that attempt to protect the organism. Thus the 
increased risk associated with intermittent exposure may be because such exposures occur on 
relatively unprotected skin, giving high transmission to the level of the melanocytes. Regular 
exposure on tanned and thickening skin may be more effectively blocked at the epidermal 
level.252 
In some studies the researcher tried to look at the effect of sun exposure at different 
times in life but they were not able to make any firm conclusions primarily because recorded 
sun exposure for an individual tended to be somewhat similar throughout life. Actually 
subjects tended to behave in the same way at each period of life and it is difficult to separate 
the effects of differences in sun exposure at different ages.252 However this may represent an 
interesting aspect worthy of further investigation because migrant studies indicate that the risk 
of melanoma is much lower in subjects who arrive in a country such as Australia after the age 
of 15, whereas the risk in those who arrive at around age 5 is similar to the risk of the native 
country. This suggests that exposure in childhood may be particularly important.  
 124
Some authors suggest that the various opportunities for sun exposure may combine 
their effect throughout life.301 Impact of adult sun exposure on melanoma risk may be 
influenced by sun exposure experiences during childhood. An adult with moderate sun 
exposure, but who was heavily exposed to the sun during childhood, could perhaps be at 
greater risk of developing a melanoma than an adult with high sun exposure but who was 
protected against solar radiation during childhood.  
Thus impact of sun exposure on melanoma risk in different periods of life was 
investigated in this work, analysing effects of sunburn experiences in childhood and as adult. 
 
5.3.6 Sunburn history: Introduction  
Sunburn is an inflammatory reaction that arises following acute exposure of the skin to 
intense solar radiation. It is noticeable by erythema, pain and dermal edema, and if severe, by 
blistering and desquamation of epidermis.  
Many studies show positive associations between melanoma risk and a history of 
sunburn but a straightforward interpretation of this association is complicated. In fact such 
experience, unlike everyday sun exposure, is unlikely to be forgotten and, for this reason, 
many studies consider sunburn as a marker of acute sun exposure.24  
Furthermore this inflammatory reaction may represent the increased risk of those 
with high susceptibility rather than a direct effect of the presence of sunburn. Sunburns and 
reported skin types are obviously highly correlated but the reasons for this may not be simple. 
It would seem reasonable to assume that subjects would report their skin type based upon 
their past sunburn experience. Actually skin type is usually described in terms of tanning 
ability or as susceptibility to burning and it may becomes a crude surrogate measure for 
sunburn history. It is arguable whether this factor should be treated as a confounder for the 
association between sunburn and melanoma. While skin type certainly confounds the 
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association between sun exposure and sunburn, it cannot confound any association between 
sunburn and melanoma. Thus sunburn is considered by many authors24;250;220 a biological 
marker of high dose of ultraviolet radiation penetrating to the melanocytes at the base of the 
epidermis, regardless of the degree of pigmentation in the epidermis. Nevertheless a history of 
sunburn should be associated with unusually intense sun exposure and skin sensitivity and 
therefore both questions must be addressed to make the data meaningful.  
Investigating whether the risk related to sunburn is constant throughout life or 
whether a critical period exists during which exposure is more harmful, Weinstock (1989) 220 
found significant positive effects with sunburns at ages “15-20” but not at age “30+” and 
these results are adjusted for skin sun sensitivity. The biological hypothesis is based on the 
idea that, among older subjects, the accumulation of UV may have induced skin damage over 
time and this may leave them more susceptible to the harmful effects of following sun 
exposure. Therefore one may speculate that young individuals, who experience severe, 
blistering sunburn, may show a short-term high risk of melanoma during those years. Those 
among them who do not develop melanoma at young age may subsequently tend to avoid sun 
exposure, thus we find a decreasing risk of melanoma at older ages, similar to those who 
never experienced sever sunburn whit blistering.251  
It would have been useful to distinguish whether the influence of age may be 
explained looking at a specific and critical age related sensitivity to sunlight in childhood or to 
a difference in dose. In this meta-analysis it was not possible to go into much depth because 
few studies actually include this information. In order to take into account age effect, separate 
meta-analyses on sunburns in childhood and in adulthood were carried out.  
As for sun exposure, measures adjusted for demographic factors, such as age and 
sex, and baseline characteristics, such as ethnic origin, skin pigmentation, were favoured, 
instead of measures adjusted for factors which themselves could be related to sun exposure, 
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such as number of naevi. The early influence of sun exposure may be related to the natural 
history of acquired naevi, whose frequency rises from childhood to peak in late adolescent 
and early adult life, and then diminishes in the late twenties and subsequently. If the number 
of naevi in young adults is related to previous sun exposure, UV may increase the frequency 
of naevi and also stimulate their dysplastic development. The adjustment for naevi may 
therefore not be appropriate because, if these relationships are true, it will diminish the true 
association, as naevi would lie in the causal pathway between sunburns and melanoma. Thus 
crude estimates are preferred to estimates adjusted for naevi. This choice has been evaluated 
in the sensitivity analyses. 
 
5.3.7 Sunburn in childhood 
5.3.7.1 Materials and methods 
Seventeen papers regarding the association between melanoma and sunburn in childhood 
were found. Among these, four225;290;291;299 were not independent. I finally arrived at thirteen 
eligible independent papers: twelve case-control studies and one nested case-control (Moore 
1997230), which evaluated risk of all-body melanoma. Holly 1995296 presented data 
concerning a population of only women. 
Details of all these studies, including number of cases and controls, country of origin 
and definition of exposure, are given in Tables 5.7. The definition of an episode of “sunburn” 
varied considerably among studies (Table 5.8). When in a study more variables indicating 
sunburn experiences were published, the one that expressed the greater level of severity was 
chosen to minimize the chance of misclassification. For example, from “Sunburn with 
blistering” and “Painful sunburn” the first one was chosen. Zanetti292 presented three 
estimates for sunburns in childhood: “often”, “severe” and “yes”. In order to be conservative 
last one was chosen because it presented the lowest value. 
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In this analysis “childhood” was defined as considering subjects of no more than 
fifteen years of age. However classification of periods of life varied a lot among publications, 
from use of specific age categories, to use of undefined periods such as “childhood”, 
“adolescent” and “adulthood”. Weinstock (1989)220 was not included because the age period 
considered is “15-20” and it was not coherent with the other definitions of childhood 
sunburns. 
 
5.3.7.2 Results 
Estimates included for the calculation of the final pooled RR are plotted in the Figures 5.15, 
grouping in the same plot estimates with very wide confidence intervals to have more 
readable values. As can be seen, even if the Chi-squared test shows significant between study 
heterogeneity (Chi-squared=63.33, d.f.=12, p<0.001), there is convincing consistent evidence 
for a positive association between sunburns in childhood and melanoma. Random effects 
model gives an indication of a significant risk: RR=2.23 (95% C.I.: 1.54; 3.23).  
 
5.3.7.3 Heterogeneity analysis 
Meta-regression indicates that none of the study features seem to be statistically 
significant in explaining between study heterogeneity. However we have to take into account 
that the number of studies included in this meta-analysis is not large and it is difficult to find 
significant reliable results.  
From meta-regression, adjustment fon any confounders does not seem to 
significantly explain variability among the estimates. However a history of sunburn indicates 
both an unusually intense exposure and skin sensitivity, and therefore studies which assessed 
sunburn while controlling for sensitivity, through a separate question on tendency to burn, are 
important. Looking at the influence of adjustment by sub-group analysis, on the fully adjusted 
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estimates, it was observed that heterogeneity is not any more significant (Chi-square=14.58, 
d.f.=9, p=0.10) for the subgroup of 10 studies that adjusted for phenotype. Furthermore, the 
pooled estimate from the fixed effects model is lower than the one obtained in the main 
analysis, but it still statistically significant RR=1.67 (95% C.I.: 1.39, 2.01). Only three studies 
did not adjust for phenotype and the pooled estimate from these three studies is not very 
reliable because it presents very wide confidence intervals (RR=1.96; 95% C.I.: 0.51, 7.61). If 
we look at the six studies that published two estimates, adjusted and not adjusted, we have 
results similar to the ones obtained for sun exposure. The pooled adjusted estimate, obtained 
with the fixed effects models (heterogeneity is not any more significant: Chi=7.61, d.f.=6, 
p=0.18 and Chi=6.48, d.f.=6, p=0.26, for adjusted and not adjusted respectively), is lower 
(RR=2.03, 95% C.I.: 1.43; 2.90) than the not adjusted one (RR=2.82, 95% C.I.: 2.02; 3.95). 
However the pooled RR remains highly significant.  
When I considered the six studies that adjusted for phototype or other measures of 
skin sensitivity, again the pooled adjusted estimate, obtained with the fixed effects model 
(heterogeneity not significant: Chi=6.75, d.f.=5, p=0.24) is lower (RR=1.61, 95% C.I.: 1.24; 
2.11) than the not adjusted one (RR=2.02, 95% C.I.: 1.01; 5.04). However the pooled RRs 
remains highly significant. Therefore this meta-analysis demonstrated a strong association 
between melanoma risk and sunburns history, which persisted after controlling for tendency 
to burn and other measures of skin sensitivity. 
Only six studies published information on percentages of fair skin subjects in the 
sample under study. Looking at these percentages in cases and controls it was seen a highly 
significant difference (p<0001) in the percentages of fair skin subjects between cases and 
controls in the different studies (mean percentage=45.7 in cases and 27.2 in controls). 
However this difference is not significantly associated with the estimates, probably because 
the majority of them are adjusted for phenotype or phototype. 
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None of the studies adjusted for total sun exposure or chronic sun exposure and only 
one (Autier 1998301) adjusted for intermittent sun exposure.  
 
5.3.7.4 Sensitivity analysis  
The pooled RR calculated on fully adjusted estimates shows a decreased risk, even if still 
significant, for sunburns in childhood RR=1.87, (95% C.I.: 1.32, 2.67). Heterogeneity also 
decreases but remains highly significant: Chi-squared=48.65 with 12 d.f., p<0.001. 
Holly 1995296 presented data concerning a female population but the results from this 
study are not significantly different from the others. 
A slight asymmetry can be observed in the funnel plot. However the sensitivity 
analysis on publication bias proposed by Copas and Shi evaluates a not significant p-value 
(p=0.36) for the fit to the funnel plot (Figure 5.16) suggesting a not significant effect of 
publication bias.  
 
5.3.8 Sunburns in adulthood 
5.3.8.1 Materials and methods 
Thirty-five papers were identified on the association between melanoma and sunburn in 
adulthood. Ten studies164;217;219;225;250;251;265;290;291;293;299, out of the thirty-five papers found, 
presented results on data already used in other papers. One study (Sorahan 1985247) was 
excluded because it did not publish information to calculate the variance of the estimates. I 
finally used twenty-five independent case-control studies (two were nested case-control 
studies: Weinstock 1989220 and Moore 1997230) and twnty-six datasets because Mackie 
(1989)183 presented estimates separately for sex. Holly (1995)296 and Weinstock (1989)220 
analysed female populations. As for sun exposure, Chen (1996)234 and Green (1986)250 were 
not included for the calculation of the main pooled estimate because it was not possible to 
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extract an estimate not adjusted for naevi. A further pooled estimate with their inclusion is 
presented in the sensitivity analysis. 
General features of studies included in the analysis are shown in Tables 5.9.  
The variety of definitions for sunburns, considered by the authors, are presented in 
Tables 5.10. Those chosen for the meta-analysis are indicated in bold. As can be seen the 
definitions of an episode of sunburn vary considerably among studies. Sunburn was defined 
considering “blistering”, “erythema”, asking about type of pain, using a “vacation sunburns 
score”, or evaluating simply “ever sunburns”. 
To assess the event in adulthood it was decided to include studies with clear 
indication that experiences occurred at major age (>19 years of age) or more general, when 
the exact age was not expressed. The choice to include both types of definitions was 
investigated in the heterogeneity analysis looking at latency period.  
When papers presented more definitions of sunburn I included the ones with the 
widest period of exposure (for example, between “sunburns 5 years before diagnosis” and 
“sunburns 18-20 years before diagnosis” I have chosen the later) and the most severe sunburn 
description (for example, between “painful erythema” and “blistering sunburns” the latter was 
chosen). Grob (1990)170 presented estimates for two quite comparable definitions of sunburn: 
“Frequency of sunburns per year in recent years: >2” and “Severity of sunburn in recent 
years: at least one severe burn”. The first one was chosen because apparently the second one 
presented some inconsistencies with levels of sunburn severity assigned to people that never 
had sunburns.  
Carli published estimates obtained by two different datasets, acquired from the same 
study, in two papers: the one published in 1999219 included the data investigated in 1995217. In 
the 1999 Carli presented two estimates with huge confidence intervals, regarding sunburns in 
adulthood and in childhood: OR=2.7 (95% C.I.: 0.4; 29.4) and OR=4.9 (95% C.I.: 0.4; 265.0) 
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respectively. In 1995 Carli presented a more precise estimate concerning sunburns lifetime: 
OR=1.8 (95% C.I.: 0.6, 5.5). The reason for the considerable difference in the estimates was 
not worked out by looking at the difference in the sets of confounders (sex, country of birth 
and residence, for the study in 1995, and age, sex and level of education, for the study in 
1999) and by looking at the categories that are compared (“Never, occasionally, easily, 
usually” in 1995 and “0, 1-2, 3-5, >5” in 1999). To be consistent with the previous choices the 
most recent study (Carli 1999219), which analyses the biggest number of cases and controls, 
was chosen for the main pooled RR, but this choice was investigated in the sensitivity 
analysis. 
 
5.3.8.2 Results 
Estimates, included for the calculation of the final pooled RR, are plotted in two Figures 5.17a 
and 5.17b. Highest estimates are grouped in the same plot, to be more readable. It can be 
noticed that all the estimates are greater or equal to 1 indicating a risk factor for adulthood 
sunburns and, even if the lowest limits of the confidence intervals are not all above 1, there is 
reasonable consistent evidence for a positive association between adulthood sunburns and 
melanoma.  
The random effects model gives an indication of a significant effect (RR=1.84; 95% 
C.I.: 1.54, 2.20) and between-study heterogeneity is highly significant (Chi-squared=47.6 
with d.f=22., p=0.001). 
 
5.3.8.3 Heterogeneity analysis 
Meta-regression indicates that the only characteristic explaining variability among the 
estimates is latitude: at higher latitudes we have a greater association between sunburns and 
melanoma (p=0.022). Latitude was calculated by looking at the city where the study is 
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conducted, whereas for studies performed on whole regions the average latitude was 
considered. When I categorized the variable “latitude”, comparing the studies done in 
countries at latitude greater than 50 with the ones conducted in countries at latitude lower than 
50 (see Figure 5.18), the p-value was even lower than considering latitude as continuous 
variable (p=0.005). The studies are quite well distributed in the two subgroups and the 
average latitude among all the studies is 48. Chi-squared tests, assessing heterogeneity within 
the two subgroups of studies, are not any more significant (Chi=14.82, d.f.=10, p=0.139 for 
latitude<50, and Chi=15.59, d.f.=10, p=0.148 for latitude>50). The pooled estimates, from the 
fixed effects model, is much higher for the studies at higher latitudes (RR=2.34; 95% C.I.: 
1.93, 2.82) suggesting an higher risk for melanoma due to sunburns at higher latitudes. 
However for the studies carried out at lower latitudes the pooled estimate still indicates a 
significant association between melanoma and sunburns (RR=1.42; 95% C.I.: 1.23, 1.65).  
One study (Weinstock 1989311) was not included in the heterogeneity analysis that 
evaluates latitude because it was carried out in different parts of the USA.  
This finding may be explained taking into account that at higher latitudes the 
frequency of fair skinned people is greater and also intermittent sun exposure probably plays a 
special role inducing more easily sunburn episodes. Actually several authors169;311;312 consider 
sunburn history to be an important indicator of intermittent sunlight exposure. Furthermore 
some suggest that the effects of intermittent sunlight exposure can be best studied in 
populations living at higher latitudes.300,302 Elwood show that, for identical outdoor exposure 
patterns, an individual at higher latitude will receive a relatively higher amount of total 
ultraviolet dosage from the intermittent component of their outdoor exposure.279  
Subgroup analysis shows that pooled estimates do not change significantly in terms 
of the different factors considered. However the Chi-squared, testing heterogeneity, becomes 
not significant for many subgroups of studies. As we have seen previously, lentigo maligna is 
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very probably associated with sun exposure and the inclusion of this melanoma type could 
introduce an overestimation of the relative risk. If we observe the Chi-squared for the sub-
group of studies, which do not include acral and lentigo melanoma, we note that heterogeneity 
is not any more significant (Chi-squared=7.13 with d.f.=5, p=0.211; pooled RR=2.019 95% 
C.I.: 1.47; 2.76). Looking at other features, typical of well conducted studies, we can see that 
in the sub-group of the studies that used blinding for interviewers again the Chi-squared is not 
any more significant (Chi-squared=11.61 with d.f.=7, p=0.312; pooled RR=1.81 95% C.I.: 
1.51; 2.16). Similar results are obtained for the subgroup of studies that use detailed 
definitions of exposure with a clear indication of latency period considered (Chi-
squared=14.33 with d.f.=8, p=0.07; pooled RR=1.78 95% C.I.: 1.35; 2.35). In all these 
situations the estimates are significantly greater than one, suggesting a significant positive 
association with melanoma, and there is not indication of heterogeneity.  
In only two papers (Dubin 1990214and Wolf 1998298) the authors stated that controls 
with dermatological problems were included and in one paper (Nelemans 1993287) the author 
wrote that other cancers were included among controls, but their estimates are very similar to 
the others. 
As for sunburn in childhood there is a highly significant difference (p<0001) in the 
percentages of fair skinned subjects between cases and controls, in the thirteen studies that 
published this information (mean percentage=54.6 in cases and 39.4 in controls). However 
this difference is not significantly associated with the estimates and again the adjustment for 
phenotype or phototype, of the majority of them, probably has a significant effect on the 
estimates. 
Looking at the influence of adjustment, on the estimates obtained from saturated 
models, similar results to the ones observed for sunburns in childhood were found. Meta-
regression shows that the adjustment for phenotype and phototype does not seem to 
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significantly explain variability among the estimates. For the subgroup of ten studies that 
adjust for phototype or other measures of skin sensitivity, that are adjusted also for phenotype, 
the pooled estimate (RR=1.53 95% C.I.: 1.31, 1.78) is slightly lower than the one obtained on 
the sixteen not-adjusted estimates (RR=1.59 95% C.I.: 1.37, 1.85) but it still statistically 
significant. Both the pooled estimates are obtained with the fixed effects models because 
heterogeneity was not any more significant (Chi=14.30, d.f.=9, p=0.11 and Chi=20.06, 
d.f.=15, p=0.17, for adjusted and not adjusted respectively). Again we can see that the 
association between melanoma risk and sunburn history persists after controlling for tendency 
to burn and other measures of skin sensitivity. 
Only one study adjusted for total sun exposure and intermittent sun exposure (Chen 
1996234) and only one (Cristofolini 1987235) adjusted for intermittent and chronic sun 
exposure.  
 
5.3.8.4 Sensitivity analysis 
Two studies are notable: MacKie (1989)183 presented a very high risk estimate (for men 
RR=9.3 95%; C.I.: 2.39; 24.95) and Autier (1998)301 showed a very precise estimate, and then 
a considerable weight (Standard Error=0.150). In Mackie, the odd result is due to the fact that 
for the highest category of exposure (severe sunburn = “3+”) the number of controls was zero. 
In Autier, on the other hand, analyses were based on a considerable number of subjects and on 
a high prevalence of exposure results. A further meta-analysis was carried out taking out 
MacKie (males estimates, 1989) and Autier (1998). We can observe a reduction of between-
study heterogeneity, 34.9 with 20 d.f., p=0.02, whereas final risk estimate does not change 
significantly: pooled RR=1.79 95% C.I. (1.51; 2.12). 
When the fully adjusted estimates are considered and Chen (1996)234 and Green 
(1986)250 are included in the analysis, a considerable reduction in between-study 
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heterogeneity can be noticed (Chi-squared=34.2 with 24 d.f., p=0.08). The pooled RR is very 
similar to the one obtained in the main analysis (RR=1.59; 95% C.I.: 1.38; 2.82). 
Looking at the funnel plot (Figure 5.19) we can notice a clear asymmetry that 
suggests a possible problem of publication bias. Investigating publication bias with the 
sensitivity analysis proposed by Copas and Shi52, a quite strong positive trend in the funnel 
plot was found, well fitted by the dashed line in Figure 5.20. In this figure, where the log-RRs 
are plotted against a measure of the uncertainty of those log-RRs (e.g. the standard 
deviation=“s”), a trend can be seen with smaller studies (the ones on the right, with greater 
standard deviation) that give more positive results than larger studies. The dotted line is the 
usual random effects model. As the number of unpublished studies increases, and the 
probability of publication bias decreases, the estimate of the pooled relative risk becomes 
smaller. Thus the main pooled estimate calculated at the beginning is probably too high. 
However the precision of the studies is sufficiently strong for the overall evidence of a 
positive increased in risk and even if we assume 45 unpublished studies the pooled RR 
remains significant: 1.29 (with 95% C.I.: 1.07; 1.55). In this case the p-value for publication 
bias, calculated with the method proposed by Copas and Shi, is not any more significant 
(p=0.10).  
When I evaluated the funnel plot looking at the studies grouped by latitudes, the 
indication of publication bias evidently decreases: for studies carried out at lower latitudes it 
is not any more significant. At higher latitudes sensitivity analysis proposed by Copas and Shi 
shows that, with only three unpublished studies added, the indication of publication bias 
disappeared but the pooled estimate does not present a considerable change: RR=2.18 (with 
95% C.I.: 1.59; 2.98). 
 
5.3.9 Discussion on sunburn 
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The greater danger to the validity of the results of meta-analysis on sunburns is 
misclassification of sunburn exposure. There is a strong possibility that the interpretation of 
sunburn has a cultural element, which is different among populations. Systematic 
misclassification also may occur among the studies as a result of different definitions of 
sunburns or according to constitutional factors, as skin colour, for example. Furthermore, as 
for the measures of sun exposure, systematic misclassification of sunburn exposure could 
occur in those studies where cases reported higher sunburn exposures than controls due to 
recall bias. However a population-based case-control study on melanoma, published in 1995, 
looked at the reliability of reported sunburn history. One hundred subjects were interviewed 
in 1987 and in 1989 and re-interviewed after more than 10 years and the results excluded a 
significant effect of recall bias.313  
The greater consistency of a positive association for sunburn, compared to that with 
intermittent exposures, may indicate a specific relationship of melanoma with sunburn per se, 
or it may be that sunburn is simply a more easily remembered measure of intermittent 
exposure to the sun.169;311 A relationship between sunburns and intermittent sun exposure is 
suggested also by the association, that we found, between sunburn and latitude, but it is not 
easy to understand if sunburn is an indicator of intermittent sun exposure and it lies in the 
causal chain with melanoma.  
Tanning ability is one of the pigmentary characteristics that very likely has a 
modification effect on the relationship between sun exposure measures and the risk of 
melanoma. Subjects with little or no ability to tan usually exhibit higher risk relative risk, for 
sun exposure and for history of severe sunburn than good tanners. For good tanners, moderate 
exposure very likely is protective against melanoma, and excessive sun exposure increases the 
risk but not as high as for poor tanners. One can in fact speculate that tanning may confer a 
protecting effect on the skin and that moderate sun exposure may actually protect against 
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melanoma by promoting a tan in individuals who do so easily. However heterogeneity 
analysis suggests that the association between melanoma risk and sunburn history may persist 
after controlling for tendency to burn and other measures of skin sensitivity. Probably 
excessive sun exposure overwhelms the protective mechanism provided by tanning. 
Even if pooled estimates for sunburns in childhood are higher than pooled estimates 
for sunburns in adulthood, the difference among them was not considered valuable. To make 
an evaluation on more comparable estimates a further analysis was carried out on the eleven 
studies that published both estimates, in childhood and in adulthood. As can be seen in Figure 
5.21, in nine, out of eleven studies, the estimates are higher in childhood than in adulthood. 
The estimates are higher in adulthood in two studies: Osterlind (1988)226, but the values are 
very similar, and Westerdhal (1994)293 who presented an estimate for sunburns in childhood 
equal to 1. Meta-regression shows not significant difference among the estimates of the two 
groups (p=0.338).  
The bivariate approach, on these pairs of estimates, indicates a slightly higher risk 
for sunburn in childhood (RR=1.87 and 95% C.I. 1.27; 2.75) than sunburn in adulthood 
(RR=1.45 and 95% C.I. 1.16; 1.82) but both RR suggest a significant association between 
melanoma and sunburns. Measures of the correlation between the estimates of sunburn in 
childhood and in adulthood were not available. Therefore the bivariate model was built 
assuming independence. From the model an estimate of the correlation equal to 0.17 was 
found suggesting that independence is not a trusty hypothesis. As for the univariate analysis, 
meta-regression with the bivariate approach shows that latitude and adjustment for phenotype 
(for sunburn in adulthood) are factors that significantly explain between-study heterogeneity. 
No significant differences between sunburns in adulthood and in childhood were found also in 
two meta-analyses24,28 and one overview.280 However in the recent work published by 
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Whiteman28 conclusions are somewhat different because the author, looking at ecological 
studies, suggests a special role of sunlight in childhood. 
In these comparisons it should be taken into account that there is some evidence that 
self reported childhood sun exposure is less reproducible than sun exposure at older age and 
this may question the veracity of comparisons of period-specific exposure for sunburns.282 
 
5.3.10 Conclusions on sunburns and sun exposure 
Given these results showing the link between sun exposure, sunburns and melanoma, the first 
step in photoprotection should be to reduce exposure to sunlight sufficient to cause sunburn. 
However avoidance of sunburn may be a confusing target for education campaigns, because 
we cannot exclude the idea that sunburns may be merely an indicator of the combination of 
susceptibility to sun and intermittent exposure.  
This is an important concept as sunscreens filter out only a proportion of the solar 
spectrum and could allow prolonged sun exposure, a situation that could lead to increased 
melanoma.301 It is in fact suggested that the use of sunscreens may fail to achieve sun 
protection if the behavioural change, which they produce, is increased suntan. People should 
be advised that the use of sunscreen may prolong recreational sun exposure, because the 
marketing of these products persuades that excessive sun exposure is safe with their use314. In 
reality it is not clear what exactly could be the benefit of sunscreen against the risk of 
melanoma: whereas it may be used to block certain types of ultra-violet light from reaching 
the skin, it may allow an increased exposure to other types which may be harmful.152 A 
broader message to reduce total sun exposure, by changing patterns of outdoor exposure, 
using clothing and shade, may be more effective. However, we should think that reduction of 
exposure to sunlight, particularly only an internediate reduction, may actually increase the 
risk of melanoma by changing someone from a regular frequent exposure pattern to an 
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episodic exposure pattern. Thus the finding that regular frequent exposure to sunglight might 
be associated with a lower relative risk of melanoma should be taken into account in public 
health programs. Furthermore, it is important to remember that sun exposure shows a 
protective effect against many other types of cancer.315-319 The lack of sufficient UV-B 
radiation is considered the cause for a large proportion of twelve types of cancers.320;321 The 
ideal case would, therefore, be to find a way of obtaining the beneficial effects of UVB 
exposure without suffering the increased incidence of skin cancer. Thus, further studies on the 
relationship between vitamin D, regional UV doses and the rates of different types of cancers 
should be worthwhile.  
 
5.4 Family history of melanoma 
5.4.1 Introduction 
The first report in malignant melanoma was that of familial melanoma, documented in 
1820.322 Subsequently several other investigations on familial melanoma were published. At 
present a family history is considered an extremely important risk factor for cutaneous 
malignant melanoma and researches into potential melanoma susceptibility genes are 
ongoing. Approximately 8-12% of melanoma patients has a family history.323  
It was reported worldwide that persons with the atypical mole (dysplastic nevus) 
syndrome are at much higher increased risk. Families with multiple cases of melanoma often 
exhibit the dysplastic nevus syndrome, a syndrome characterized by multiple atypical moles 
that continue to appear in adulthood. Greene (1985)324 estimates that a person who has 
dysplastic naevi and at least two family members with melanoma has a 500-fold increase in 
melanoma risk. However so few people have this syndrome that in unselected series they 
account for less than 5% of total melanoma incidence. Furthermore one must take into 
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account the fact that in many of these families dysplastic naevi as well as environmental 
factors are involved. 
As I said previously, in this work I considered family history alone, without the 
contemporaneous presence of dysplastic naevi. 
 
5.4.2 Materials and methods 
Thirteen publications were identified on the association between family history and 
melanoma. Among them two225;250 were not independent. I determined eleven eligible 
independent case-control studies that evaluated risk of melanoma in all body. Holly 1995 296 
analysed a female population. 
The results of each study were transformed in order to obtain a dichotomous 
exposure: subjects were classified as having a positive family history of melanoma if they 
reported one or more affected first-degree relatives. Some studies also collected information 
on more distant relatives but this information is unlikely to be complete and has not been 
analysed in this work.  
Estimates and some information for Holly (1987)169, Swerdlow (1986)168 and Walter 
(1999)325 were obtained from the meta-analysis on individual data published by Ford (1995). 
In Swerdlow, controls did not have any subject with family history, therefore 0.5, instead of 0, 
was assigned into the cell of the 2x2 table used for calculation of the estimates. 
Some general features of the studies included in the meta-analysis are presented in 
Tables 5.11. 
 
5.4.3 Results 
Estimates, adjusted for the maximum number of confounders, are presented with their 
confidence intervals in two Figures 5.22a and 5.22b, to be more readable. 
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The fixed effects model was used to pool the estimates because between-study 
heterogeneity was not significant (Chi=9.567, d.f.=10, p=0.48). The pooled estimate 
(RR=1.79, 95% C.I.: 1.46; 2.19) indicates a highly significant association between family 
history and melanoma and this is consistent with the pooled analysis on individual data 
published by Ford (1995) (RR=2.24, 95%CI: 1.76-2.86). For Ford’s meta-analysis, which 
include studies published before 1990, strict inclusion criteria were considered. The authors 
stated that they had included in the analysis melanoma case-control studies “which had 
included an independent physical examination of naevi by a trained individual, for which data 
collection was completed and where cases and controls were treated similarly”. Even though 
the subset of studies considered for the analysis was not large (only 8 studies) between-study 
heterogeneity was found to be significant for some factors and in these cases the pooled 
estimate was not calculated. Inconsistencies and differences in patterns of estimates were not 
investigated. 
 
5.4.4 Sensitivity analysis 
The analysis was repeated on not adjusted estimates in order to evaluate effect of confounders 
but the results are very similar. Fixed effects models are used to obtain the pooled estimate 
(RR=1.87, 95% C.I.: 1.55; 2.27) because heterogeneity was not significant (Chi=11.61, 
d.f.=10, p=0.31). 
The funnel plot (Figure 5.23) seems clearly asymmetrical suggesting a significant 
effect of publication bias. However both methods proposed by Copas and Shi and Egger tests 
give indication of no significant effect of a possible publication bias. 
 
5.4.5 Discussion on family history 
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The familial relative risk was quite similar in all studies, like in Ford’s meta-analysis27, 
suggesting similar risks for family history even in completely different countries, which 
present a variability of 10 fold of incidence rates. This provides an indication for the 
hypothesis of independence between sun exposure and genetic susceptibility. However 
Siskind, in a recent publication (2002)326,  found a significant interaction between the effect of 
sun exposure on melanoma risk and familial susceptibility to melanoma. He suggested that 
melanoma may develop in a susceptible subset of the population who receives a threshold UV 
dose and that high genetically susceptible subjects have a lower threshold and reach this 
earlier than others in the same environment. In area of high solar radiation, within high-risk 
families, genetic factors rather than differences in sun exposure determine who will get the 
disease. Within families at relatively low genetic risk cumulative sun exposure is likely to be 
a more important determinant of melanoma risk.  
 
5.5 Indicators of Photodamage 
5.5.1 Introduction 
Solar keratoses are benign tumours that are at least ten times commoner than skin cancers and 
premature skin ageing (photoageing of the skin) is even more common.327 Melanoma-
susceptible individuals may have two distinct cutaneous phenotypes: one associated with 
multiple naevi, without signs of marked photoageing, the other characterized by solar damage 
with actinic keratoses but no excess of naevi.328  
Actinic keratoses are also called solar keratoses because they indicate that sun 
damage has occurred. They are precursors of cancers, which means they can be the first step 
in the development of skin cancer. It is estimated that up to 10 percent of active lesions will 
take the next step and progress to squamous cell carcinoma.328 
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As indicators of actinic damage I considered the presence of lesions as solar lentigo, 
elastosis, actinic keratoses, and others objective measurements of actinic damage as cutaneous 
microphotography. Cutaneous tumours, different from melanoma, are also included because 
European cancer registries demonstrated an increased incidence of melanoma following an 
initial diagnosis of squamous cell skin cancer (SSC) and basal cell skin cancer (BSC).  
 
5.5.2 Materials and methods 
Among the nineteen papers that were found on the association between indicators of actinic 
damage and melanoma, five164;225;251;284;300 reported results concerning data already published 
in other articles. I finally arrived at fourteen independent papers on eleven case-control 
studies (Moore 1997230 is a nested case-control study) and three cohort studies. One of the 
cohort studies (Lindelof 1991329) presented results separately for women and men. All papers 
analysed the risk associated with melanoma on all the body. 
Some general features of the studies included in the analysis are listed in Table 5.12.  
Definitions adopted by the various authors, presented in Table 5.13, are classified 
into two groups: 
-Pre-Malignant and Cancer Lesions (PMCL): actinic keratoses and other cutaneous 
tumours were included in this group. 
-Other Indicators of Actinic Damage (OIAD): solar lentigo, elastosis and indicators 
found by cutaneous microphotograph were included in this group. 
As can be seen in Tables 5.13, definitions used by the authors of the papers are very 
mixed. Some of them are very precise, where the extent of actinic damage is measured by a 
technique (CMT) that takes an impression of the skin texture and it is graded using a 
microscope. Other works use much more rough definitions quantifying lentigines with very 
broad categories, as “any” versus “none” or “many” versus “few”, or considering only the 
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presence of “splotchy freckles”. Furthermore it must be remembered that the distinction 
between solar lentigines and freckles is not always straightforward in case-control studies on 
melanoma and this may be a further cause of bias. 
From the fourteen datasets found, I obtained 18 estimates, adjusted for the greater 
number of confounders, on “pre-malignant and cancer lesions” (n=10) and on “other 
indicators of actinic damage” (n=8).  
 
5.5.3 Results 
ORs and RRs for the presence of pre-malignant cancer lesions and other indicators of 
photodamage, are plotted in three Figures 5.24 and 5.25, with their confidence intervals. From 
these extracted estimates a strong positive association with melanoma is suggested. The 
calculation for the pooled RR confirms this indication: 2.98 (95% C.I.: 2.04; 4.36), for the 
presence of indicators of actinic damage considered all together. However there is a very high 
value for the Chi-squared (Chi=141.62, d.f.=17, p<0.001) revealing highly significant 
heterogeneity.  
Looking separately at the two main sub-groups of studies, for “pre-malignant and 
cancer lesions (PMCL)” I obtained a very high estimate (RR=4.33 with 95% C.I.: 2.74; 6.82) 
which is more than twice that calculated for “other indicators of actinic damage (OIAD)” 
(RR=1.96 with 95% C.I.: 1.06; 3.61). The difference between the two is significant at 8%. 
However heterogeneity remains highly significant with p<0.001 for both groups (Chi=44.58 
with d.f.=9 and Chi=65.65 with d.f.=7, for PMCL and OIAD respectively).  
 
5.5.4 Heterogeneity analysis 
“Matching” can be considered a marker of fine design. In fact when confounding cannot be 
controlled by randomization, individual cases may be matched with individual controls that 
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have similar confounding factors, such as age, to reduce the effect of the confounding factors 
on the association being investigated in analytic studies. However matching can be 
counterproductive if one matches in a case-control study on strong correlates of exposure in 
the base population that are not risk factors (or proxy risk factors) for the disease. This type of 
overmatching results in a decrease in statistical efficiency (i.e., less precision for a given 
number of cases and controls) The problem is that the net effect of matching in case-control 
studies (but not in cohort studies) is to introduce selection bias that must be controlled in the 
analysis.  
A considerable reduction in heterogeneity, among OIAD studies, can be observed when I 
classified studies by “matching”. Heterogeneity analysis shows that Chi-squared indicates not 
significant heterogeneity in both sub-groups of studies, matched (Chi=3.21; d.f.=4; p=0.52) 
and unmatched (Chi=0.59; d.f.=1; p=0.79). The latter was calculated excluding one odd 
estimate (Halpern, 1991238), which increases heterogeneity very much. Pooled estimates of 
the two subgroups, calculated with the fixed effects model, are quite different: for matched 
studies I obtained a pooled estimate significantly (p=0.01) greater (RR=3.47 with 95% C.I.: 
2.57; 4.69) than for unmatched studies (RR=1.35 with 95% C.I.: 1.06; 1.71). In all studies 
matching was carried out by age, sex and place of residence and estimates were obtained by a 
conditional logistic model adjusted for some important confounding variables. Thus there not 
seem to be a problem of overmatching and the analysis looks well conducted.     
These findings, obtained exploring heterogeneity, should be interpreted with concern 
because the number of studies is very low and there may be a problem of multiple testing. 
However the decrease in heterogeneity in the subgroup of matched studies is an indication 
suggesting that the pooled estimate is reliable and that the association between melanoma and 
“pre-malignant and cancer lesions” and “other indicators of actinic damage” is significant. 
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5.5.5 Sensitivity analysis  
Halpern (1991)238 presented a very odd estimate. It is the only estimate indicating a protective 
effect of the indicators of photodamage and the RR is also significant. If I exclude this study 
from the subgroup of OIAD I can observe a considerable reduction in heterogeneity, which, 
however, remains highly significant (Chi=27, with d.f.=6, p<0.001) and the increase in the 
pooled estimates leaves a considerable relative risk (RR=2.60 with 95% C.I.: 1.66; 4.09).  
Lindelof (1991)329) presented results separately for sex but the confidence intervals 
of the RRs overlaps indicating not statistically significant difference between men and 
women. 
There is some indication for publication bias when I considered PMCL together with 
OIAD (Figure 5.26). However with only three added publications the p-value for the funnel 
plot is no longer significant and the pooled estimate does not change very much: (RR=2.18 
with 95% C.I.: 1.59; 2.98). If the analysis is carried out separately, for the two main sub-
groups of indicators of photomage, the suggestion for publication bias disappears. 
 
5.5.6 Discussion on indicators of photodamage 
It is important to take into account that the apparent association of melanoma with some 
indicators of photodamage may be due to intensified medical surveillance in patients with a 
history of other cancers, a shared internal pathway of cancer induction and adverse effects of 
agents used in the treatment of non melanoma skin cancers.330 A shared internal pathway of 
induction may be important in the association of actinic keratoses and photoageing with 
melanoma. Actinic keratoses, for example, are more common in fair-skinned, fair-haired, 
light-eyed individuals subjected to high levels of sun exposure. Because their skin has less 
protective pigment, they are the most susceptible to sunburn that is strongly associated with 
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solar keratoses.331 Strong association between degree of photoageing and lifetime sun 
exposure has also been found in extensive longitudinal studies conducted in Australia.327 
 
5.6 Host factors 
5.6.1 Freckles  
5.6.1.1 Materials and methods  
Thirty-two studies recorded an assessment of individual propensity to freckles and melanoma. 
Eight of them (seven original works164;217;224;225;250;251;332 and one revision of literature25) 
showed results already analysed in other publications. I finally arrived at twenty-four 
independent case-control studies (Moore 1997 is a nested case-control study). Mackie 
(1989)183 presented estimates separately for sex, Chen (1996)234 separately for four body sites 
(head and neck, upper limbs, lower limbs and truck). Hezerfeld (1993)295 analysed a male 
population and Holly (1995)333 a female population.  
Some general features, definitions and categorizations used by the authors are 
described in Tables 5.14 and 5.15. As can be seen measurements and classifications of 
freckles density varied substantially between studies. Classification of freckling varied from 2 
to 5 categories; some authors were interested in a classification between people with freckles 
and those without freckles and others evaluated their intensity with more precise 
categorization. Some authors asked about freckles after sun or on summertime (Chen 1996234, 
Dubin 1986164, Elwood 1986236, Marret 1992186 and Moore 1997230). Some of them used very 
detailed definitions (Holly, 1987169) or diagrams for comparison (Grulich, 1996171), some 
others used a general indication of “freckles”. Some authors asked about freckles as adult 
(Holly 1995333 and Osterlind 1988226) some other as child or teenager (White 1994249, Grulich 
1996171, Gallagher 1986332 and Chen 1996234).  
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Elwood in 1986236 and in 1990237 published two different estimates, evaluating 
freckles as adult and in childhood. Freckles in adulthood is the definition chosen for the main 
analysis, as I did in the rest of the analysis, thinking that more recent information is probably 
more reliable. However these estimates present huge confidence intervals whereas RRs for 
freckles in childhood are much more precise. Therefore the choice to include Elwood’s 
estimate on freckles as adult was evaluated in the sensitivity analysis. 
In order to reduce the problem of misclassification bias the estimates extracted are 
those comparing highest categories versus lowest categories, as I did for the other risk factors. 
However this choice was checked in the sensitivity analysis because many authors consider 
only two rough categories. A further pooled estimate was calculated reducing to a dichotomy 
the larger number of groupings. Cases and controls from the categories defined as “none, few, 
sparse, absent, no” were included into the category “none/few”, and the subjects belonging to 
categories defined as “some, many, moderate, yes, present” into the category “many/some”. 
Thus we can make a comparison with results of the meta-analysis on individual data 
published by Bliss25.  
Many of the papers presented both estimates: for dichotomous exposure and for a 
higher number of categories. When the former was not published it was calculated from the 
raw data. 
To be able to evaluate influence of adjustment for various confounders, a further 
pooled estimate was obtained considering only the raw data in the calculation of the pooled 
RR for a dichotomous exposure.  
 
5.6.1.2 Results 
ORs adjusted for the maximum number of confounders are presented in Figures 5.27, with 
their confidence intervals. As it ca be seen, for several studies, the risk for high density of 
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freckles is 2 to 3 times greater than the risk of having no or sparse freckling. In fact the pooled 
estimate, obtained from the random effects model, indicates high density of freckles as a 
highly significant risk factor: (RR=2.11; 95% C.I.: 1.76; 2.53). However the between-study 
heterogeneity is considerable (Chi=71.03; d.f.=24; p<0.001)  
Chen (1996)234 presented only estimates separately for the four body sites, and not 
raw data. However, the four estimates being very similar (Chi-squared is 0.38 with 3 d.f., p-
value for heterogeneity is 0.94), a weighted average of the four estimates was included. This 
decision was made in order not to give too much weight to this study, mainly in the subgroups 
analysis that investigates heterogeneity. The choice of including only a weighted average of 
the four estimates was evaluated in the sensitivity analysis. 
 
5.6.1.3 Heterogeneity analysis 
Interesting results, similar to sunburns and chronic sun exposure, were found for freckles 
density from meta-regression analysis. Two factors, “Latitude” and “country”, significantly 
explain variability among the estimates. In Figure 5.28 and in Figure 5.29 histograms present 
the studies by country (classified in two broad categories: “at higher” and “at lower 
incidence”) and latitude (higher and lower than 50). As can be seen, at high latitude and in 
“low incidence” countries the estimates are higher albeit less precise.  
Looking at study location, I obtained similar results to the ones found for chronic sun 
exposure (see Figure 5.28). Considering the subgroup of fourteen studies coming from 
Australia and USA (classified as “high incidence” countries), the pooled estimates for high 
density of freckles (RR=1.72; 95% C.I.: 1.42, 2.09) is significantly lower (p=0.006) than the 
one obtained for the other countries (RR=3.21; 95% C.I.: 2.29, 4.46). The Chi-squared 
indicates still significant heterogeneity within the 14 “high incidence” countries (Chi=33.56 
and d.f.=13; p=0.001) and within the others (Chi=24.53 and d.f.=10; p=0.006).  
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The distribution of freckles in cases and in controls, in the studies that published this 
information, was investigated to see if it might be a different distribution by country. The 
percentages of subjects in the highest category of freckles and in the lowest category, 
calculated on the total number of subjects included in the study, were evalauted for the 
various countries. Percentages in highest categories of papers published “high incidence” 
countries were found not significantly different from the percentages in the highest categories 
of other countries. This could suggest that the indication for a different estimate in “high 
incidence” countries may be mainly due to different study features. However we should be 
carefull in the interpretation of these results, because the same highest categories (usually it is 
“many freckles”) may have a different meaning in “high incidence” countries, where fair-
skinned people are characterized by high frequence of freckles, compared to other countries.  
As for chronic sun exposure, an indication for a lower RR should be considered 
carefully because RRs obtained from “high incidence” countries are probably the most 
reliable. The vast majority of the studies conducted in these countries does not in fact include 
subjects with dermatological problems (only 1 in 14); in most of them (10 out of 20 studies) 
controls are drawn from community; the vast majority of studies that adopts blinding for 
interviewers is in high incidence countries; almost 50% of them adjust for phototype and 
phenotype and the few studies that adjust for family history or sunburns are among them.  
As can be seen in plot 5.29, at latitudes greater than 50 the association between 
freckles and melanoma is significantly (p=0.04) greater (RR=2.81; 95% C.I.: 2.02; 3.91) than 
at lower latitude (RR=1.83; 95% C.I.: 1.45; 2.31). In both sub-groups, heterogeneity 
decreases but it is still highly significant (for “latitude>50”: Chi=23.59, d.f.=9; p=0.005; for 
“latitude<50”: Chi=40.75, d.f.=13; p<0.001). Tucker (1997)172 was not included, when the 
factor “latitude” was explored in the heterogeneity analysis, because it was carried out in two 
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very distant cities (Philadelphia and S. Francisco). This finding may be related to a higher 
frequency of people with fair phenotype at higher latitude, as I suggested for sunburns. 
Bliss (1995)25 found that freckle density at young ages defines a more extreme 
phenotypic risk group than at older ages. In this analysis I was unable to analyse the 
interaction with age. The only observation that I could make regards the influence of 
adjustment for some confounders and on the latency period considered. Few studies (n=8) 
evaluate the risk for high density of freckles in childhood, but for this subgroup of studies the 
pooled RR (RR=1.82; 95% C.I.: 1.56; 2.11; Chi=14.25; d.f.=7; p=0.16), is not significantly 
(p=0.75) different from the RR calculated for high density freckles in adulthood (RR=2.15; 
95% C.I.: 1.69; 2.74; Chi=57.70; d.f.=17; p<0.001). As in the meta-analysis published by 
Bliss, phenotype and phototype do not seem to play an important role because adjustment for 
these confounders does not influence significantly the estimates for freckles density.  
 
5.6.1.4 Sensitivity analysis 
When the dichotomous exposure is considered (“none/few” versus “many/some” freckles), I 
obtained results very similar to the ones obtained in the meta-analysis on individual data 
published by Bliss25. The subjects with medium-high density of freckles are at very high risk, 
compared to subjects with medium-low density of freckles (RR=2.16; 95% C.I.: 1.86; 2.51). 
Between-study heterogeneity is still very elevated (Chi=86.89; d.f.=24; p<0.001).  
In order to evaluate effect of adjustment, the pooled RR on the dichotomous 
exposure is calculated considering raw data. I observed a higher RR, but the change is not 
considerable (RR=2.33; 95% C.I.: 1.98; 2.75; Chi=111.46, with d.f.=23; p<0.001). For this 
last estimate Chen has not been included because raw data were not available from this paper. 
As mentioned previously, Elwood in 1990237 and in 1986236 presented two estimates 
concerning freckles in adulthood and in childhood and the first ones were included in the 
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main analysis. If estimates evaluating freckles in childhood are considered for the pooled RR, 
results do not change notably (RR=2.13; 95% C.I.: 1.77; 2.57). Chi-squared decreases but the 
between-study heterogeneity remains highly significant (Chi=77.36; d.f.=24; p<0.001)  
When the estimates published by Chen (1996)234, on the four body sites considered 
separately, are included as they are, without any weighting average, a considerable change 
was not found (RR=2.06; 95% C.I.: 1.74; 2.45). Chi-squared decreases a bit but the between-
study heterogeneity remains highly significant (Chi=71.41; d.f.=27; p<0.001)  
Looking at the funnel plot a clear asymmetry can be observed (Figure 5.30). From 
the sensitivity analysis, investigating publication bias, proposed by Copas and Shi, we have a 
suggestion of a significant effect of publication bias. The publication probability becomes 1 
(no bias) if we add 7 unpublished studies and, in this case, the pooled RR decreases. However 
the pooled RR remains highly significant (RR=1.99; 95% C.I.: 1.48; 2.68) 
It is interesting to note that from the analysis on publication bias, as from 
heterogeneity analysis on “countries”, we have an indication to take into consideration an 
estimate of risk lower than the main pooled Relative Risk found in “Results” section 
(RR=2.11; 95% C.I.: 1.76; 2.53). 
Looking at the weights of the study estimates it can be seen that there is a very 
influential study (Holly, 1995333). The weight of the estimate extracted from this study is 
greater than 80. However the pooled RR, calculated with the exclusion of it, does not change 
very much (RR=2.16; 95% C.I.: 1.78; 2.63; Chi=67.25; d.f.=24; p<0.001) 
 
5.6.2 Eye colour  
5.6.2.1 Materials and methods 
Thirty-four papers published information on eye colour and melanoma. Five164;217;225;251;332 
among them analysed data already used for other publications. I finally arrived at twenty-nine 
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independent case-control studies (Moore 1997230 is a nested case-control study) and thirty 
datasets because Graham (1985)286 published estimates separately for men and women. In all 
studies, except that of Chen (1996)234, risk associated with melanoma in all body was 
evaluated. Hezerfeld (1993)295 presented estimates only for men and Holly (1995)333 only for 
women. 
General features of all studies included in the analysis are reported in Tables 5.16 
and categories and descriptions of assessment for eye colours are presented in Tables 5.17.  
Classification of eye colour was very similar across studies. The majority of the 
authors considered three qualitative categories: “black/brown”, “blue or blue/grey” and “green 
or green/grey/hezel”. It was difficult to define a single category of colour at consistent higher 
risk. However the main analysis and the investigation for heterogeneity were performed on 
“blue eye” because more studies were available (30 versus 21 for “green eye”). Results on 
“green eye” are presented in the sensitivity analysis.  
As mentioned previously, Chen (1996)234 presented only estimates separately for the 
four body sites. However, these estimates are very similar (Chi-squared is 1.23 with 3 d.f., p-
value for heterogeneity is 0.74), therefore, in order to not give to much weight to this study a 
weighted average of the four estimates was included. This choice was checked in the 
sensitivity analysis. 
 
5.6.2.2 Results 
Extracted OR and corresponding confidence intervals are presented in two plots (Figures 
5.31). As can be seen, all of them indicate a positive association between blue eye colour and 
melanoma and the majority is statistically significant. 
The pooled estimate indicates that subjects with blue eyes are at higher risk than 
subjects with dark eyes (RR=1.51; 95% C.I.: 1.30; 1.76). Even if the methods of assessment 
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and the categories used to classify eye colour are quite consistent, a considerable between 
study heterogeneity is indicated by the high significant value of the Chi-squared (Chi=94.53; 
d.f.=29; p<0.001). 
 
5.6.2.3 Heterogeneity analysis 
Adjustment for phenotype explains some variability between the estimates. In Figure 5.32 
indication of adjustment is presented for each estimate comparing “blue versus black” eye 
colour. Similarly to the results obtained in the meta-analysis published by Bliss25, we can 
notice that not adjusted estimates are higher than adjusted estimates. In fact seven, out of 
nineteen, not adjusted estimates are around two or above. Meta-regression indicates an almost 
significant difference between adjusted and not adjusted estimates (p=0.059). Furthermore 
heterogeneity, in the subgroup of estimates adjusted for phenotype, is not any more 
significant, whereas for not adjusted is still highly significant (Chi=8.6, d.f.=10, p=0.57 for 
adjusted and Chi=79.43, d.f.=18, p<0.001 for not adjusted). The pooled RR from the fixed 
effects model on estimates adjusted for phenotype (hair colour, freckles, skin colour…) are 
lower (RR=1.25, 95% C.I.: 1.11; 1.42) than the not adjusted estimates (RR=1.68, 95% C.I.: 
1.34; 2.11). This suggests a considerable correlation between these host factors.  
Only five studies adjust for a measure of sun exposure, as intermittent, chronic sun 
exposure or sunburns, and five studies adjust for naevi. However these adjustments do not 
seem to influence significantly the estimates. 
Heterogeneity Chi-squared test is highly influenced by one study (Osterlind, 
1988226), which presented an estimate below one (suggesting a negative association) and a 
very high weight (w=113.6), and by two studies (Dabkowski, 1997188 and Beitner, 1990334), 
which showed estimates above one  and not too big weights (w=41.2 and 11.2). Excluding 
these three estimates the heterogeneity is not any more significant for both the analyses.  
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5.6.2.4 Sensitivity analysis 
The analysis conducted on “green” versus “dark” eye colour leads to considerations similar to 
the previous results on “blue” eyes. The pooled RR suggests “green” eye colour as a 
significant risk factor (RR=1.41, 95% C.I.: 1.14; 1.75 with Chi=57.17; d.f.=20; p<0.001).  
Very similar results are obtained in the heterogeneity analysis performed on “green” 
versus “black”. As we have seen for “blue”, the pooled relative risk (RR=1.15, 95% C.I.: 
0.95, 1.41) on estimates adjusted for phenotype is lower than that on not adjusted estimates 
(RR=1.54, 95% C.I.: 1.15; 2.07), and it is not significant. However the difference between the 
two estimates is not statistically significant. The pooled RR, calculated on adjusted estimates, 
is obtained with the fixed effects model because heterogeneity was not significant (Chi=8.06, 
d.f.=6, p=0.233). 
As was the case for freckles, a pooled estimate was calculated reducing to a 
dichotomy the larger number of groupings. Data from the categories defined as “black” and 
“brown” were included into the category “dark”, and data belonging to the categories 
described as “hazel”, “green”, “grey”, “blue” into “light”. The calculations on crude data, 
when they were available, show that the pooled RR does not change significantly (RR=1.56, 
95% C.I.: 1.36; 1.76; Chi=67.05; d.f.=25; p<0.001). Chen (1996)234, Holly (1995)333, Holman 
(1984)150 and Beitner (1990)334 could not be included in this pooled RR. 
Graham (1985)286 published estimates separately for sex, with slightly higher 
estimates for men, but the difference was not statistically significant. 
When the four estimates published by Chen (1996)234, for the four different body 
sites, are included in the analysis, as they are, the pooled relative risk does not change 
significantly (RR=1.53, 95% C.I.: 1.34, 1.76; Chi-squared=95.59, d.f.=32; p<0.001). 
No indication for publication bias was found (Figure 5.33). 
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5.6.3 Hair colour  
5.6.3.1 Materials and methods  
There are forty identified publications, which analysed association between melanoma and 
hair colour. Five164;212;217;225;251;332 of them were not independent from other studies. I finally 
arrived at thirty-five case-control studies (Weinstock 1991335 and Moore 1997230 are nested 
case-control studies) and thirty-six datasets, because Graham presented estimates separately 
for sex. In all but Chen (1996)234, risk associated with melanoma in all body was evaluated.  
General features of studies included in the analysis are shown in Tables 5.18. 
Definitions, categorization and methods of assessment of hair colour are presented in Tables 
5.19. As can be seen definitions and assessments vary considerably between studies. In some 
studies the interviewer was a dermatologist or trained physician, in others a general 
questionnaire was used; some authors referred to independent colour or density charts, for 
classification of pigmentary characteristics, whereas in others broad categorical rating was 
used. Some studies asked about a natural hair colour, other simply about hair colour; some 
questions were about adult hair colour (at time of interview), others about hair colour at 20 
years or in childhood. Lock-Anderson (1998) presented two estimates, as adult and before age 
of 7; hair colour as child was chosen because the majority of the studies considered hair 
colour before age of 20. 
As for eye colour, classification of hair colour was quite similar across studies. The 
majority of the authors considered three main categories for hair colour: “black or brown”, 
“blond, fair or auburn” and “red or blond-red”. Generally people with “red or blond red” hair 
were considered at higher risk than “blond, fair or auburn”. Actually the risk for “red” versus 
“black” hair colour was evaluated in all thirty-five studies, whereas “blond” versus “black” 
was calculated in only twenty-seven studies. For this reason the main analysis was conducted 
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for “red” versus “black” estimates. In the sensitivity analysis further investigations on “blond” 
hair were carried out. 
Chen (1996)234 only presented estimates separately for the four body sites. However, 
these estimates are very similar (Chi-squared is 2.79 with 3 d.f., p-value for heterogeneity is 
0.42), therefore, in order to not give to much weight to this study a weighted average of the 
four estimates was included. This choice was checked in the sensitivity analysis. 
 
5.6.3.2 Results 
OR are presented with their confidence intervals in Figures 5.34. The pattern of risk of 
melanoma by hair colour is reasonably consistent across studies and red hair is shown to be 
significantly associated to melanoma. In the vast majority of the studies statistical significance 
is reached.  
The pooled estimate indicates that subjects with “red” hair colour are at significantly 
higher risk than subjects with “dark” hair colour (RR=2.79, 95% C.I.: 2.15; 3.61). This 
association is much stronger than that observed for eye colour. However, a very high between 
study heterogeneity was found (Chi=135.82; d.f.=35; p<0.001). 
Hair colour was also considered on an ordinal categorical scale and the possibility of 
a trend across hair colour categories was investigated. In order to apply this model the data 
were categorised into four distinct groups, corresponding to the levels of an ordinal 
categorical variable: black = 0; brown = 1; blond = 2; red = 3. A meta-analysis, on the 
fourteen publications that reported estimates for all four categories, was carried out. The 
approach of pooling, proposed by Greenland and Longnecker72, described in Chapter 2, was 
used to take into consideration correlation between cateogories. As can be seen from Table 
5.20, the pooled estimates showed a marked positive trend and subjects with red hair are 
clearly at greater risk compared to subjects with brown and blond hair. The random effects 
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model was used for the calculation of the pooled RR because a significant heterogeneity was 
found (Chi=63.11; d.f.=13, p<0.001). 
 
5.6.3.3 Heterogeneity analysis 
Heterogeneity become any more significant when two studies (Beitner, 1990334 and Grob, 
1990170), which presented very large estimates, were excluded from the main analysis.  
From meta-regression it was found that estimates adjusted for phenotype or for 
phototype are almost significantly (p=0.059) lower than the ones not adjusted. In fact we can 
see in Figure 5.35 that the not adjusted estimates are very high and nine (out of twenty-one) 
are around or above 4. The pooled RR, calculated with the fixed effects model on the 
estimates adjusted for phenotype or photoype (hair colour, freckles, skin colour, skin reaction, 
skin type…), is lower (RR=2.08, 95% C.I.: 1.61; 2.69 and Chi=19.97, d.f.=13, p=0.10) than 
the one, from random effects model, on not adjusted estimates (RR=3.51, 95% C.I.: 2.38; 5.18 
and Chi=112.21; d.f.=21; p<0.001). The pooled RR on not adjusted estimates is still highly 
significant but the decrease, compared to the pooled RR on adjusted estimates, suggests a 
considerable correlation between these host factors. As we saw previously for eye colour. 
Only three studies adjusted for intermittent or chronic sun exposure, some more for 
sunburns (6) and for naevi (11). However these adjustments do not significantly influence the 
estimates.  
Heterogeneity decreases substantially (Chi=35.92; d.f.=29; p=0.18) when the pooled 
RR was calculated on the raw data, recoded to reduce to a dichotomy the larger number of 
groupings. For hair colour “black” and “dark brown” were combined into “dark” category and 
“light brown”, “blond” and “red” into “light” category. The pooled RR becomes lower but it 
still significant (RR=1.72, 95% C.I.: 1.59; 1.85). The relative risk was calculated with the 
fixed effects model because there was not any more heterogeneity. Autier (1995)288, Chen 
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(1996)234, Holly (1995)333, Holman (1984)150, Beitner (1990)334 and Rosso (1998)299 did not 
present crude data and they were not included in this part of the analysis. 
Bliss (1995)25 showed higher relative risk for hair colour assessed in younger 
individuals. In fact it is possible that melanoma risk is related to hair colour at a younger age, 
and that hair colour in older individuals is a less accurate measure. However when I looked at 
differences between hair colour in childhood and hair colour with the other more general 
definitions, I did not find any significant difference among the estimates. 
 
5.6.3.4 Sensitivity analysis 
Pooled estimate of “blond” versus “black” indicates that subjects with “blond” hair colour are 
also at significantly higher risk than subjects with “dark” hair colour (RR=1.94, 95% C.I.: 
2.44; 2.69), even if the RR is lower than that for “red” colour. A very high between study 
heterogeneity (Chi=315.54; d.f.=26; p<0.001) was found also for this comparison and, as for 
“red” versus “black”, is largely due to Beitner (1990)334. 
When the four estimates published by Chen (1996)234, for the four different body 
sites, are included in the analysis, as they are, the pooled relative risk does not change 
significantly (RR=2.73, 95% C.I.: 2.18; 3.41 and Chi-squared=137.96, d.f.=38; p<0.001). 
The funnel plot is clearly asymmetrical (Figure 5.36) however the method proposed 
by Copas and Shy does not suggest a statistically significant effect of publication bias. As a 
check, I verified the results from the other methods that investigate asymmetry of the funnel 
plot. Begg’s method, which considers the Kendall’s score, gives a slight indication of 
publication bias (p=0.047). However Egger’s linear regression approach does not (p=0.106) 
and “Trim and fill” random effects method does not suggest to consider “missing” studies to 
adjust the pooled estimate for a possible publication bias. 
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5.6.4 Skin colour 
5.6.4.1 Materials and methods 
In twenty-eight papers it was possible to find an estimate of the association between 
melanoma and skin colour. Four217;224;225;332 sets of analysed data were already investigated in 
other publications. The twenty-four independent papers presented results all acquired from 
case-control studies (one is a nested case-control study: Weinstock, 1991335). I finally arrived 
at twenty-five datasets because Graham (1985)286 published estimates separately for sex. 
Hezerfeld (1993)295 published estimates only on men and Holly (1995)333 and Weinstock 
(1991)335 only on women. In all but Chen (1996)234 study, it was evaluated risk for all body.  
General features of studies included in the analysis are shown in Table 5.21 and 
methods of assessment for skin colour are presented in Table 5.22. Some studies used 
previously validated skin colour charts; some used prosthesis and wigmakers’ samples 
whereas others made a simple broad visual assessment. Some authors judged skin colour with 
scores on a quartile or quintile scale, others considered a rough coding classification as 
“dark”, “medium”, “fair”. Some papers investigated skin colour presenting estimates for sun-
exposed and unexposed body sites (e.g. upper inner arm) and the latter was chosen for the 
meta-analysis. 
It is hard to measure skin colour because it exhibits a much narrower colour range 
than hair or eye colour. Therefore, in order to reduce the problem of misclassification bias, it 
was decided to include the estimates comparing highest versus lowest categories. However in 
the sensitivity analysis a pooled RR was calculated reducing to a dichotomy the larger number 
of groupings, because many authors considered only two broad categories. Data from the 
categories defined as “dark” and “medium” were collapsed into “dark/medium”, and data 
belonging to the categories described as “light” or “fair” and “very fair” into the category 
“light”. Calculations are on the studies that published raw data. Three studies (Holman 
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1984150, Holly 1995333 and Chen 1996234) were not included because they presented only 
adjusted estimates. 
 
5.6.4.2 Results 
ORs, adjusted for the maximum number of confounders, are presented in Figures 5.37, with 
their confidence intervals. As can be seen, the majority indicates that people with light skin 
are at considerable higher risk compared to people with dark skin.  
Coefficients of the studies were summarized with random effects models, 
heterogeneity being highly significant (Chi=160.77, d.f.=24, p<0.001), and the pooled relative 
risk for “light” skin colour, compared to “dark”, is 2.02 (95% C.I.: 1.60; 2.55). 
 
5.6.4.3 Heterogeneity analysis 
Even if adjustment for phenotype and phototype are not significant in explaining variability 
among the estimates, it was observed a reduction in the pooled RR calculated on the estimates 
adjusted for phenotype or phototype. Pooled estimate on unadjusted is RR=2.48 (95% C.I.: 
1.61, 3.82; Chi=123.22, d.f.=12, p<0.001) whereas the pooled RR on adjusted estimates is 
RR=1.71 (95% C.I.: 1.44, 2.03; Chi=17.41, d.f.=11, p=0.096). Similar trends were observed 
previously for hair and eye colour suggesting a correlation between these factors. 
Seven studies adjusted for a measure of sun exposure (intermittent, chronic sun 
exposure or sunburns) and eight studies adjusted for naevi. However these adjustments do not 
significantly influence the estimates. 
 
5.6.4.4 Sensitivity analysis 
Rodenas (1996)184 presented an adjusted estimate much lower than the crude one (OR=4.2 
and 95% C.I. 1.67, 10.57; OR=0.5 and 95% C.I. 0.11, 2.18, for crude and adjusted estimates 
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respectively), and there is a suspicion of a type error. However these two ORs are not outliers 
and their weights are not large (w=1.77 and 4.51, for adjusted and not-adjusted estimates 
respectively) therefore they have no considerable influence on the pooled estimates. 
In Nelemans (1993)336 it is not completely clear which are the reference categories. 
In the first table that was published in their paper, only the highest category was indicated 
(“light”) and it is not obvious which is the reference category; in the second table they 
presented cases and controls were from North Europeans and Middle Europeans and probably 
North Europeans were considered as “light skin”. If this hypothesis is correct this study 
should not be included in the meta-analysis because classification of all North European 
people as light skin subjects is too much rough. However the weight of this study is not very 
big (w=10.42). 
Male estimates extracted from Graham (1985)286 are quite unstable because very few 
subjects are in the reference category; however its weight is quite low (w=2.69). 
Freedman (1997)308 compared deaths from melanoma with non-cancer deaths, drawn 
from a database supported by two American national health institutes. Subjects were 
classified in “fair” or “other white” and were defined fair skinned if they were Caucasians and 
coming from Britain, Ireland, Germany, Scandinavia, Poland or other Northern European 
countries. Weight of the relative risk estimate published in this paper is really huge (w=435) 
but the estimate is very low and not significant (RR=1.01 and 95% C.I. 0.92, 1.11) therefore 
the decision to include this estimate is conservative. 
A further analysis was carried out excluding the four previously cited odd studies 
(Rodenas, 1996184, Nelemans, 1993336, Graham, 1985286 and Freedman, 1997308). 
Heterogeneity decreases but remains highly significant (Chi=67,22, d.f.=19, p<0.001) and the 
pooled RR is very similar to the one obtained in the main analysis (RR=2.11 and 95% C.I. 
1.62, 2.47). However when I exclude another study (Dabkowski 1997 188), which presented a 
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very high estimate (OR=15.41 and 95% C.I. 7.82, 30.38) and influenced heterogeneity very 
much, Chi-squared decreases considerably (Chi=28.51; d.f.=18, p=0.056) and the pooled 
estimate remains highly significant (RR=1.77 and 95% C.I. 1.53, 2.04). 
Pooled RR on the dichotomous exposure, “dark/medium” versus “light”, is very 
similar to the one comparing adjusted estimates of the highest versus the lowest categories 
(RR=1.84 and 95% C.I. 1.48, 2.29). Chi-squared remains highly significant (Chi=153.87, 
d.f.=21, p<0.001). 
Gender does not seem to have any influence in results variation. In fact estimates 
from Hezerfeld (1993)295, which considered only men, are very similar to the results 
published by Holly (1995)333 and Weinstock (1991)335 that regarded only women. 
A clear asymmetry can be seen in the funnel plot shown in Figure 5.39. Sensitivity 
analysis on publication bias, proposed by Copas and Shi, gives an indication of an 
overestimation of the risk for light skin colour. However with only four more papers p-value 
for publication bias is not any more significant and the new pooled RR still indicates light 
skin colour as a significant risk factor (RR= 1.75 and 95% C.I. 1.35, 2.27). 
 
5.6.5 Skin phototype 
5.6.5.1 Materials and methods  
Twenty-two articles on the association between melanoma and phototype (also known as skin 
type) were identified: three212;217;332 of them analysed data published in other papers. I finally 
narrowed this down to nineteen independent case-control studies and twenty datasets (Mackie 
1989183 presented estimates separately for sex). Holly (1995)333 published estimates only on 
women. 
Marret (1992)186 published two estimates looking at “skin's reaction to strong 
sunlight after the first summer exposure” and “after repeated exposures”. The second one was 
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chosen because it was considered more appropriate to have a reliable estimate for skin 
phototype. 
Studies included in the meta-analysis are presented in Table 5.23 with some general 
features. Definitions of “skin type” used by the authors are described in Tables 5.24. As can 
be seen some papers evaluated “skin type” in general and some others presented more 
detailed definitions, considering reaction of the skin after few days of sun exposure, 
investigating differences between childhood and adulthood, or using Fitzpatrick classification.  
Fitzpatrick created a standard method for classifying individual skin types, according 
to their skin colour and burning and tanning responses to sun light exposure. This 
classification of skin type into four categories, from type I (always burn, never tan) to type IV 
(never burn, tan easily), is widely used clinically, although the precise questions asked and the 
responses coded vary between studies.  
The main analysis was conducted considering the estimates calculated for the highest 
category at risk (type I), as I did for the other risk factors, in order to reduce misclassification. 
Actually skin type is a subjective, self-reported assessment and, as such, is prone to 
substantial misclassification.  
Five authors presented only dichotomous estimates, whereas ten papers considered 
skin type as an ordinal categorical variable and published three estimates comparing each skin 
type level with the fourth level (never burn, tan easily). A further investigation was carried out 
on these studies that published three estimates, in order to evaluate a trend in melanoma risk 
among skin type categories. 
 
5.6.5.2 Results 
ORs, with their confidence intervals, are shown in Figures 5.40. As can be seen, all but two 
studies (Lock-Andersen, 1998337 and Ammannatti, 1987338) presented positive relative risk 
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estimates and the majority are significant. The pooled relative risk (RR=2.29 and 95% C.I. 
1.73, 3.05) showed that people who always burn and never tan are at significantly higher risk 
than people who never burn and tan easily. 
Dose-response model was used considering skin type as an ordinal categorical 
variable, categorized as follows: IV type (no burn, tan easily) is coded with 0; III type is 
coded with 1; II type is coded with 2; I type (burn, no tan) is coded with 3. Statistical 
methods, proposed by Greenland and Lognecker72, was applied on the ten articles that 
published all three ORs, comparing I, II and III versus IV skin type. Random effects model 
was used even if the between study heterogeneity was not highly significant (p=0.072), given 
the low power of Chi-squared test. A clear increasing trend in melanoma risk, with decreasing 
skin type levels, was found (see Table 5.25).  
 
5.6.5.3 Heterogeneity analysis 
Random effects model was used to calculate pooled RR because heterogeneity is significant 
(Chi=63.98; d.f.=19; p<0.001). However from meta-regression it was found that none of the 
study characteristics, analysed to investigate heterogeneity, is significantly associated with the 
variability between the estimates.  
Even if adjustment for phenotype is not significant in explaining variability among 
the estimates, it was observed a reduction in the pooled RR calculated on the adjusted 
estimates. Pooled RR of not adjusted estimates is RR=2.66 (95% C.I.: 1.68, 4.22; Chi=20.58, 
d.f.=8, p=0.008) whereas the pooled RR of adjusted estimates is RR=2.06 (95% C.I.: 1.44, 
2.95; Chi=38.28, d.f.=10, p<0.001). Similar trends were observed for hair, eye and skin 
colour, suggesting a correlation between these host factors. 
Being described usually in terms of tanning ability or as susceptibility to burning, 
skin type may become a crude surrogate measure for sunburn history. Actually the pooled RR 
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of estimates adjusted for sunburns is a much lower (RR=1.60 and 95% C.I.: 1.17, 2.19), even 
if not statistically different (p=0.378), than pooled RR of unadjusted estimates (RR=2.55 and 
95% C.I.: 1.78, 3.63). Between-study Chi-squared, calculated on adjusted estimates, is not 
significant (Chi=3.07, d.f.=4, p=0.801), whereas it remains highly significant (Chi=59.28, 
d.f.=14, p<0.001) for unadjusted. 
 
5.6.5.4 Sensitivity analysis 
Heterogeneity is highly influenced by the study published by Rodenas (1996)184, which 
presented a very large estimate (OR=29.8 and 95% C.I. 8.90, 99.89). However this OR does 
not have a considerable weight (w=2.69), the confidence intervals being quite wide, and 
exclusion of this study does not make a big change in the pooled estimate (RR=2.06 and 95% 
C.I. 1.61, 2.63) 
Mackie (1989)183 presented estimates separately for sex and Holly (1995)333 
published estimates only on women. Again the confidence intervals of the ORs for men and 
women published by Mackie overlaps and I cannot suggest a significant influence of gender. 
However it is interesting to note a similar trend for almost all studies that presented separately 
for sex. In Mackie (1989) for freckles, Graham (1985) for eye colour, Lindelof (1991) for 
photodamage, Graham (1985) for skin colour and Mackie (1989) for sunburns in adulthood 
estimates for men are higher and with wider confidence intervals. It is not clear if this finding 
is due merely to chance or if it is due to some other unknown factor. 
Sensitivity analysis, proposed by Copas and Shi, suggests that there may be some 
indications for publication bias but, with only two papers more, p-value for the funnel plot 
(Figure 5.41) is not any more significant and the pooled relative risk does not show a 
considerable decrease (RR=2.01 and 95% C.I. 1.44, 2.82) 
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5.6.6 Discussion on host factors 
If in ascertaining ability to tan problems of recall bias and reliability may arise, in the findings 
related to differences in eyes or hair colour definitions, it is more difficult to raise the question 
of misclassification bias. Therefore relative risk estimates for the established host factors 
should be quite reliable.309  
In heterogeneity analysis I found suggestions for a considerable correlation between 
skin, hair and eyes colours, as is suggested in the literature. At the opposite in Bliss (1995)25 
individual subjects meta-analysis, hair, eye and skin colours appear largely independent and 
the authors discuss the possibility of combining them to demarcate high risk groups who can 
be targeted for prevention.  
Clearly hair and eye colours cannot be considered directly in a causal relationship 
with melanoma and are likely to be risk factors by virtue of their correlation with skin 
phenotype. Their association with melanoma may be because it is easier to have an indicative 
measure of hair and eye colour. They have a wide colour range in many populations whereas 
skin colour is difficult to measure and has a much narrower colour range. This makes more 
difficult to obtain a reliable estimate of risk for skin colour. 
 
5.7 Conclusions 
A systematic meta-analysis looking at all published studies for all risk factors for melanoma 
was carried out to obtain summary estimates and investigate between-study heterogeneity. 
Published literature showed strong associations of melanoma with several factors. 
Sun exposure is one of the main factors analysed and discussed and it is the most important 
modifiable factor in the aetiology of melanoma. Influence of sun exposure is investigated in 
this chapter considering several variables, indicating direct or indirect measure of sun 
exposure: cumulative exposure, acute intermittent exposure, chronic exposure and history of 
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sunburns in childhood and adulthood. The overall conclusion of a positive association with 
intermittent exposure and a protective or uncertain effect for chronic sun exposure is 
consistent with the previous meta-analyses. Another related characteristic, shown to be 
strongly positively associated with melanoma, is the frequency of previous sunburns. 
However it is important to take into account that for all these variables there is a relevant 
problem of measurement of exposure due to absence of standardized instruments of 
measurement. Recall bias in this situation is a very important problem.  
Some photodamage indicators, which may also be considered indicators of acute and 
chronic exposure to sun radiations, are analysed and the pooled estimates show that they are 
highly associated to melanoma.  
Some genetically controlled features influence individual susceptibility to the sun. 
These include skin pigmentation, which, in turn, is related to hair and eye pigmentation; and 
tendency to burn or ability to tan, which is clinically characterized as skin type. The 
historically classic risk factors (fair or red hair, blue eyes, and fair skin) are confirmed to be 
highly associated with melanoma and pooled estimates are calculated. These are not 
modifiable risk factors but higher risk individuals may be identified and targeted for increased 
frequency of screening and intensified efforts at primary intervention. The other set of factors, 
which are very strong and useful clinically as risk indicators, includes the number of acquired 
naevi and presence of atypical naevi, as we have seen in the previous chapter.  
The remaining major factor is family history, which confers an extremely high risk estimated 
by a pooled estimate not affected by heterogeneity.  
Fixed effects and random effects models have been applied to compared usually 
highest versus lowest category of exposure. Dose-response models are used to estimate the 
dose-response relationship across categories of exposure. Multivariate approach was 
considered to compare multiple risk factors. 
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Between-study heterogeneity was found to be significant for the majority of the risk 
factors considered. Therefore results from subgroup analysis and meta-regression should be 
regarded with much attention. The studies were classified according to several features that 
may have been responsible for the variability in the estimates. I had expected in advance that 
specific methodological aspects, such as type of study, source of cases and controls, matching, 
blinding, exclusion of lentigo maligna, acral melanoma or subjects with family history, 
adjustment for certain confounders, or features of the population under study as age, latitude 
or country of the study, would be associated with considerable changes in the estimates. Thus 
several important conclusions were made looking at the factors found to be significantly 
associated with variation in the estimates.  
Sensitivity analyses are also carried out to investigate choices regarding inclusion or 
exclusion of studies, methodologies applied and influence of singles studies. Publication bias 
was expplored to verify relibility of pooled estimates.  
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5.8 Tables 
5.8.1 Total sun exposure Tables 
 
Table 5.1. Characteristics of the studies on total sun exposure. 
First author, Year  Country N° 
Cases 
N° 
Controls 
Source 
Cases 
Source 
Controls 
Cristofolini, 1987 235  Italy 103 205 Hospital Hospital 
Dabkowski, 1997188  Poland 74 300 Hospital Population 
Dubin., 1990214  USA 289 527 Hospital Hospital 
Elwood, 1985304  Canada 595 595 Population Population 
Graham, 1985286 (women) USA 186 319 Hospital Hospital 
Graham, 1985 286 (men) USA 218 202 Hospital Hospital 
Green, 1986250-1985167  Australia 183 183 Population Population 
Grob, 1990170  France 207 295 Hospital Population 
Holman, 1986300  Australia 507 507 Population Population 
Rodenas, 1996184  Spain 105 138 Hospital Visitors to 
hospital 
White, 1994249 USA 256 273 Population Population 
 
Table 5.2a. Definitions of total sun exposure. 
First author, year   Definition of exposure 
Cristofolini, 1987  1 Heavy or frequent exposure to sunlight in the last 20 years: 
yes 
Dabkowski, 1997  1 History of intensive UV exposure: yes 
Dubin, 1990  1 Hours of sun exposure 0-5 years previously, h/day: 5+ 
 2 Hours of sun exposure 6-10 years previously, h/day: 5+ 
 3 Hours of sun exposure 11-20 years previously, h/day: 5+ 
 4 Overall sun exposure: Much 
Elwood, 1985  1 Whole-body equivalent hours of sun exposure from all sources 
per year. One whole body equivalent hour of exposure 
represents 1 hr of sun exposure of the whole body surface, and 
recorded exposures were converted to equivalent hours using 
estimates of the proportion of surface area exposed.: 500+ 
Graham, 1985 
(men)  
1 Cumulative sun exposure, hours (thousands): >160 
 2 Average annual sun exposure, h/year: >3200 
 3 Exposure level: 5 
Graham, 1985 
(women) 
1 Cumulative sun exposure, hours (thousands): >100 
 2 Average annual sun exposure, h/year: >2000 
 3 Exposure level: 5 
Green, 1986-1985  1 Cumulative hours of sun exposure during whole of life: 50000 
 2 Cumulative hours of sun exposure during ages 10-19 years: 5000 
 3 Cumulative hours of sun exposure during the 5 years prior to case 
diagnosis: 5000 
Definitions included are in bold. 
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Table 5.2b. Definitions of total sun exposure. 
First author, year   Definition of exposure 
Grob, 1990  1 Cumulative lifetime outdoor sun exposure index: SU=sun 
exposure unit (a day with at least 2 h of direct sun exposure): 
>2000SU 
Holman, 1986  1 Mean total outdoor exposure in summer, hr/week: >23 
Rodenas, 1996  1 Total sun exposure (hrs): > 8501 
White, 1994  1 Average yearly sun exposure (hours) over the 10 years before 
reference date, h/year. Reference date was 2 years prior to 
diagnosis for the cases and a comparable date for controls: 
500-2880 
 2 Sun exposure index at ages 2-10 years. Sun exposure index was 
calculated as number of days per year in the sun divided clothing 
category: 91-365  
 3 Sun exposure index at ages 11-20 years. Sun exposure index was 
calculated as number of days per year in the sun divided clothing 
category: 91-365 
Definitions included are in bold. 
 
5.8.2 Intermittent sun exposure Tables 
 
Table 5.3a. Characteristics of the studies on intermittent sun exposure. 
First author, Year  Country N° Cases N° controls Source 
of Cases 
Source of 
controls 
Autier, 1998301 Germany, France 
and Belgium 
420 447 Hosp Pop 
Beitner, 1990334  Sweden 523 505 Hosp Pop 
Bell, 1987297  UK 268 1577 Hosp Hosp 
Carli, 1995217  Italy 106 109 Hosp Pop 
Chen, 1996234 
(head/neck)  
USA 85 494 Pop Pop 
Chen, 1996234 (lower 
limb)  
USA 97 494 Pop Pop 
Chen, 1996234 
(trunk) 
USA 265 494 Pop Pop 
Chen, 1996234 
(upper limb)  
USA 101 494 Pop Pop 
Dubin, 1990214  USA 289 527 Hosp Hosp 
Dunn-Lane, 1993339  Ireland 100 100 Hosp Hosp 
Elwood, 1985304  Canada 595 595 Pop Pop 
Fritschi, 1996340  Canada 103 533 Pop Pop 
Green, 1986250  Australia 183 183 Pop Pop 
Grob, 1990170  France 207 295 Hosp Pop 
Herzefeld, 1993295 
(men, trunk) 
USA 324 415 Pop Pop 
Holly, 1995296 
(women) 
USA 452 930 Pop Pop 
Holman, 1986300  Australia 507 507 Pop Pop 
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Table 5.3b. Characteristics of the studies on intermittent sun exposure. 
First author, Year  Country N° Cases N° controls Source 
of Cases 
Source of 
controls 
Lock-Andersen, 
1998337 
Denmark 168 176 Hosp Pop 
Moore, 1997230  USA 69 69 Pop Pop 
Nelemans, 1993336  Netherlands 141 183 Pop Pop 
Osterlind, 1988302  Denmark 474 926 Pop Pop 
Weiss, 1991213  Germany 204 200 Hosp Hosp 
Westerdahl, 1995221  Sweden 400 640 Pop Pop 
Wolf, 1998298  Austria 193 319 Hosp Hosp 
Zaridze, 1992224  Russia 96 96 Hosp Visitor to 
hosp 
 
Table 5.4a. Definitions of intermittent sun exposure. 
First author, 
Year  
 Definizione dell'esposizione 
Autier, 1998  1 Index of sun exposure during childhood (residency>=1 year in 
Mediterranean, tropical or subtropical area starting before 10 years 
old; ever sunburn between 5 and 10 years, and between 10 and 14 
years old; never been protected against sunlight during holidays in 
sunny resorts: high (2 risk factors) 
 2 Index of sun exposure during adulthood (on average >2 
holidays weeks spent each year in sunny resorts; during 
holidays, sun exposure during the hot hours of the day; search 
for suntan during residence of >=1 year in Mediterranean, 
tropical or subtropical area; ever sunburn after 14 years old; 
sunscreen use; never suffered from non-malignant skin disease 
that lasted for >=1 year): extreme (5-7 risk factors) 
Beitner, 1990 1 Number of sunbathes April-Sept. Per year: >30 
 2 Sunbathing vacations abroad: >= once a year 
Bell, 1987  1 Frequent sunbathing: yes 
 2 Keen gardener: yes 
 3 Outdoor sportsman: yes 
Carli, 1995  1 Cumulative sunbathing until age 20 yr (hr): >800 
 2 Sunbathing (hr/yr) after age 20 yr: >80 
Chen, 1996  1 Total recreational sun exposure index. Sun exposure index was 
created by assigning scores to 2 recreational sun exposure 
history variable, number of vacations to places sunnier than the 
usual residence and number of days spent in outdoor 
recreational activities per year, and summing the scores for 2 
periods of time (before 16 years and during last 10 years): level 
4 
Dubin, 1990  1 Recreation type: mostly outdoors 
Dunn-Lane, 
1993  
1 Holidays in the sun: yes 
 2 Sunbathing at every opportunity: yes 
Definitions included are in bold. 
 
 173
Table 5.4b. Definitions of intermittent sun exposure. 
First author, 
Year  
 Definizione dell'esposizione 
Elwood, 1985 1 Recreational, summer, group A equivalent hours of 
exposure/season. One whole body equivalent hour of exposure 
represents 1 hr of sun exposure of the whole body surface, and 
recorded exposures were converted to equivalent hours using 
estimates of the proportion of surface area exposed. group A 
referred to activities where to activities where a bathing suit or 
very light clothing to be worn (e. g. sunbathing, swimming).: 
160+ 
 2 Vacation, summer, groups A&B equivalent hours of 
exposure/season. One whole body equivalent hour of exposure 
represents 1 hr of sun exposure of the whole body surface, and 
recorded exposures were converted to equivalent hours using 
estimates or the proportion of surface area exposed. Group A 
referred to activities where a bathing suit or very light clothing to 
be worn (e. g. sunbathing, swimming). Group B referred to 
activities where light clothing would to be worn (e. g. team games, 
camping, gardening).: 40+ 
 3 Sunny vacations per decade, number (equivalent hours of 
exposure). One whole body equivalent hour of exposure represents 
1 hr of sun exposure of the whole body surface, and recorded 
exposures were converted to equivalent hours using estimates of the 
proportion of surface area exposed.: 4+ 
Fritschi, 1996 1 Hobbies, gardening: yes 
 2 Hobbies, outdoor sports: yes 
Green, 1986  1 Recreation hours spent in sun on beach over whole life: 5000 
 2 Recreation hours spent on the beach in sun during ages 10-19 years: 
500 
 3 Recreational hours spent on the beach in the sun during the 5 years 
prior to case diagnosis: 500 
Grob, 1990  1 Outdoor leisure sun exposure per year in the last 2 years: 
SU=sun exposure unit (a day with at least 2 h of direct sun 
exposure): >60 SU 
Herzfeld, 1993 1 Participate in water sports: yes 
 2 Bathe more than once per day: yes 
Holly, 1995  1 Time spent outdoors on weekends with arms and legs exposed to 
the sun (past 10 years): >=3/4 of time 
 2 Time sunbathing in a typical year (past 10 years): >= once/week
Holman, 1986 1 Recreational outdoor exposure proportion in summer at ages 
10-24 yr, %: >60 
 2 Boating-frequency of participation in summer: once or more/wk 
 3 Fishing-frequency of participation in summer: once or more/wk 
 4 Swimming-frequency of participation in summer: once or more/wk
 5 Sunbathing, ages 15-24 yr-frequency of participation in summer: 
once or more/wk 
 6 Sunbathing, 0-9 yr pre-diagnosis, frequency of participation in 
summer: once or more/wk 
 7 Mean time spent outdoors in summer aged 10-20 (h/week): >=16 
Definitions included are in bold. 
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Table 5.4c. Definitions of intermittent sun exposure. 
First author, 
Year  
 Definizione dell'esposizione 
Lock-
Andersen, 
1998  
1 Childhood: sun exposure in leisure time: always or very often 
 2 Adulthood: sun exposure in leisure time: always or very often 
 3 VAS, visual analogue scale with end points: 0=never sun exposed; 
10=always sun exposed. 
Moore, 1997  1 Did you ever sunbathe?: yes 
 2 Sunbathing during 10 years prior to diagnosis (hr/wk): >=0,45 
 3 Sunbathing ages 15-25 (days/year): >=7,5 
 4 Hiking: yes 
 5 Swimming: yes 
 6 Boating-sailing: yes 
 7 Water skiing: yes 
Nelemans, 
1993  
1 Sunbathing: yes 
 2 Water sports: yes 
 3 Vacations in sunny countries: yes 
 4 <15 years of age, swimming pools only: yes 
 5 <15 years, open waters only: yes 
 6 <15 years, any type of polluted water: yes 
 7 15-25 years of age, swimming pools only: yes 
 8 15-25 years of age, open waters only: yes 
 9 15-25 years of age, any type of polluted waters: yes 
 10 >25 years of age, swimming pools only: yes 
 11 >25 years of age, open waters only: yes 
 12 >25 years of age, any type of polluted water: yes 
 13 Age at which swimming was learned (years): <9 
Osterlind, 
1988  
1 Sunbathing: at some time 
 2 Boating: at some time 
 3 Skiing: at some time 
 4 Swimming (outdoor): at some time 
 5 Vacations in sunny resorts: very sunny resorts 
Rodenas, 1996 1 Outdoor leisure exposure (hrs): >=951 
 2 Childhood sunbaths: >=211 
Rosso, 1998  1 Holidays at beach (no. of hours in a lifetime): >4000 
 2 Holidays at beach during childhood (n. of hours in a lifetime): 
>1600 
 3 Holidays t beach during adulthood (n. of hours in a lifetime): >2200
 4 Outdoor sports (n. of hours in a lifetime): >2800 
Walter, 1999  1 Beach vacation in the past 5 years: yes 
 2 Beach vacations at age 12 years: yes 
 3 Beach vacations at age 18 years: yes 
Weiss, 1991  1 Recreational sun exposure: high/medium 
Definitions included are in bold. 
 
 175
Table 5.4d. Definitions of intermittent sun exposure. 
First author, 
Year  
 Definizione dell'esposizione 
Westerdahl, 
1995  
1 Sunbathing frequently during the summer (April-September): 
yes 
 2 Sunbathing vacations abroad (per year): one or more 
Wolf, 1998  1 Leisure sun exposure: >50% 
 2 Vacation in sunny areas: every other year 
 3 Sunbath per year: >30 
Zaridze, 1992 1 Sunbathing at age 18-20: often 
Definitions included are in bold. 
 
5.8.3 Chronic sun exposure Tables 
 
Table 5.5a. Characteristics of the studies on chronic sun exposure. 
First author, Year Type of 
study 
Country N° 
Cases
N° 
controls
Source of 
Cases 
Source of 
controls 
Autier, 1994233 CC Germany, 
France and 
Belgium 
420 447 Hospital Population
Beitner, 1990334 CC Sweden 523 505 Hospital Population
Bell, 1987297 CC UK 268 1577 Hospital Hospital 
Carli, 1995217 CC Italy 103 109 Hospital Population
Chen, 1995 217 
(head/neck)  
CC USA 85 494 Population Population
Chen, 1996234 (lower 
limb)  
CC USA 97 494 Hospital Hospital 
Chen, 1996 234 (trunk) CC USA 265 494 Hospital Hospital 
Chen, 1996 234 (upper 
limb)  
CC USA 101 494 Hospital Hospital 
Cooke, 1984305 Cohort New Zealand 501 n.a. Population Population
Cristofolini, 1987235 CC Italy 103 205 Population Population
Dubin, 1990214 CC USA 289 527 Hospital Hospital 
Dunn-Lane, 1993339 CC Ireland 100 100 Other Other 
Elwood, 1985304 CC Canada 595 595 Hospital Hospital 
Elwood, 1986236 CC UK 83 83 Hospital Hospital 
Freedman, 1997308 CC USA 12156 23845 Population Population
Garbe, 1989210 CC Germany 200 200 Hospital Population
Goodman, 1995307 CC USA 3527 53129 Population Population
Graham, 1985307 
(men) 
CC USA 218 202 Population Population
Grob, 1990170 CC France 207 295 Hospital Population
Herzfeld, 1993295 
(men, trunk)  
CC USA 324 415 Hospital Population
Holly, 1995296 
(women) 
CC USA 452 930 Hospital Hospital 
Holman, 1986300 CC Australia 507 507 Population Population
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Table 5.5b. Characteristics of the studies on chronic sun exposure. 
First author, Year Type of 
study 
Country N° 
Cases
N° 
controls 
Source of 
Cases 
Source of 
controls 
Lock-Andersen, 1998 
337 
CC Denmark 168 176 Hospital Population
Nelemans, 1993336 CC Netherlands 141 183 Population Population
Osterlind, 1988302 
men 
CC Denmark 194 390 Population Population
Osterlind, 1988302 
(women) 
CC Denmark 280 536 Population Population
Pion, 1994303 (women) Nested CC USA 1494 4467 Population Population
Pion, 1994303 (men) Nested CC USA 1305 3910 Population Population
Rodenas, 1996184 CC Spain 105 138 Hospital Visitors to 
hospital  
Rosso, 1998299 CC Italy 260 416 Population Population
Vagero, 1986306 Cohort Sweden 4706 2630458* Population Population
Walter, 1999325 CC Canada 583 608 Population Population
Weiss, 1991213 CC Germany 204 200 Hospital Hospital 
Westerdahl, 1994293 CC Sweden 400 640 Population Population
White, 1994249 CC USA 256 273 Population Population
Wolf, 1998298 CC Austria 193 319 Hospital Hospital 
(*) number refers to the cohort size; n.a.: not available 
 
Table 5.6a. Definitions of chronic sun exposure.  
First authorm, year   Exposure definitions  
Autier, 1994 1 Past or present occupation in farming or building 
construction: yes 
 2 Duration of occupation in farming or building construction: 
>30 years 
Beitner, 1990 1 Outdoor workers: yes 
Bell, 1987 1 Occupation: outdoor 
Carli, 1995 1 Outdoor job: yes 
Chen, 1996 1 Total years in outdoor jobs: 5+ 
Cooke, 1984 1 Occupational units groups: who have worked outside of any 
building for 10 h or more per week (outdoor) 
Cristofolini, 1987 1 Main occupation: outdoor 
Dubin, 1990 1 Occupation type: mostly outdoors 
Dunn-Lane, 1993 1 Work outside for >30 hrs/week: yes 
Elwood, 1986 1 Outdoor exposure (h): 25000+ 
Elwood, 1985 1 Occupational, summer, equivalent hours of 
exposure/season: One whole body equivalent hour of 
exposure represents 1 hr of sun exposure of the whole body 
surface, and recorded exposures were converted to 
equivalent hours using estimates of the proportion of 
surface area exposed.: 400+ 
Freedman, 1997 1 Occupation: outdoor (non-farmer) 
Garbe, 1989 1 Occupational sun exposure: sometimes/nearly every time 
Goodman, 1995 1 Sun exposure during work: mainly outdoor 
Definitions included are in bold. 
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Table 5.6b. Definitions of chronic sun exposure. 
First author, year  Exposure definitions  
Graham, 1985 1 Hours of cumulative occupational sun exposure: >45000 
Grob, 1990 1 Indoor or outdoor occupation: outdoor only 
Herzfeld, 1993 1 Occupation: mostly outdoor 
Holly, 1995 1 Time spent outdoors on weekdays with arms and legs 
exposed to the sun: >1/2 of time 
Holman, 1986 1 Outdoor work in summer: >2 hr/day 
Lock-Andersen, 1998 1 Sun exposure in working hours: always or very often 
Nelemans, 1993 1 Occupational exposure: ever 
Osterlind, 1988 1 Working outside in the summer (held for at least 6 months): 
yes 
 2 Working in outdoor occupations: yes 
Pion, 1994 1 Occupational location: outdoor 
Rodenas, 1996 1 Occupational exposure (hrs): >11501 
Rosso, 1998 1 Outdoor work (n. of hours in a lifetime): >22000 
Vagero, 1986 1 Type of work: outdoor 
Walter, 1999 1 Outdoor activity days between ages 10 and 20: >100 
 2 Outdoor job hours 5 years ago: >0 
Weiss, 1991 1 Occupational sun exposure: continuously/part-time 
Westerdahl, 1994 1 Outdoor employment during the summer: yes 
White, 1994 1 Lifetime occupational sun exposure (%): >50 
Wolf, 1998 1 Occupational sun exposure: yes 
Definitions included are in bold. 
 
5.8.4 Sunburns in childhood Tables 
 
Table 5.7. Characteristics of the studies included on sunburns in childhood. 
First author, Year Country N° 
Cases
N° 
controls
Source of 
Cases 
Source of 
controls 
Autier, 1998301 Germany, 
France and 
Belgium 
420 447 Hospital Population 
Carli, 1995217 Italy 103 109 Hospital Population 
Cristofolini, 1987235 Italy 103 205 Hospital Hospital 
Elwood, 1984294 Canada 595 595 Population Population 
Elwood, 1990237 UK 195 195 Population Hospital 
Holly, 1987169 USA 121 139 Hospital Hospital 
Holly, 1995296 (women) USA 452 930 Population Population 
Holman, 1986300 Australia 507 507 Population Population 
Moore, 1997230 USA 69 69 Population Population 
Osterlind, 1988302 Denmark 194 390 Population Population 
Rodenas, 1996184 Spain 105 138 Hospital Visitors to 
hospital 
Westerdahl, 1994293 Sweden 400 640 Population Population 
Zanetti, 1992292 Italy 260 416 Population Population 
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Table 5.8. Definitions for sunburns in childhood.  
First author, year  Definizione dell'esposizione 
Autier, 1998 1 Ever sunburn between 5 and 10 years and between 10 and 
14 years old: yes 
Carli, 1995 1 Childhood sunburn (pain for 2 or more days or blistering): 
usually 
Cristofolini, 1987 1 Painful and blistering sunburn in childhood and adolescence
Elwood, 1984 1 Childhood sunburn: severe or frequent 
Elwood, 1990 1 Severe sunburn (pain for 2 or more days or blistering) age 
8-12 
Holly, 1987 1 Sunburns with blisters, score value: the score combined 
number of sunburns that caused blisters reported during 
elementary school, high school and young adult years: 3+ 
Holly, 1995 1 Sunburn before age 12 years: severe/frequent burns 
 2 Number of painful sunburns during elementary school>=7 
Holman, 1986 1 Sunburn causing pain for >=2 days, <10 years of age: 5+ 
Moore, 1997 1 Sunburn with blistering: one or more episodes 
 2 Painful sunburn: one or more episodes 
Osterlind, 1988 1 Number of sunburns before age 15: 5+ 
Rodenas, 1996 1 Childhood painful erythema: often 
 2 Childhood blistering sunburns: yes 
Westerdahl, 1994 1 Number of sunburns before age 15 years: >5 times 
Zanetti, 1992 1 Sunburns in childhood: often 
 2 Sunburns in childhood: severe 
 3 Sunburns in childhood: yes 
Definitions included are in bold. 
 
5.8.5 Sunburns in adulthood Tables 
 
Table 5.9a. Characteristics of the studies on sunburns in adulthood. 
First author, Year  Country N° 
Cases
N° 
controls
Source of 
cases 
Source of 
controls 
Autier, 1998301  Germany, 
France and 
Belgium 
420 447 Hospital Population 
Beitner, 1990334  Sweden 523 505 Hospital Population 
Carli, 1995217 Italy 131 174 Hospital Population 
Carli, 1999219  Italy 103 109 Hospital Population 
Chen, 1996234 (head neck)  USA 85 494 Population Population 
Chen, 1996 234 (lower limb)  USA 97 494 Population Population 
Chen, 1996 234 (trunk)  USA 265 494 Population Population 
Chen, 1996 234 (upper limb)  USA 101 494 Population Population 
Cristofolini, 1987235  Italy 103 205 Hospital Hospital 
Dabkowski, 1997188  Poland 74 300 Hospital Population 
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Table 5.9b. Characteristics of the studies on sunburns in adulthood. 
First author, Year  Country N° 
Cases
N° 
controls
Source of 
cases 
Source of 
controls 
Dubin, 1990214  USA 289 527 Hospital Hospital 
Dunn-Lane, 1993339  Ireland 100 100 Hospital Hospital 
Elwood, 1985304  Canada 595 595 Population Population
Elwood, 1986236  UK 83 83 Hospital Hospital 
Elwood, 1990237  UK 195 195 Population Hospital 
Green, 1985312  Australia 183 183 Population Population
Grob, 1990170  France 207 295 Hospital Population
Holly, 1995296 (men)  USA 452 930 Population Population
Holman, 1986300  Australia 507 507 Population Population
MacKie, 1989183 (women)  UK 181 181 Population Hospital 
MacKie, 1989183 (men)  UK 99 99 Population Hospital 
Moore, 1997230  USA 69 69 Population Population
Nelemans, 1993336  Netherlands 141 183 Population Population
Osterlind, 1988302  Denmark 194 390 Population Population
Rodenas, 1996184  Spain 105 138 Hospital Visitors to 
hospital 
Weinstock, 1989311 (women)  USA 130 300 Population Population
Westerdahl, 1994293  Sweden 400 640 Population Population
Wolf, 1998298  Austria 193 319 Hospital Hospital 
Zanetti, 1992292  Italy 260 416 Population Population
 
Table 5.10a. Definitions of sunburns in adulthood. 
First author (year)  Definizione dell'esposizione 
Autier, 1998 1 Ever sunburn after 14 years old: yes 
Beitner, 1990 1 Erythema after sunbathing: often, very often 
Carli, 1995 1 Adulthood sunburn (pain for 2 or more days or blistering): 
usually 
Carli, 1999 1 Number of sunburns (pain for 2 or more days or 
blistering): 6+ 
Chen, 1996 1 Number of sunburns (pain for 2 or more days or 
blistering): 3+ 
Cristofolini, 1987 1 Sunburn: frequent/constant 
Dabkowski, 1997 1 History of sunburn: yes 
Dubin, 1990 1 Severe sunburn with blistering: ever 
Dunn-Lane, 1993 1 History of severe sunburn with blistering: ever 
Elwood, 1985 1 Vacation sunburn score: was taken as the sum of the 
maximum grading score for each of the four body areas.: 
very severe, 10-12 
Elwood, 1986 1 History of sunburn causing pain for 2 days or more: yes 
Elwood, 1990 1 Severe sunburn (causing blistering or pain for 2 days or more) 
5 years before diagnosis: moderate/max 
 2 Severe sunburn (causing blistering or pain for 2 days or 
more) 18-20 years before diagnosis: moderate/max 
Definitions included are in bold.
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Table 5.10b. Definitions of sunburns in adulthood.  
First author (year)  Definizione dell'esposizione 
Green, 1986 1 Pain longer than 48 hours, with or without blistering: 6+ 
Grob, 1990 1 Frequency of sunburns per year in recent years: >2 
 2 Severity of sunburn in recent years: at least one severe burn 
Holly, 1995 1 Ever sunburned with pain that lasted for>=2 days: yes 
 2 Ever sunburned with pain that lasted for >=2 days in past 10 
years: >=4 episodes 
 3 Number of painful sunburns over age 30 years: >=7 
 4 Number of painful sunburns during ages 23-30 years: >=7 
Holman, 1986 1 Highest severity of past sunburn: blistering sunburn 
 2 Sunburn causing pain for >= 2 days, during last 10 years: yes 
MacKie, 1989 1 Number of severe sunburns in life: 3+ 
Moore, 1997 1 Sunburn with blistering (18-29): one or more episodes 
 2 Painful sunburn (18-29): one or more episodes 
 3 Sunburn with blistering (30+): one or more episodes 
 4 Painful sunburn (30+): one or more episodes 
Nelemans, 1993 1 History of sunburns: yes 
Osterlind, 1988 1 Number of sunburns in last 10 years: 5+ 
Rodenas, 1996 1 Adulthood painful erythema: often, very often 
 2 Adulthood blistering sunburns: yes 
 3 Total episodes of blistering sunburns: >=2 
Weinstock, 1989 1 Number of blistering sunburns reported after age 30 y: 5+ 
 2 Number of blistering sunburns reported per year after age 30 y: 
at least 1/5 y 
Westerdahl, 1994 1 Episodes of sunblisters: yes 
 2 Formation of ulcer: yes 
 3 Average number of episodes of sunburn per year: >=3 
 4 Number of sunburns (causing severe erythema and pain 
for a few days) after age 19 years: >5 times 
 5 History of sunburns: yes 
Wolf, 1998 1 History of sunburn: yes 
 2 Erythema due to sunlight: often 
 3 Skin rash due to sunlight: yes 
Zanetti, 1992  Severe sunburns lifelong: ever 
Definitions included are in bold. 
 
5.8.6 Family history Tables 
 
Table 5.11a. Characteristics of the studies on family history.  
First author, Year  Country N° 
Cases
N° 
controls
Sources of 
cases 
Sources of 
controls 
Cristofolini, 1987235 Italy 103 205 Hospital Hospital 
Dubin, 1986164  USA 289 527 Hospital Hospital 
Green, 1985167  Australia 183 183 Population Population 
Holly, 1987169  USA 121 139 Hospital Hospital 
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Table 5.11b. Characteristics of the studies on family history.  
First author, Year  Country N° 
Cases
N° 
controls
Sources of 
cases 
Sources of 
controls 
Holly, 1995333 (women)  USA 452 930 Population Population 
Holman, 1984150 Australia 507 507 Population Population 
MacKie, 1989183 (women)  Scotland 280 280 Population Hospital 
Osterlind, 1988 226  Denmark 474 926 Population Population 
Swerdlow, 1986168  Scotland 180 197 Hospital Hospital 
Walter, 1999325  Canada 583 608 Population Population 
Westerdahl, 1994293  Sweden 400 640 Population Population 
 
5.8.7 Indicators of photodamage Tables 
 
 Table 5.12. Characteristics of the studies on indicators of photodamage. 
First author, Year Type of 
study 
State N 
cases 
N 
controls 
Source
cases 
Source 
control 
Bataille, 1998328 CC Australia 259 281 Hosp Hosp 
Dubin, 1990214 CC USA 289 527 Hosp Hosp 
Frish, 1996 341 Cohort Denmark 134 37674* Pop Pop 
Garbe, 1989210 CC Germany 200 200 Hosp Hosp 
Garbe, 1994165 CC Germany, 
Austria, 
Switzer. 
513 498 Hosp  Hosp 
Green, 1986250 CC Australia 183 183 Pop Pop 
Halpern, 1991238 CC USA 105 181 Hosp Pop 
Holly, 1987169 CC USA 121 139 Hosp Hosp 
Holman, 1984273 CC Australia 507 507 Pop Pop 
Lindelof, 1991329 
(women) 
Cohort Sweden 9 934* Pop Pop 
Lindelof, 1991329 
(men) 
Cohort Sweden 6 1039* Pop Pop 
Marghoob, 1995342 Cohort USA 10 290* Pop Pop 
Marrett, 1992186 CC Canada 583 608 Pop Pop 
Moore, 1997230 Nested 
CC 
USA 69 69 Pop Pop 
Osterlind, 1988343 CC Denmark 474 926 Pop Pop 
(*) number refers to the cohort size. 
 
Table 5.13a. Definitions and classification for indicators of photodamage.  
First author (year) Definitions  Classification 
Bataille, 1998 Number of solar keratoses on left 
forearm: 10+ 
Pre-mal. and cancer 
les. 
Bataille, 1998 Degree of solar elastosis: severe Other indic. of act. 
damage 
Dubin, 1990 Prior non-melanoma skin cancer or 
solar keratosis: yes 
Pre-mal. and cancer 
les. 
Frisch, 1996 Previous basal cell carcinoma: yes Pre-mal. and cancer 
les. 
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Table 5.13b. Definitions and classification for indicators of photodamage. 
First author, year Definitions  Classification 
Garbe, 1989 Actinic lentigines: moderate to large 
numbers 
Other indic. of act. 
damage 
Garbe, 1994 Actinic lentigines: many Other indic. of act. 
damage 
Green, 1986 Lentigines on arms: any Other indic. of act. 
damage 
Green, 1986 Actinic tumor on face:yes Pre-mal. and cancer les.
Halpern, 1991 Actinic damage: severe Other indic. of act. 
Damage 
Holly, 1987 Previous skin cancer: yes Pre-mal. and cancer les.
Holman, 1984 Cutaneous microphotograph (grade): 6+ Other indic. of act. 
Damage 
Holman, 1984 History of non-melanocytic skin cancer: 
yes 
Pre-mal. and cancer les.
Lindelof, 1991 (women) Previous basal cell carcinoma (BCC): 
yes 
Pre-mal. and cancer les.
Lindelof, 1991 (men) Previous basal cell carcinoma 
(BCC):yes 
Pre-mal. and cancer les.
Marghoob, 1995 Patients who had a BCC and/or 
squamous cell carcinoma (SCC): yes 
Pre-mal. and cancer les.
Marrett, 1992 Splotchy freckles: yes Other indic. of act. 
damage 
Moore, 1997 Previous skin cancer: yes Pre-mal. and cancer les.
Osterlind, 1988 Cutaneous microphotograph (grade): 4+ Other indic. of act. 
damage 
 
5.8.8 Freckles Tables 
 
Table 5.14a. Characteristics of the studies on freckles. 
First author, Year Country N° 
Cases
N° 
Controls
Sources 
of cases 
Source of 
controls 
Carli, 1999219 Italy 131 174 Hosp Pop 
Chen, 1996234 (head/neck) USA 85 494 Pop Pop 
Chen, 1996234 (lower limb) USA 97 494 Pop Pop 
Chen, 1996234 (trunk) USA 265 494 Pop Pop 
Chen, 1996234 (upper limb) USA 101 494 Pop Pop 
Dubin, 1990214 USA 1103 585 Hosp Hosp 
Elwood, 1984294 England 595 595 Pop Pop 
Elwood, 1986236 England 83 83 Hosp Hosp 
Elwood, 1990237 England 195 195 Pop Hosp 
Green, 1986250 Australia 183 183 Pop Pop 
Grulich, 1996171 Australia 242 276 Hosp Hosp 
Halpern, 1991238 USA 105 181 Hosp Pop 
Herzfeld, 1993295 USA 324 415 Pop Pop 
Holly, 1987169 USA 121 139 Hosp Hosp 
Holly, 1995333 USA 452 930 Pop Pop 
MacKie, 1989183 (women) Scotland 181 181 Pop Hosp 
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Table 5.14b. Characteristics of the studies on freckles. 
First author, Year Country N° 
Cases
N° 
Controls
Sources 
of cases 
Source of 
controls 
MacKie, 1989183 (men) Scotland 99 99 Pop Hosp 
Marrett, 1992186 Canada 583 608 Pop Pop 
Moore, 1997230 USA 69 69 Pop Pop 
Nelemans, 1993336 Netherl. 141 183 Pop Pop 
Osterlind, 1988226 Denmark 474 926 Pop Pop 
Rodenas, 1996184 Spain 105 138 Hosp Visitors to 
hosp 
Tucker, 1997172 USA 716 1014 Hosp Hosp 
Walter, 1990344 Canada 583 608 Pop Pop 
Westerdahl, 1995221 Sweden 400 640 Pop Pop 
White, 1994249 USA 256 273 Pop Pop 
Wolf, 1998298 Austria 193 319 Hosp Hosp 
Zaridze, 1992224 Russia 96 96 Hosp Other 
 
Table 5.15a. Definitions and categories for freckles. 
First author, year Definition of exposure Categories 
Carli, 1999 Tendency to freckles Present vs Absent 
Chen, 1996 Number of freckles on face after sun 
exposure before age 25 years 
“50+” vs “0” 
Dubin, 1990 Freckles are brown spots which come 
and go with sun exposure: degree of 
freckling on summertime. History of 
freckles. 
Yes vs No 
Eldwood, 1986 Freckles as an adult, summer only Many vs None 
Elwood, 1990 Current freckling on the face and 
arms. 
Many vs None 
Green, 1986 Propensity to freckles. Present vs Absent 
Grulich, 1996 Freckling as a 15 year old from a 
groups of diagrams of the face. 
Many vs None 
Halpern, 1991 Freckles. Present vs Absent 
Herzfeld, 1993 Freckles Yes vs No 
Holly, 1987 Freckles < 3mm; Profile: Flat, 
macular; Colour: Light to medium 
brown; Border: Even and sometimes 
poorly defined. 
Many vs None 
Holly, 1995 Presence of freckles as a young adult Yes vs No 
MacKie, 1989 (women) Freckling tendency Some vs None 
MacKie, 1989 (men) Freckling tendency Some vs None 
Marrett, 1992 Freckles after sun exposure Many vs None or 
few 
Moore, 1997 Freckles that change with sun Yes vs No 
Nelemans, 1993 Degree of freckling Many vs None 
 184
 
Table 5.15b Definitions and categories for freckles. 
First author, year Definition of exposure Categories 
Osterlind, 1988 Degree of freckling on the arms as an 
adult reported by the subject. 
Many vs None 
Rodenas, 1996 Freckles on face, forearms, shoulders 
and upper back were assessed by 
comparison with an analog scale from 
0 to 100 (maximum intensity). 
“40+” vs “0” 
Tucker, 1997 Freckling pattern Many vs None or 
few 
Walter, 1990 Density of normal freckles Density categories: 
4 vs None 
Westerdahl, 1995 Freckles. Yes vs No 
White, 1994 Number of freckles on face before age 
20 years 
“50+” vs “0” 
Wolf, 1998 Freckles Many/several vs 
NOne 
Zaridze, 1992 Freckles on arms Yes vs No 
 
5.8.9 Eye colour Tables 
 
 Table 5.16a. Characteristics of the studies on eye colour. 
First author, year Country N° 
Cases
N° 
controls
Sources of 
cases 
Sources of 
controls 
Ammannatti, 1987338 Italy 104 104 Hospital Hospital 
Augustsson, 1991208 Sweden 121 378 Population Population 
Beitner, 1990334 Sweden 523 505 Hospital Population 
Bell, 1987297 UK 268 1577 Hospital Hospital 
Carli, 1995217 Italy 106 109 Hospital Population 
Chen, 1996234 (head/neck) USA 85 494 Population Population 
Chen, 1996234 (lower limb) USA 101 494 Population Population 
Chen, 1996234 (trunk) USA 97 494 Population Population 
Chen, 1996234 (upper limb) USA 265 494 Population Population 
Cristofolini, 1987235 Italy 103 205 Hospital Hospital 
Dabkowski, 1997188 Poland 74 300 Hospital Population 
Dubin, 1990214  USA 289 527 Hospital Hospital 
Dunn-Lane, 1993339 Ireland 100 100 Hospital Hospital 
Elwood, 1984294 Canada 595 595 Population Population 
Elwood, 1986236 UK 83 83 Hospital Hospital 
Graham, 1985286 (men) USA 218 202 Hospital Hospital 
Graham, 1985286 (women) USA 186 317 Hospital Hospital 
Green, 1986250 Australia 183 183 Population Population 
Grulich, 1996171 Australia 244 276 Hospital Hospital 
Halpern, 1991238  USA 105 181 Hospital Population 
Herzfeld, 1993295 men USA 324 415 Population Population 
Holly, 1987169 USA 121 139 Hospital Hospital 
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 Table 5.16b. Characteristics of the studies on eye colour. 
First author, year Country N° 
Cases
N° 
controls
Sources of 
cases 
Sources of 
controls 
Holly, 1995333 (women) USA 452 930 Population Population 
Holman, 1984150 Australia 507 507 Population Population 
Lock-Andersen, 1998337 Denmark 168 176 Hospital Population 
Marrett, 1992186 Canada 583 608 Population Population 
Moore, 1997230 USA 69 69 Population Population 
Nelemans, 1993336 Netherlands 141 183 Population Population 
Osterlind, 1988226 Denmark 474 926 Population Population 
Rodenas, 1996184 Spain 105 138 Hospital Visitors to 
hospital 
Rosso, 1998299 Italy 260 416 Population Population 
Westerdahl, 1994293 Sweden 400 640 Population Population 
Wolf, 1998298 Austria 193 319 Hospital Hospital 
 
Table 5.17a. Categories and methods of assessment for eye colour. 
First author, year Categories Methods of assessment 
Ammannati, 1987 1)black/brown; 2)blue; 
3)grey/green 
Questions to the interviewees 
Augustsson, 1991 1)brown/mixed; 2)blue/grey; 
3)green 
Assessed by interviewer 
Beitner, 1990 1) brown, mixture (mainly 
brown); 2)blue, grey-blue; 
3)green 
Questions to the interviewees 
Bell, 1987 1)brown; 2)blue Questions to the interviewees 
Carli, 1995 1)black/brown; 2)green; 
3)grey/blue 
Questions to the interviewees 
Chen, 1996  1)med/dark brown; 
2)grey/hazel; 3)blue 
Assessed by direct inspection 
against a group of standardized 
photos of eye colour (by 
interviewer) 
Cristofolini, 1987 1)black; 2)hazel, green, grey; 
3)blue 
Standard questionnaire and 
assessment by the interviewing 
dermatologist 
Dabkowski, 1997 1)other; 2)blue/green Questionnaire filled in 
together with the interviewer 
Dubin, 1990 1)brown; 2)grey; green; hazel; 
3)blue 
Assessed by interviewer 
Dunn-Lane, 1993 1)brown/hazel; 
2)blue/grey/green 
Questions to the interviewees 
Elwood, 1984 1)brown; 2)grey; green; hazel; 
3)blue 
Assessed by interviewer 
Elwood, 1986 1)brown; 2)green, hazel; 
3)blue, grey 
Graham, 1985 (women) 1)brown; 2)hazel; 3)blue-
green; grey; 4)blue 
Questions to the interviewees 
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Table 5.17b. Categories and methods of assessment for eye colour. 
First author (year) Categories Methods of assessment 
Graham, 1985 (men) 1)brown; 2)hazel; 3)blue-
green; grey; 4)blue 
Questions to the interviewees 
Green, 1986 1)brown; 2)blue, grey; 
3)green, hazel 
Grulich, 1996 1)brown; 2)hazel; 3)green; 
4)blue/grey 
Halpern, 1991 1)brown; 2)blue; 3)hazel/other Questions to the interviewees 
Herzfeld, 1993 1)other; 2)blue Interview by trained 
Holly, 1987 1)dark; 2)light Questions to the interviewees 
Holly, 1995 1)brown; 2) green, gay, hazel; 
3) blue 
Questions to the interviewees 
Holman, 1984 1)brown; 2)hazel; 3)green; 
4)grey; 5)blue 
Assessed by interviewer 
Lock-Andersen, 1998 1)brown; 2)grey/green; 3)blue Assessed by interviewer 
Marrett, 1992 1)brown; 2)blue; 3)hazel, 
green, grey 
Questions to the interviewees 
Moore, 1997 1)other; 2)blue Questionnaire filled in 
together with the interviewer 
Nelemans, 1993 1)brown; 2)grey/green; 3)blue Examined by a physician 
trained in dermatology 
Osterlind, 1988 1)brown; 2)grey/green; 3)blue Inspection of the left eye 
Rodenas, 1996 1)black/brown; 2)hazel; 
3)blue/green 
Rosso, 1998 1)dark; 2)blu/green/hazel  
Westerdahl, 1994 1)other; 2)blue Questions to the interviewees 
Wolf, 1998 1)brown; 2)green; 3)grey; 
4)blue 
Questions to the interviewees 
 
5.8.10 Hair colour Tables 
 
Table 5.18a. Characteristics of the studies on hair colour. 
First author, Year Country N° 
Cases
N° 
controls
Sources 
of cases 
Sources of 
controls 
Ammannatti, 1987338 Italy 104 104 Hosp Hosp 
Augustsson, 1991208 Sweden 121 378 Pop Pop 
Autier, 1995288 Germany, 
France and 
Belgium 
420 447 Hosp Pop 
Beitner, 1990334 Sweden 523 505 Hosp Pop 
Bell, 1987297 UK 268 1577 Hosp Hosp 
Carli, 1999219 Italy 131 174 Hosp Pop 
Chen, 1996234 (head/neck) USA 85 494 Pop Pop 
Chen, 1996234 (lower limb) USA 97 494 Pop Pop 
Chen, 1996234 (trunk) USA 265 494 Pop Pop 
Chen, 1996234 (upper limb) USA 101 494 Pop Pop 
Cristofolini, 1987235 Italy 103 205 Hosp Hosp 
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Table 5.18b. Characteristics of the studies on hair colour. 
First author, Year Country N° 
Cases
N° 
controls
Sources 
of cases 
Sources of 
controls 
Dubin, 1990214 USA 289 527 Hosp Hosp 
Dunn-Lane, 1993339 Ireland 100 100 Hosp Hosp 
Elwood, 1984294 Canada 595 595 Pop Pop 
Elwood, 1986236 UK 83 83 Hosp Hosp 
Elwood, 1990237 UK 195 195 Pop Hosp 
Garbe, 1994165 Germany; 
Austria; 
Switzer. 
513 498 Hosp Hosp 
Graham, 1985286 (women) USA 186 317 Hosp Hosp 
Graham, 1985286 (men) USA 218 202 Hosp Hosp 
Green, 1986250 Australia 183 183 Pop Pop 
Grob, 1990170 France 207 295 Hosp Pop 
Grulich, 1996171 Australia 244 276 Hosp Hosp 
Halpern, 1991238 USA 105 181 Hosp Pop 
Herzfeld, 1993295 (men) USA 324 415 Pop Pop 
Holly, 1987169 USA 121 139 Hosp Hosp 
Holly, 1995333 (women) USA 452 930 Pop Pop 
Holman, 1984150 Australia 507 507 Pop Pop 
Lock-Andersen, 1998337 Denmark 168 176 Hosp Pop 
Marrett, 1992186 Canada 583 608 Pop Pop 
Moore, 1997230 USA 69 69 Pop Pop 
Nelemans, 1993336 Netherlands 141 183 Pop Pop 
Osterlind, 1988226 Denmark 474 926 Pop Pop 
Rodenas, 1996184 Spain 105 138 Hosp Visitors to 
hosp 
Rosso, 1998299 Italy 260 416 Pop Pop 
Weinstock, 1991335 (women) USA 130 300 Pop Pop 
Weiss, 1991213 Germany 204 200 Hosp Hosp 
Westerdahl, 1994293 Sweden 400 640 Pop Pop 
White, 1994249 USA 256 273 Pop Pop 
Wolf, 1998298 Austria 193 319 Hosp Hosp 
Zanetti, 1988290 Italy 260 416 Hosp Hosp 
 
Table 5.19a. Definitions and methods of assessment of hair colour.  
First author, year Category Definitions Assessment 
Ammannati, 1987 1) black/brown; 
2)blond/red 
Hair colour Questions to the 
interviewees 
Augustsson, 1991 1)dark brown; 2)light 
brown; 3)red/blond 
Hair colour at 
the age of 20 
Estimated and rated 
according to a three-
point scale 
Autier, 1995 1)black; 2)brown; 
3)blond; 4)red 
Hair colour By interview and by 
observation with 
guidance charts  
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Table 5.19b. Definitions and methods of assessment of hair colour.  
First author, year Category Definitions Assessment 
Beitner, 1990 1)black; 2)ash-blonde, 
brown; 3)red; 4)blonde 
Original hair 
colour 
Questions to the 
interviewees 
Bell, 1987 1)other; 2)dark; 3)auburn 
+ red 
Hair colour Questions to the 
interviewees 
Carli, 1999 1)black; 2)dark brown; 
3)light brown; 
4)blond/red 
Hair colour Questions to the 
interviewees 
Chen, 1996 1)dark brown; 
2)light/med brown; 
3)blonde; 4)red/auburn 
Natural hair 
colour at age 
20 years 
Graded visually by 
the subject against a 
color sample chart 
Cristofolini, 1987 1)black; 2)brown; 3)light 
brown, blond or red 
Hair colour 
(adult) 
Standard 
questionnaire and 
assessment by the 
interviewing 
dermatologist 
Dubin, 1990 1)dark brown; 2)black; 
3)light brown; 4)blond; 
5)red 
Natural colour 
during the 
winter at age 
of 20 years 
Self-administered 
reliability 
questionnaire 
Dunn-Lane, 1993 1)brown/black; 2)blond; 
3)red 
Hair colour at 
age 20 
Questions to the 
interviewees 
Elwood, 1984 1)black; 2)dark brown; 
3)brown; 4)red and light 
brown; 5)blonde 
Adult hair 
colour 
Direct comparison 
with prosthesis and 
wigmakers samples 
Elwood, 1986 1)black, dark brown; 
2)light brown; 3)red, 
blonde 
Natural hair 
colour in 
childhood and 
as a young 
adult 
Structured 
questionnaire and 
comparison chart 
developed by the 
Western Canada 
Melanoma Study 
Elwood, 1990 1)black/dark brown; 
2)mid brown; 3)fair; 
4)blonde; 5)light red; 
6)dark red 
Hair colour By interviewer using 
standardized hair 
samples 
Garbe, 1994 1)black or brown; 
2)blond; 3)red 
Hair colour at 
the age of 20 
Dermatologic 
examinations 
Graham, 1985 1)brown or black; 
2)blond; 3)red 
Hair colour as 
a child 
Questions to the 
interviewees 
Green, 1986 1)black/dark brown; 
2)light brown/blonde; 
3)red 
Hair colour at 
age 21 as 
graded against 
a standard 
colour chart 
Questions to the 
interviewees 
Grob, 1990 1)black; 2)brown; 
3)blond; 4)red/reddish 
blond 
Natural colour 
of hair 
Questions to the 
interviewees 
Grulich, 1996 1)black/dark brown; 
2)medium brown; 3)light 
brown; 4)blonde; 5)red-
brown/red 
Natural hair 
colour at the 
age of 15 
years 
Questions to the 
interviewees 
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Table 5.19c. Definitions and methods of assessment of hair colour.  
First author, year Category Definitions Assessment 
Halpern, 1991 1)black; 2)brown; 
3)blond/red 
Natural hair 
colour at age 20
Questions to the 
interviewees 
Herzfeld, 1993 1)other; 2)blond or red Hair colour Interview, 
administered by 
trained 
Holly, 1987 1)brown or black; 2)red 
or blond 
Natural hair 
colour at age 20
Questions to the 
interviewees 
Holly, 1995 1)black or brown; 
2)blond or ligth brown; 
3)red 
Hair colour Questions to the 
interviewees 
Holman, 1984 1)black or dark brown; 
2)light brown; 3)fair or 
blond; 4)red 
Natural hair 
colour  
Graded visually 
against 23 samples of 
human hair selected 
from the JL 
International Colour 
Range 
Lock-Andersen, 1998 1)black/brown; 2)blond; 
3)red 
Hair colour 
before age of 7 
Assessed by a pre-
tested questionnaire 
Marrett, 1992 1)black; 2)brown; 3)light 
brown; 4)blond or fair; 
5)red 
Natural hair 
colour at age 20
Questions to the 
interviewees 
Moore, 1997 1)other; 2)blond or red Hair colour Questionnaire, done 
face-to-face 
Nelemans, 1993 1)brown/black; 2)blond; 
3)red/fair 
Hair colour Examined by a 
physician trained in 
dermatology 
Osterlind, 1988 1)dark brown/ black; 
2)light brown; 
3)blond/fair; 4)red 
Natural hair 
colour 
Graded visually 
against 20 samples of 
human hair 
Rodenas, 1996 1)black; 2)brown; 
3)blond/red 
Hair colour at 
age 20 to 30 
Rosso, 1998 1)black/brown; 2)light 
brown; 3)blond/red 
Hair colour Using a visual scale 
on 11 levels 
Weinstock, 1991 1)black; 2)dark brown; 
3)light brown; 4)blonde 
or auburn; 5)red 
Natural hair 
colour at age 20
Questions to the 
interviewees 
Weiss, 1991 1)black/dark; 2)blond; 
3)red 
Natural hair 
colour at age 20
Westerdahl, 1994 1)dark brown/ black; 
2)light brown; 
3)blond/fair; 4)red 
Hair colour Questions to the 
interviewees 
White, 1994 1)brown/black; 
2)red/blond 
Hair colour 
before any 
greying 
Questions to the 
interviewees  
Wolf, 1998 1)black; 2)brown; 
3)blond; 4)red 
Hair colour 
before any 
greying 
Questions to the 
interviewees 
Zanetti, 1988 
 
 Using a visual scale 
on 11 levels 
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Table 5.20. RR estimates from meta-analysis.  
 RR Low CI Up CI 
“brown” versus “black” 1.34 1.18 1.53 
“blond” versus “black” 1.80 1.58 2.06 
“red” versus “black” 2.42 2.12 2.76 
 
5.8.11 Skin colour Tables 
 
Table 5.21. Characteristics of studies on skin colour. 
First author, Year Country N° 
Cases
N° 
Controls
Source 
of cases 
Source 
controls 
Ammannatti, 1987338 Italy 104 104 Hosp Hosp 
Carli, 1999219 Italy 131 174 Hosp Pop 
Chen, 1996234 (head/neck) USA 85 494 Pop Pop 
Chen, 1996 234 (lower limb) USA 97 494 Pop Pop 
Chen, 1996234 (trunk) USA 265 494 Pop Pop 
Chen, 1996234 (upper limb) USA 101 494 Pop Pop 
Cristofolini, 1987235 Italy 103 205 Hosp Hosp 
Dabkowski, 1997188 Poland 74 300 Hosp Pop 
Dubin, 1986164 USA 1103 585 Hosp Hosp 
Elwood, 1984294 Canada 595 595 Pop Pop 
Elwood, 1990237 England 215 215 Pop Hosp 
Freedman, 1997308 USA 12156 23845 Other Other 
Graham, 1985286 (women) USA 186 319 Hosp Hosp 
Graham, 1985286 (men) USA 218 202 Hosp Hosp 
Green, 1986250 Australia 183 183 Pop Pop 
Grob, 1990170 France 207 295 Hosp Pop 
Herzfeld, 1993295 (men) USA 324 415 Pop Pop 
Holly, 1995333 (women) USA 452 930 Pop Pop 
Holman, 1984150 Australia 507 507 Pop Pop 
Lock-Andersen, 1998 Denmark 168 176 Hosp Pop 
Marrett, 1992186 Canada 583 608 Pop Pop 
Nelemans, 1993336 Netherlands 141 183 Pop Pop 
Osterlind, 1988226 Denmark 474 926 Pop Pop 
Rodenas, 1996184 Spain 105 138 Hosp Visitors 
to hosp 
Walter, 1990344 Canada 583 608 Pop Pop 
Weinstock, 1991335 (women) USA 130 300 Pop Pop 
Wolf, 1998 298 Austria 193 319 Hosp Hosp 
Zaridze, 1992224 Russia 96 96 Hosp Other 
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Table 5.22. Methods of assessment for skin colour. 
First author, year Methods of assessment  
Ammannati, 1987 Questionnaire 
Carli, 1999 Interview 
Chen, 1996 Assessed by the nurse-interviewer at the inner aspect of 
the upper arm 
Cristofolini, 1987 Standard questionnaire and assessment by the 
interviewing dermatologist 
Dabkowski, 1997 Questionnaire filled in together with the interviewer 
Dubin, 1986 Skin colour chart used during an interview (of area 
exposed to sun and not exposed) 
Elwood, 1984 Prosthesis and wigmakers samples used during an 
interview (of area exposed to sun and not exposed) 
Elwood, 1990 Visual-skin colour chart 
Freedman, 1997 
Graham, 1985 Ascertained by direct questions to the interviewees, self-
assessed complexion colour 
Green, 1986 Determined by interviewer (left forearm) 
Grob, 1990 Determined by interviewed: Complexion colour 
Herzfeld, 1993 (men) Interview, administered by trained 
Holly, 1995 (women) Interview, self-assessed complexion colour 
Holman, 1984 Interviewers use goggles fitted with monochromatic filters 
and complexion chart (left dorsum of hand, left shoulder 
tip and upper inner arm ) 
Lock-Andersen, 1998 Measurements were taken by metropolitan interviewers 
using goggles fitted with monochromatic filters; in rural 
areas skin colour was graded visually against a 10-step 
complexion chart 
Marrett, 1992 Assessed by the interviewer, who compared the skin on 
the subject's upper inner arm to a 15 colour prosthetic 
skin-tone panel 
Nelemans, 1993 Examined by a physician trained in dermatology 
Osterlind, 1988 Complexion chart at 3 sites-the dorsum of the left hand, 
the tip of the left shoulder and the inner side of the left 
upper arm 
Rodenas, 1996 Determined by interviewed on sun-exposed skin (dorsum 
of hand and upper inner arm) 
Walter, 1990 Assessed using prosthetic skin sample on the inner surface 
of the upper left arm 
Weinstock, 1991 (women) Questionnaire 
Wolf, 1998 Questionnaire 
Zaridze, 1992 
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5.8.12 Phototype Tables 
 
Table 5.23. Characteristics of the studies on skin phototype. 
First author, year Country N° 
Cases
N° 
Controls
Source of 
cases 
Source of 
controls 
Ammannati, 1987338 Italy 104 104 Hosp Hosp 
Augustsson, 1991208 Sweden 121 378 Pop Pop 
Autier, 1995288 Germany, 
France and 
Belgium 
420 447 Hosp Pop 
Bataille, 1996215 England 426 416 Pop Hosp 
Beitner, 1990334 Sweden 523 505 Hosp Pop 
Carli, 1999219 Italy 131 174 Hosp Pop 
Chen, 1996234 (head/neck) USA 85 494 Pop Pop 
Chen, 1996234 (lower limb) USA 97 494 Pop Pop 
Chen, 1996234 (trunk) USA 265 494 Pop Pop 
Chen, 1996234 (upper limb) USA 101 494 Pop Pop 
Elwood, 1984294 Canada 595 595 Pop Pop 
Elwood, 1986236 UK 83 83 Hosp Hosp 
Garbe, 1989210 Germany 200 200 Hosp Hosp 
Garbe, 1994165 Germany; 
Austria; 
Switzer. 
513 498 Hosp Hosp 
Holly, 1995333 (women) USA 452 930 Pop Pop 
Lock-Andersen, 1998337 Denmark 168 176 Hosp Pop 
MacKie, 1989183 (women) Scotland 181 181 Pop Hosp 
MacKie, 1989183 (men) Scotland 99 99 Pop Hosp 
Marrett, 1992186 Canada 583 608 Pop Pop 
Rodenas, 1996184 Spain 105 138 Hosp Visitors to 
Hosp 
Rosso, 1998299 Italy 260 416 Pop Pop 
Weiss, 1991213 Germany 204 200 Hosp Hosp 
Wolf, 1998298 Austria 193 319 Hosp Hosp 
Zanetti, 1988290 Italy 260 416 Hosp Hosp 
 
Table 5.24a. Definitions and methods of assessment for phototype. 
First author, year Definition of exposure 
Ammannati, 1987 Phototype 
Augustsson, 1991 Melski classification 
Autier, 1995 Skin phototype 
Bataille, 1996 Fitzpatrick classification 
Beitner, 1990 Fitzpatrick classification 
Carli, 1999 Fitzpatrick classification 
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Table 5.24b. Definitions and methods of assessment for skin phototype. 
First author, year Definition of exposure 
Chen, 1996 After repeated and prolonged exposure to sunlight, skin 
become i) only freckled or no suntan at all (skin type I), ii) 
only mildly tanned due to a tendency to peel (skin type II), 
iii) moderately tanned (skin type III), or iv) very brown  
Elwood, 1984 Sensitivity to sun burning and tanning as an adult and in 
childhood 
Elwood, 1986 Usual skin reaction to exposure to sunlight, over a few days 
of sun 
Garbe, 1989 Pigmentation behaviour after sun exposure 
Garbe, 1994 Skin type 
Holly, 1995 Skin's reaction after a few days of exposure to the sun 
Lock-Andersen, 1998 Skin type 
MacKie, 1989 Skin type graded: 1= always burns never tans; 2= usually 
burns, tans rarely and with difficulty; 3= rarely burns, tans 
easily; 4= tans very readily, never burns 
Marrett, 1992 Skin's reaction to strong sunlight after the first summer 
exposure (repeated exposure) 
Rodenas, 1996 Skin reaction to an initial sun exposure (45 to 60 minutes of 
noontime exposure in the early summer) taking into account 
the reaction after 24 hr (propensity to burn) and after seven 
days (ability to tan). Fitzpatrick Classification 
Rosso, 1998 Skin reaction to sun exposure when 20 years old  
Weiss, 1991 Skin type 
Wolf, 1998 Skin phototype 
 
Table 5.25. RR estimates from Meta-analysis for skin phototype. 
 RR Low CI Up CI 
III vs IV: “tan with protection” vs “tan, no burn” 1.27 1.16 1.40 
II vs IV: “burn then tan” vs “tan, no burn” 1.62 1.47 1.78 
I vs IV: “burn, never tan” vs “tan, no burn” 2.06 1.87 2.26 
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5.9 Figures 
 
Figure 5.1. Scheme summarising some hypotheses on the disease model. 
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5.9.1 Total sun exposure Figures 
 
Figure 5.2a. RR and CI for total sun exposure (first group of studies).  
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Figure 5.2b. RR and CI for total sun exposure (second group of studies). 
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Figure 5.3. RR and CI for total sun exposure by type of controls. 
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Hospital-based studies are indicated with dark bars and Population-based and other 
designs with grey bars. 
 
 
 
Figure 5.4. RR and CI for total sun exposure by publication year. 
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Studies conducted Before 1990 are indicated with dark bars and studies conducted in 
1990 or After with grey bars.  
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Figure 5.5. RR and CI for total sun exposure by adjustment for phenotype. 
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Estimates Adjusted for phenotype are indicated with dark bars and  
Not Adjusted estimates with grey bars. 
 
 
 
Figure 5.6. Funnel plot on total sun exposure. 
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5.9.2 Intermittent sun exposure Figures 
 
Figure 5.7a. RR estimates and CI on intermittent sun exposure (first group of studies). 
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Figure 5.7b. RR estimates and CI on intermittent sun exposure (second group of 
studies). 
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Figure 5.8. Funnel plot on intermittent sun exposure. 
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5.9.3 Chronic sun exposure Figures 
 
Figure 5.9a. RR estimates and CI on chronic sun exposure (first group of studies). 
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Figure 5.9b. RR estimates and CI on chronic sun exposure (second group of studies). 
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Figure 5.10. RR and CI for chronic sun exposure by type of controls. 
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Hospital-based studies are indicated with dark bars and studies with controls drawn  
from Population or other sources with grey bars. 
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Figure 5.11. RR and CI for chronic sun exposure by inclusion of subjects with 
dermatological problems.  
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Studies that wrote to have Included subjects with dermatological problems are 
indicated with dark bars and the others, which Not Include them, with grey bars. 
 
 
 
 
 
Figure 5.12. RR and CI for chronic sun exposure by type of country. 
0
1
2
3
4
5
6
7
Ho
lm
an
 H
Elw
oo
d H
Be
itn
er 
H
Wh
ite
 H
Lo
ck
-A
nd
ers
en
 H
Gr
ah
am
 H
He
rzf
eld
 H
Os
ter
lin
d (
me
n) 
H
Du
nn
-La
ne
 H
W
alt
er 
H
W
es
ter
da
hl 
H
Ho
lly
 H
Va
ge
ro 
H
Elw
oo
d H
Pio
n (
me
n) 
H
Fre
ed
ma
n H
Os
ter
lin
d (
wo
me
n) 
H
Co
ok
e H
Go
od
ma
n H
Be
ll H
Pio
n (
wo
me
n) 
H
Du
bH
n H
Au
tie
r L
Ne
lem
an
s L
Cr
ist
ofo
lin
i L
Wo
lf L
Ca
rli 
L
Ro
ss
o L
Ga
rbe
 L
We
iss
 L
Gr
ob
 L
Ro
de
na
s L
7.77
 
“High incidence” countries are indicated in dark and “Low incidence” countries with 
 grey bars. 
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Figure 5.13. Funnel plot chronic sun exposure. 
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Figure 5.14a. RR and CI for Chronic and Intermittent sun exposure (first group of 
studies). 
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Intermittent sun exposure estimates are indicated in dark and chronic sun exposure 
estimates with grey bars 
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Figure 5.14b. RR and CI for Chronic and Intermittent sun exposure (second group 
of studies). 
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Intermittent sun exposure estimates are indicated in dark and Chronic sun exposure 
estimates with grey bars. 
 
 
 
 
5.9.4 Sunburns in childhood 
 
Figure 5.15a. RRs and CI on sunburns in childhood (first group of studies). 
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Figure 5.15b. RRs and CI on sunburns in childhood (second group of studies). 
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Figure 5.16. Funnel display of sunburns in childhood. 
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5.9.5 Sunburns in adulthood Figures 
 
Figure 5.17a. RRs and CI for sunburns in adulthood (first group of studies). 
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Figure 5.17b. RRs and CI for adulthood sunburns (second group of studies). 
0
5
10
15
20
25
30
Rodenas 1996 Osterlind 1988 Dunn-Lane
1993
Elwood 1986 MacKie 1989
women
Grob 1990 MacKie 1989
men
OR
Low CI
Up CI
 
 206
 
Figure 5.18. RR and CI for sunburns in adulthood by latitude. 
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Figure 5.19. Funnel plot for adulthood sunburns. 
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Figure 5.20. Log Relative Risk (y) vs its standard deviation (s), for sunburns in 
adulthood. 
 
 
 
 
 
Figure 5.21. RR and CI for sunburns in Adulthood and Childhood.  
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5.9.6 Family history Figures 
 
Figure 5.22a. RR and CI for family history (first group of studies). 
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Figure 5.22b. RR and CI for family history (second group of studies). 
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Figure 5.23: Funnel plot for family history 
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5.9.7 Indicators of photodamage Figures 
 
Figure 5.24a. RR and CI on pre-malignant cancer lesions (first group of studies). 
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Figure 5.24b. RR and CI on pre-malignant cancer lesions (second group of studies). 
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Figure 5.25. RR and CI on other indicators of photodamage. 
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Figure 5.26. Funnel plot on indicators of photodamage. 
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5.9.8 Freckles density Figures 
 
Figure 5.27a. RR and CI for high freckle density (first group of studies). 
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Figure 5.27b. RR and CI for high freckle density (second group of studies). 
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Figure 5.28. RR and CI for Freckles density by type of country. 
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Figure 5.29. RR and CI for Freckles density by latitude. 
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Studies conducted in countries at Lower latitude (<50) are indicated with dark bars and 
studies conducted in countries at High latitude with grey bars. 
 
 
 
 
 
Figure 5.30. Funnel plot for high freckles density. 
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5.9.9 Eye colour Figures 
 
Figure 5.31a. RR and CI for blue versus dark eye colour (first group of studies). 
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Figure 5.31b. RR and CI for blue versus dark eye colour (second group of studies). 
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Figure 5.32. RR and CI for blue eye by adjustment for phenotype. 
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Estimates Adjusted for phenotype are indicated with dark bars and Not Adjusted 
estimates with grey bars. 
 
 
 
 
 
Figure 3.33. Funnel plot for blue eyes. 
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5.9.10 Hair colour Figures 
 
Figure 5.34a. RR and CI for red versus dark hair colour (first group of studies). 
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Figure 5.34b. RR and CI for red versus dark hair colour (second group of studies). 
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Figure 5.34c. RR and CI for red versus dark hair colour (third group of studies). 
0
20
40
60
80
100
120
140
160
Augustsson
(1991)
Lock-
Andersen
(1998)
Halpern
(1991)
Autier (1995) Grob (1990) Wolf (1998) Beitner
(1990)
OR
Low CI
Up CI
 
 
 
Figure 5.35. RR and CI for red hair by adjustment for phenotype or phototype. 
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Figure 5.36. Funnel plot for red hair. 
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5.9.11 Skin colour Figures 
 
Figure 5.37a. RR and CI for “light” versus “dark” skin colour (first group of studies). 
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Figure 5.37b. RR and CI for “light” versus “dark” skin colour (second group of 
studies). 
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Figure 5.38. RR and CI for light skin colour by type of cases. 
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Figure 5.39. Funnel plot for light skin versus dark skin colour. 
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5.9.12 Skin phototype Figures 
 
Figure 5.40a. RR and CI for skin phototype (first group of studies). 
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Figure 5.40b. RR and CI for skin phototype (second group of studies). 
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Figure 5.41. Funnel plot for skin phototype. 
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CHAPTER 6. CONCLUSIONS 
 
6.1 Introduction 
Previous reviews on epidemiological studies mostly had a narrative style. Meta-analytic 
techniques allow a more systematic way of assessing information from independent 
publications. The explosion of information in the scientific literature has amplified the require 
to synthesize research results. 
In cancer epidemiology meta-analysis plays a special role because of the need to 
summarize the evidence for risks that are small, but that may have large public interest. Most 
epidemiological studies do not permit the detection of anything but a large effect associated 
with a fairly common exposure. Thus meta-analyses can assess weak risk factors that have a 
large public health impact summarizing information from several studies.  
A published meta-analysis on breast cancer and vegetable and fruit consumption was 
described to present an approved methodology for meta-analysis on epidemiological studies. 
Several meta-analyses of published data on melanoma were carried out in order to summarise 
and investigate all its main risk factors.  
Meta-analysis was not applied merely as a statistical method, which combined 
published results, because non-experimental studies, such as case controls studies, do not 
allow for the assumption that the variation between studies is only attributable to statistical 
sampling error. It is unlikely that this so-colled homogeneity assumption is fulfilled. Part of 
the variation in the estimates is prabably due to differences in definitions, in measurements of 
the exposure, features of the studies and of the populations. An important function of these 
meta-analyses was the exploration of sources of variation in study results, which should be 
viewed as strength of this work. A systematic investigation of between-study heterogeneity, 
as a function of differences in design features, types of analyses and populations 
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characteristics, helped to explain the controversy between study results and provided 
interesting considerations for cancer epidemiology.  
 
6.2 Breast cancer  
A large and consistent body of epidemiological evidence indicated a strong protective effect 
of higher intakes of vegetables and fruit for a wide variety of forms of cancer. This meta-
analysis aimed to show that there is a considerable influence attributed to diet also for a 
hormone related cancer as cancer of the breast.  
Relative risk estimates for breast cancer were extracted from twenty-six published 
studies, from 1982 to 1997, reporting data on fruit and vegetables consumption. Meta-analysis 
confirmed the association between intake of vegetables and, to a lesser extent, fruit and breast 
cancer risk. Increasing vegetable consumption might reduce the risk of breast cancer. Vitamin 
C and beta-carotene were also found associated with a decreased risk for breast cancer. 
However colinearity between and confounding by antioxidants is a fundamental issue as 
intakes of these micronutrients tend to be positively correlated.  
Several factors were analysed to investigate between-study heterogeneity and the use 
of validated questionnaires was found slightly significantly associated with a change in the 
estimate. Some other factors seem to influence variation in the estimates, even if they were 
found not statistically significant. They are related to the design of the study, the kind of 
controls used in case-control studies, the adjustment for confounders and study location.  
It is important to bear in mind that measurements of dietary intake do not in any way 
eliminate the possibility that some other factors in fruits and vegetables are responsible or that 
they simply reflect evidence of a protective effect of vegetarism for breast cancer. Either 
measure may be a marker for other substances or other factors. Vegetarianism, for example, 
may be associated with a high consumption of soy-based foods which have been shown to be 
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associated to significantly lower levels of a class of estrogens normally associated with breast 
cancer risk in postmenopausal women.345 Specific dietary habits could reflect education and 
consequently socio-economic status, which in turn, may be closely related to reproductive 
history. In my analysis adjustment for parity did not significantly explained between-study 
heterogeneity, however, the pooled estimate calculated on RRs not adjusted for parity 
indicates a significant protective effect of high vegetables consumption wereas the pooled 
estimate from adjusted RRs did not. Any way these findings are only indicative because the 
number of available studies was too small to have enough power to test the relevance of all 
possible confounding factors. Problems of confounding by some yet unrecognised factors 
could not be ruled out and the role of residual confounding is an important issue in the 
epidemiology of weak associations. 
A relationship between breast cancer and diet was also demonstrated by a recent 
paper that showed that tall adult height, which is positively associated with breast cancer risk, 
may partly determined by several dietary factors, from those vegetables and fruit, during 
childhood and adolescent. Furthermore it was shown that obesity increases the risk of breast 
cancer in postmenopausal women by around 50%, probably increasing serum concentration of 
free oestradiol.346 Fruit and vegetables consumption may be implicated globally in several 
factors that affect diet and the style of life. Much research has surrounded the hypothesis that 
a high intake of fat increase risk of breast cancer. Many studies, however, do not support this 
hypothesis.347 However the food pattern may be of special interest as high fat or energy intake 
is often associated with a low consumption of fruits and vegetables. Therefore, it is possible 
that a lower intake of fat simply implies a high fruit and vegetable consumption. An 
adjustment for energy-intake to address the issue of diet composition rather than absolute 
intake can be conceived.91;92;122;125-127;130 However, in this analysis, there seems to be no 
particular influence on the estimated relative risks due to energy adjustment. 
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Smith-Warner et al.348 published recently a meta-analysis on primary data from 
cohort studies. The authors evaluate the negative association between fruit and vegetable 
consumption and breast cancer that was found in many case-control studies. Strict inclusion 
criteria, within the Pooling Project17;348, were adopted to select a homogeneous subset of 
studies suitable to investigate relationship between diet and cancer. Considering only 
prospective studies, because case-control studies are easily affected by recall and selection 
bias, they found a not significant protective effect of fruit and vegetable consumption on 
breast cancer risk. Similar results were found in my work when only cohort studies or 
population-based case-control studies were considered, even if in my meta-analysis the 
difference with the other studies was not statistically significant. It is interesting to note in 
Smith-Warner’s analysis that when the estimates are adjusted for fat intake, the pooled RR for 
highest versus lowest quartiles of total fruit and total vegetables consumption became 
statistically significant (p=0.04). 
Another remarkable meta-analysis84 was published quite recently. Summary 
estimates for several fruit and vegetables groups were shown and 53% of the 70 risk estimates 
reported in the summary show at least a 25% reduction in breast cancer risk for the highest 
versus lowest consumers. As in my work evidence was more consistent for vegetables than 
for fruits. 
In conclusion, it is not possible to recommend dietary supplementation to reduce 
breast cancer risk, based on the evidence from this meta-analysis, but high consumption of 
fruit and vegetables is suggested. In line with European Code Against Cancer,349 fruit and 
vegetables should be taken with each meal whenever possible, because high consumption of 
them could lead to a reduction in all type of cancer and probably for breast cancer too. 
 
6.3 Melanoma  
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Cutaneous melanoma is potentially a curable cancer if it is discovered in an early stage of 
development. The positive aspect of melanoma is that it is readily detectable simply by 
examining the skin, unlike other cancers, which are usually hidden from detection until they 
are relatively large or metastatic disease has occurred. Thus, pooled estimates from this meta-
analysis could be essential in selecting groups of people at greatest risk. Selective screening of 
individuals who have these risk factors should reduce the morbidity and mortality of 
cutaneous melanoma.  
A systematic meta-analysis of epidemiological data (110 independent published 
studies included in the analysis, from 1966 to 2002 for pigmented lesions and from 1984 to 
1999 for the other risk factors) was carried out for all risk factors of cutaneous malignant 
melanoma: exposure to ultraviolet sun radiations, sunburns, indicators of actinic damage, 
family history of melanoma, phenotype characteristics, pigmented lesions and skin type.  
Even though differences in definitions, in population features, methodological 
variability, problems with confounders and unexplained heterogeneity, from these series of 
published studies conducted over the past few decades, a great deal was learned about the 
relationship between all main risk factors and melanoma.  
The pooled estimate for one or more affected first-degree relatives suggested a 
considerable risk (pooled RR=1.79; 95% C.I.: 1.46; 2.19). The pooled estimate was highly 
reliable because no between-study heterogeneity or indications for publication bias were 
found. Thus, given the implications of a positive family history, verification of family history 
is essential. Family members of all patients with cutaneous melanoma should be examined for 
suspicious moles and it has been suggested to practice periodic mole surveillance for 
life.350;351  
Improvement of the methodology of epidemiological studies, together with 
interesting laboratory results, led to general acceptance of solar ultraviolet light as the major 
 227
environmental cause of melanoma.24;352 From this work it emerged that epidemiological 
evidence suggested that the effect of long continued heavy exposure, such as that received by 
persons with outdoor occupations, is different from the effect of intermittent exposure, 
received typically in recreational and vacation activities. It is this latter exposure that is likely 
to be the major factor (pooled RR=1.58; 95% C.I.: 1.26; 1.99) associated with melanoma in 
developed countries and it is reduction in this exposure that public health programs should 
address. Considerably larger total doses of sun exposure, but given by relatively constant 
occupation exposure over a long period of time, were associated with a decreased risk of 
melanoma (pooled RR=0.93; 95% C.I.: 0.84; 1.04). In fact, if the overall pooled estimate does 
not show a significant protective effect, this suggestion came from studies with a better design  
and a quite detailed information on sun exposure. Intermittent and constant exposure may be 
intrinsically different, with conflicting effects, so that the risk for an individual depends on the 
balance between these two exposures. Intermittent sun exposure is intrinsically related to 
sunburn, which also presents very high estimates (pooled RR=1.84; 95% C.I.: 1.54, 2.20). 
Sunburn in childhood showed an even greater risk (pooled RR=2.23; 95% C.I.: 1.54; 3.23), 
even if not significantly different from the previous estimate.  
Even if sunburn seems to have a considerable effect on melanoma, we must be 
careful about using apparently simple but possibly misleading messages such as avoiding 
sunburn. Actually it may well be that avoidance of sunburn is only effective on melanoma if 
intermittent ultraviolet exposure is reduced. Furthermore these messages may increase the use 
of sunbed tanning or sun blockers, to allow greater outdoor exposure without burning, but this 
may not be helpful in terms of melanoma. The public health message should be the simple 
one that sunbathing (with or without sunscreen) is hazardous behaviour, there is no such thing 
as a safe tan, and whenever possible, it is better to stay in shade.353 However, given the 
finding that regular frequent exposure to sunglight is associated with a lower relative risk of 
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melanoma compared with having only occasional exposure, population-based 
recommendations are not easy to give. It has been postulated that reduction of exposure to 
sunlight, particularly only an internediate reduction, may actually increase the risk of 
melanoma by changing someone from a regular frequent exposure pattern to an episodic 
exposure pattern. This should be taken into account in public health programs considering that 
phenotypical factors play also an important role. Furthermore, it is worthy to remember that 
sun exposure shows a protective effect against many other types of cancer.315-319 The ideal 
case would, therefore, be to find a way of obtaining the beneficial effects of UVB exposure 
without suffering the increased incidence of skin cancer. However it is suggested that 
standing outside 15 minutes a day three times a week lets the skin produce enough vitamin D 
most of the year.  
Subjects who exhibited some indicators of photodamage, which are intrinsically 
related to sun exposure, also showed a considerable risk (RR=2.98; 95% C.I.: 2.04; 4.36). 
Among them, those revealed pre-malignant and cancer lesions had a very high risk (RR=4.98 
with 95% C.I.: 2.74; 6.82), compared to people who do not have any pre-malignant or cancer 
lesion. A lower risk, even if still significant, was observed for subjects that presented other 
indicators of actinic damage (RR=1.96 with 95% C.I.: 1.06; 3.61). 
Interrelationship between the external agent of ultraviolet exposure and personal 
characteristics of the subject is the central issue in many aetiological researches in melanoma. 
In this analysis RR estimates for total sun exposure, adjusted for phenotypic characteristics or 
phototype, were slightly significantly (p=0.09) higher than unadjusted ones and this trend was 
seen for all measures of sun exposure.  
Among phenotypic characteristics, number of common naevi and large atypical 
naevi were very important risk factors for melanoma occurrence. Risk for people with many 
common naevi was almost ten times the risk for people with few naevi (pooled RR=6.89; 
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95% C.I.: 4.63; 10.25, for “100+” compared to “0-15”). Subjects with five atypical naevi 
presented a risk ten times higher than the people with none atypical nevus (RR=10.49; 95% 
C.I.: 5.05; 21.76). 
People with few or none freckles or a brown colour for hair, eyes or skin, showed 
less than half the risk of people with many freckles (RR=2.11; 95% C.I.: 1.76; 2.53), red hair 
(RR=2.79; 95% C.I.: 2.15; 3.61), blue eyes (RR=1.52; 95% C.I.: 1.30; 1.76), and fair skin 
(RR=2.02; 95% C.I.: 1.60; 2.55). Skin type also played a relevant role and subjects with type 
I, who do not burn and tan easily, presented a RR more than two fold higher that IV type, who 
burn and do not tan (RR=2.31 and 95% C.I. 1.73, 3.05). 
Conflicting results in the literature are mainly a reflection of differences in 
epidemiological methods, which despite using increasingly sophisticated analyses were still 
relying on the data, which were basically biased. Meta-analysis always suffers from 
methodological problems that inaevitably arise when combining data from several 
epidemiological investigations. In fact if many research papers publish modest estimates, 
those RRs may well be due to same biases in all the studies. If the same systematic biases are 
present across a range of studies, the only effect of meta-analysis is to reinforce them, 
generating spurious statistical results. Thus meta-analysis can lead to insights when study 
design, exposure assessment or exposure levels, study populations, etc., are found to relate to 
study outcome. An important function of meta-analysis is the investigation of between-study 
heterogeneity which is an opportunity to understand study variation. These points were 
carefully considered and discussed to understand their impact on the findings. 
Interesting correspondences were found looking at some methodological features of 
the studies such as type of study, source of data in case-control studies, matching, 
categorization of exposures, inclusion of subjects with dermatological problems or family 
history and features of the population or study location.  
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Relative risk estimates on naevi assessed on arms, obtained from studies with 
controls drawn from population were significantly (p=0.05) lower than estimates on studies 
with cases and controls drawn from hospitals. 
Similarly for atypical naevi, studies with controls from hospitals were significantly 
(p=0.02) lower than case-control studies with population based controls. Moreover case-
control studies presented significantly (p<0.001 for atypical naevi) lower and much more 
precise estimates compared to cohort studies. Contrary to expectations, estimates from case-
control studies are usually more reliable than the ones obtained from the other types of 
designs because assessment of naevi counts is more precise. Cohort studies usually express 
results with broad categories that presented significantly (p=0.01) higher estimates than more 
articulated categorizations of atypical naevi. Furthermore cohort studies had significantly 
(p<0.001) younger population than case-control studies and this difference may play an 
important role. 
Among papers on total sun exposure, case-control studies with hospital-based 
controls again showed significantly (p=0.002) lower estimates than case-control studies with 
population-based controls, but in this case they are probably less trustworthy, because for sun 
exposure the problem of recall bias could be important. In fact the hospital-based case-control 
studies included subjects with family history of melanoma and the majority included subjects 
with dermatological problems or any tumour. An indication in this sense came also from 
studies conducted after 1990, when much professional and common opinion was aware of the 
relationship between melanoma and sun exposure; recent studies presented estimates 
significantly (p=0.005) higher than studies published before 1990. Further work, to include in 
the meta-analysis papers published before 1984, may be useful to verify this finding. 
Unlike the studies on naevi and on the other estimates on sun exposure, significantly 
(p=0.06) lower estimates were found in studies with population-based controls evaluating 
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chronic sun exposure. A similar indication of a protective effect of chronic sun exposure came 
from studies that did not include subjects with dermatological problems (significantly 
different from the other studies: p=0.01) and from countries that conducted studies with a 
better design (significantly different from the others countries: p=0.02) and a quite detailed 
information on sun exposure. Thus, in this case, estimates from studies with population-based 
controls are probably more reliable than estimates from studies with hospital-based controls. 
In this meta-analysis matching was found to be another important design 
characteristic that may be considered a marker of well-designed studies and explained some 
of the between-study heterogeneity (for indicators of actinic damage p=0.01). 
Latitude of the study seems to be an important factor for sunburns (p=0.002) and for 
high density of freckles (p=0.04). At high latitude, sunburns and high density of freckles 
probably play a special role, increasing the risk of developing melanoma. Furthermore an 
association between them is more than likely so that subjects with a high density of freckles 
have a phenotype that induces more easily sunburns. 
A suggestion for an association among host factors also came from heterogeneity 
analysis that showed significantly lower estimates for hair colour (p=0.06) and eye colour 
(p=0.06) adjusted for phenotype and/or phototype, compared to unadjusted.  
In this analysis I could not devote much attention to the distribution of melanoma in 
different body sites, however future works should be addressed in this direction. Fascinating 
suggestions on the aetiology for melanoma come from a very recent study.203 A new 
interesting hypothesis was proposed on the relationship between sun exposure and naevi, 
based on a “divergent pathway” model for melanoma occurring in different body sites. 
Melanoma, for people with a low tendency to develop naevi, would tend to be on sun exposed 
body sites and would be associated with chronic sun exposure. On the other hand naevi-prone 
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individuals would not require much exposure, beyond that required for initiation, for the 
development of melanoma on non sun-exposed body sites. 
At the moment primary prevention behaviours should include protective clothing, 
using shade, limiting sun exposure, and avoiding sunbathing, as is suggested also by the 
European Code Against Cancer (2003)349. We will probably have to wait for more specific 
biological markers for proving previous exposures that we will have much further 
advancement in our knowledge of the relationship between sun exposure and the development 
of melanoma in those people at risk. 
Future studies should focus on developing effective strategies for determining the 
effectiveness of skin cancer screening.  
 
6.3.1 Need for screening on melanoma 
Efforts at primary and secondary prevention of coetaneous malignant melanoma have been 
ongoing for the past 15-20 years in many parts of the world. Primary prevention consists of 
public education programs that should promote sensible sun exposure, over the long-term. 
Secondary prevention is aimed at preventing deaths from melanoma and encourages early 
detection and thus removal of thin melanomas.  
Melanoma fulfils the criteria for a potentially successful screening program because 
the disease is a serious public health problem, there is a simple diagnostic test (skin 
examination), and there is improved survival with early detection. Actually the consequence 
of melanoma is directly related to the stage at diagnosis, and since melanomas take long time 
to reach an advanced stage, early detection can save many lives.175  
A NIH consensus conference in 1992 concluded that “there is sufficient evidence to 
warrant screening programmes for melanoma in the United States” and that “melanoma meets 
most of the criteria for initiating screening”.354 Argument against introducing melanoma 
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screening have been based on cost and the lack of reliable data on the efficacy of any 
screening test. Girgis published a cost-effectiveness analysis showing that a melanoma 
screening programme could be cost-efective, particularly if five yearly screening is 
implemented by family practictioners for men over the age of 50. 355 
The best evidence for the effectiveness of early diagnosis programmes involves the 
educational initiatives introduced in Western Scotland by Mackie and colleagues. Their data 
showed a remarkable increase in the proportion of thin melanomas and a decrease of thick 
melanomas, diagnosed after the programmes were introduced.356 
On the other hand, there is one major problem with melanoma screening. It is that 
the clinical signs and symptoms, which are regarded as characteristics of early melanoma, are 
not very specific. An important general population survey in Australia has shown that in the 
previous 12 months they had noted one or more changes in naevi, which would be regarded as 
suspicious; about one third of them sought medical advice. Therefore a very high proportion 
of the normal population will probably require further assessment. This has considerable 
implications in terms of health care costs and unwanted effects.355 
The ideal to measure the benefits of screening would be to conduct a large scale 
randomised study design to evaluate skin cancer screening, as it is for any other type of cancer 
screening.357 However there are consistent logistic problems with such trials, involving 
hundreds of thousands of people, millions of dollars, and years of follow-up.323;358 
Several studies demonstrate the usefulness of periodic surveillance, combined with 
total cutaneous photography, of individuals at high-risk for developing cutaneous 
melanoma.351;359 At the moment secondary prevention is based to early detection, diagnosis 
and treatment of individuals at greater risk by virtue of a persistently changed or changing 
mole, a previous cutaneous melanoma, and/or a family history of cutaneous melanoma.  
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Investigation of the literature on all main risk factors for melanoma, through this 
meta-analysis, provides further insight into the mechanisms underlying the disease, interesting 
considerations about how best to approach the conduct of future epidemiological studies, and 
last, but not least, pooled estimates to identify all individuals at high risk. 
 
6.4 Future studies 
This research showed that greater attention to heterogeneity and improved reporting of the 
variance among study results help investigators to understand exposure disease relationships. 
Country of the study, type of study design, confounders considered in the analysis are some of 
the factors that influence significantly the estimates. New approaches, such as reliable and 
robust Bayesian meta-analyses, in which evidence from observational studies may be 
incorporated either within a prior distribution or modelled explicitly using a hierarchical 
modelling framework, need to be implemented with less complex computational techniques to 
deal with all these factors that induce heterogeneity. 
In the meta-analysis on breast cancer and diet I could not evaluate influence of diet at 
young ages because there was not much information on that. In fact recall of childhood and 
adolescent diet is poor because hypotheses relating early diet to breast cancer risk decades 
later is difficult to test unless novel sources of data or methods for measuring diet in the 
distant past will improve. However the possibility that aspects of diet during childhood or 
adolescent may be associated with the risk of breast cancer decades later would be warranted.  
 Because of the extensive epidemiological studies of the last decades, we know many 
of the most important melanoma risk factors and exposures. We have much less 
understanding of the interactions of host risk factors and exposures: skin/hair 
pigmentation/sun sensitivity with differing sun and UV exposures; common nevi and 
dysplastic nevi with types or extent of sun and UV exposure, etc. This meta-analysis seems to 
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suggest a possible interaction among host factors but not between naevus density and sun 
exposure, for example. However relationship among nevi, sun exposure and phenotypic 
factors is certainly quite complex. Actually individuals who are prone to burning (red hair, 
dense freckling, very sensitive skin) may avoid sun exposure and develop fewer naevi than 
might be expected. Moreover it was suggested that the relation between sun exposure and 
melanocytic naevi might have parabolic dose-response curve. Anyhow the number of studies 
in these meta-analyses was too lo to produce reliable results on the interactions among various 
risk factors and until we complete large studies to address these questions, we will not fully 
understand the mechanisms of melanoma development.  
In line with previous reports361, this work suggests that genetic susceptibility and sun 
exposure are likely to act multiplicatively on melanoma risk. A recent area of research 
integrates the rapidly advanced knowledge of the genetic factors influencing melanoma with 
the epidemiological evidence. Furthers efforts should be done in this directions to lead to a 
much fuller understanding of the biology underlying melanoma.  
Ultraviolet light has been conclusively shown in a large number of epidemiological 
studies to be a factor in the increase in incidence. However, in analytic studies, individual sun 
exposure has been particularly difficult to quantify and neither is easily documented. As was 
seen in heterogeneity analysis, sun-related behaviour is complex and its reporting is subject to 
multiple biases and misclassification. There is strong need for future studies to use 
standardized exposure measures and methodology technique to obtained more information 
also about dose-response curves. Epidemiological studies should incorporate biologic samples 
to assess host/environmental interactions with variables less subject to misclassification and 
differential recall bias. Opportunities to study population groups with well-defined exposures 
could be very valuable, as they have been with other carcinogenic agents. In fact in 
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heterogeneity analysis country was one of the factor that significantly explained between 
study variations.  
Looking at sunburns in childhood and adulthood I did not find a significantly effect 
of age, however definitions were very heterogeneous. Furthermore a recent systematic 
review362 on ecological studies evaluating migrant population suggest that sunlight in 
childhood may be a strong determinant of melanoma risk. Therefore a more detailed 
evaluation of age-specific effect of sun exposure is suggested.  
Although it is known that increased exposure to sun is a risk factor for melanoma, 
researchers are not sure which wavelength of ultraviolet radiation—UVA, UVB, or both—
causes the cancer. Many people think that sunscreen could be effective in preventing sunburn 
and therefore melanoma. For this project sunscreen was not analysed because there is not a 
considerable number of studies on its effect and they are highly contradictory. A prospective 
study to determine sunscreen efficacy needs to be undertaken to overcome all the problems of 
previous studies.363 
It may be possible now to consider both primary and secondary prevention strategies, 
since we have identified the major environmental factor for melanoma, and many host factors 
conferring markedly increased risk. A variety of primary and secondary preventive strategies 
for controlling the problem of sun exposure have been attempted. Evaluation studies looking 
at the extend to which such programs produce behavioral changes would still be useful.  
Future studies should also focus on developing effective strategies for determining 
the effectiveness of skin cancer screening. Refining definitions of specific high-risk groups 
would greatly improve secondary prevention. Selective screening of a high-risk group would 
be less costly than population screening, as fewer subjects would have to be seen, but the rate 
of positive results would be higher with a more favourable cost-effectiveness ratio. Future 
studies should focus on developing a screening program that minimizes melanoma mortality 
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while meeting “reasonable” cost-effectiveness constraints. Further analyses should be 
completed on age and gender specific recommendations for melanoma screening, the 
frequency of screens, and the possible impact on screening recommendations of a score build 
based on the pooled estimates to identify high-risk people. Selection of high-risk individuals 
for whom a randomized trial of preventative measures might be undertaken should be 
considered. The feasibility, acceptability and reliability of a target strategy based on 
identifying, advising and possibly screening those at high risk would need to be studied before 
undertaking an appropriate intervention trial to see if such strategy was effective.  
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